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Abstract 
Design and Synthesis of Low Toxicity Biodegradable Ionic Liquids and 
their Applications in Materials Science 
 
Hannah Prydderch 
 
A series of ten ionic liquids (ILs) was synthesised from the renewable resource 
mandelic acid. Low antimicrobial activity was demonstrated towards thirteen bacterial 
and twelve fungi strains, with a general trend of increasing bacterial toxicity in the order 
methyl ester < ethyl ester < butyl ester/amide. IL biodegradability was evaluated using 
the Closed Bottle Test (OECD 301D) and increased in the order of increasing alkyl 
chain length for the ester ILs (methyl < ethyl < butyl). Despite none of the ILs 
presenting as readily biodegradable, a series of biodegradation metabolites has been 
proposed.  
 
A series of twelve 1-methylimidazolium ester ILs was synthesised with bromide, 
bistriflimide (NTf2) and octyl sulfate (OctSO4) anions. Eight ILs suitable for 
plasticisation with poly(L-lactic acid) (PLLA) were melt extruded with PLLA at 10, 20 
and 30 wt% IL. The tensile strength, Young’s modulus and elongation at break of the 
PLLA/IL films were measured. All four NTf2 ILs successfully plasticised PLLA 
(confirmed by depression of the Tg in DSC). Plasticisation was most successful at 
20 wt% NTf2 IL, with the OctSO4 ILs demonstrating poor compatibility with PLLA. 
The effects of plasticisation were retained after 100 days for the NTf2 PLLA/IL films, 
with only minimal ageing observed.  
  
The dielectric properties of seven mandelic acid ILs and three 1-methylimidazolium 
ester ILs were measured using microwave dielectric spectroscopy. An insight into the 
polarity of the ILs was gained by using a cavity perturbation technique to obtain the IL 
dielectric constant, dielectric loss factor and loss tangent. The effect of the IL physical 
state on the dielectric properties was also investigated by taking measurements for three 
ILs above their melting points. These preliminary results allow the IL structures to be 
related to their dielectric properties, enabling the design of ILs with increased polarity.   
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1.0 Literature Review 
 Introduction  1.1
The physical properties that the majority of ionic liquids (ILs) possess make them an 
attractive candidate as a ‘green’ alternative to volatile organic compounds (VOCs) 
widely used in the chemical industry. These properties include, but are not limited to, 
low vapour pressure, low flammability and high thermostability. Despite research 
showing that not all ILs possess these properties,
1,2
 an even bigger factor needs to be 
addressed when evaluating the ‘greenness’ of an IL. These factors are the environmental 
properties of ILs. 
 
Even with care taken to prevent the release of an IL utilised in an industrial setting into 
the environment, the possible outcome that some of the IL will reach the environment 
should be considered. Potential causes for this could be product contamination, release 
via wastewater streams or through solvent disposal. Even small amounts of released IL 
will interact with the environment; therefore, it is highly necessary to study and 
understand how each individual IL will interact with the environment, and the potential 
impact on the ecosystems affected. Thus, for an IL to be classified as a ‘green’ 
alternative to VOCs, environmental factors such as biocompatibility, bioaccumulation, 
toxicity and biodegradability need to be taken into account.
3
 It is also pertinent to 
evaluate the biodegradation pathways that an IL follows during breakdown.
4-7
 
Metabolites generated in the biodegradation process may be more toxic and 
bioaccumulate to a greater extent in the environment than the parent IL.
8
 Thus, an 
assessment of metabolite formation, toxicity and stability is highly recommended.
9-11
  
 
This introduction will focus on the toxicity and biodegradation of ILs by providing an 
overview of the current research in the area of IL toxicity and biodegradability. It is 
important to understand how to design an IL for increased biodegradability and low 
toxicity, and this is discussed from a structure activity perspective. IL toxicity towards 
enzymes has also been reviewed using the acetylcholinesterase (AChE) assay, providing 
an insight into how IL structures influence toxicity towards enzymes.  
 2   
 Ionic Liquids 1.2
Ionic liquids (ILs) are defined as pure compounds that consist of a cation (often organic) 
and an anion, often with a melting point at or below 100 °C.
12
 They are distinct from 
molten salts which have high melting points (e.g. 800 °C for NaCl),
13
 are highly viscous 
and corrosive.
12
 ILs that are liquid at room temperature are often referred to as room 
temperature ionic liquids (RTILs). At the COIL-6 conference in South Korea in 2015, 
Professor Kenneth Seddon proposed that the arbitrary use of 100 °C as a melting point 
cut-off for the definition of an IL was inflexible and constraining and should no longer 
be used as a prerequisite for classification as an IL.
14
 Thus, the terminology of IL is 
used throughout this thesis despite a number of the ILs described possessing melting 
points >100 °C.  
 
An IL typically consists of a bulky organic cation associated with an organic or 
inorganic anion.
15
 The ions are unsymmetrical and thus poorly coordinated, resulting in 
a destabilisation of the crystal lattice and a low melting point liquid (Figure 1.1). In a 
molten salt, such as NaCl, both ions are small and of similar shape so they can tightly 
pack together (Figure 1.1). A large amount of energy is needed to overcome the ionic 
bonding of the lattice and melt the salt; consequently, they have high melting points.  
 
 
 
 
 
 
Figure 1.1 Comparison of the ionic nature of an IL (right) and NaCl (left) at room 
temperature (rt). 
 
ILs are highly solvating, non-flammable, highly thermally stable, of low vapour 
pressure and possess a large liquid range.
16
 The physical properties of an IL can be 
altered by modifying the IL cation or anion. Properties that can be changed include 
melting point, viscosity, solvation ability, refractive index and surface tension. 
Consequently, a myriad of ILs with different properties have been synthesised, with 
applications in many areas such as electrochemistry, synthetic chemistry, engineering 
and analytical chemistry.
17
 The ability to tune an IL to a particular process has led to 
- - - 
- - - 
- - - 
+ + 
+ + 
+ 
+ 
+ 
+ 
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them being described in the literature as ‘designer solvents’. The most commonly 
utilised cations (imidazolium, pyridinium, phosphonium, ammonium and sulfonium) 
and anions (acetate, dicyanamide, bistriflimide, bromide, iodide, hexafluorophosphate, 
tetrafluoroborate, octyl sulfate and methyl sulfate) in ILs are depicted in Figure 1.2.   
 
 
 
Figure 1.2 Most commonly used cations and anions in ILs. 
 
The properties of low vapour pressure and non-flammability of ILs has also made them 
very attractive for use in the area of green chemistry. 
 Green Chemistry 1.3
Green chemistry is used in the evaluation, design and implementation of sustainable and 
environmentally friendly chemical processes. The idea of green chemistry was first 
conceptualised by Trevor Kletz in 1978, who published a pioneering article on the use 
of safer raw materials as replacements for the hazardous chemicals used in chemical 
processes and industrial plants.
18
 His idea to use safer raw materials at lower 
temperatures and pressures, to avoid problems rather than solving them at a later date, is 
a key concept of green chemistry. However, the introduction of the term green 
chemistry only began in the early 1990’s when it was coined by Paul Anastas of the US 
Environmental Protection Agency (EPA).  
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1.3.1 The 12 Principles of Green Chemistry 
Anastas and Warner published a pioneering book on the topic of green chemistry in 
1998 where they introduced the 12 principles of green chemistry.
19
 These principles still 
serve as a guideline for those who practice green chemistry research both in industry 
and academia today. These principles are as follows: 
1. Prevention 
Preventing the formation of waste is better than treating or cleaning up waste. 
2. Atom Economy 
Design synthetic methods to maximise incorporation of all materials used in the 
process into the final product. 
3. Less Hazardous Chemical Syntheses 
Design synthetic methods to utilise and generate substances with little or no toxicity 
to human health and the environment.  
4. Designing Safer Chemicals 
Design chemical products suitable for their desired function whilst minimising 
toxicity. 
5. Safer Solvents and Auxiliaries 
No unnecessary use of auxiliary substances and replace with safer alternatives when 
used. 
6. Design for Energy Efficiency 
The environmental and economic impact of energy used in chemical processes 
should be recognised and minimised. Synthetic methods should be carried out at 
ambient temperature and pressure where possible. 
7. Use of Renewable Feedstocks  
Renewable feedstocks should be used instead of finite resources wherever possible. 
8. Reduce Derivatives 
Minimise or avoid use of unnecessary derivatisation to prevent the use of additional 
reagents and additional generation of waste. 
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9. Catalysis 
Preferentially use catalysts over stoichiometric reagents. 
10. Design for Degradation  
Design chemical products to break down into innocuous, non-persistent degradation 
products at the end of their use. 
11. Real-time analysis for Pollution Prevention 
Develop analytical methodologies to allow for real-time, in-process monitoring and 
control prior to hazardous substance formation. 
12. Inherently Safer Chemistry for Accident Prevention 
Minimise the potential for chemical accidents (spills, explosions, fires) by selecting 
the appropriate substances with the appropriate form. 
1.3.2 Green Chemistry Metrics 
The ‘greenness’ of a chemical process can be evaluated using green chemistry metrics.20 
These metrics allow chemists to directly compare the ‘greenness’ of different processes 
and to determine which is ‘greener’. They also help to identify where a particular 
process needs to be improved to make it ‘greener’. These metrics are quantitative and 
examples include effective mass yield,
21
 environmental factor (E-factor),
22,23
 atom 
economy,
24
 reaction mass efficiency,
25,26
 carbon efficiency
25
 and mass intensity.
25
 
 Toxicity and Biodegradation of ILs27 1.4
Initial publications in the field of ILs focused on their suitability for a wide range of 
applications, and promoted how their esoteric physical properties made them ‘green’ 
alternatives to VOCs. It was not until the early 2000’s that the environmental impact of 
ILs was investigated, with the first toxicity tests being carried out by Jastorff et al. in 
2002.
28
 In this work, the environmental risk potential of ILs was evaluated and 
theoretical toxicity evaluations of the commonly used C4 and C10 [BF4] ILs were made. 
A high ‘uncertainty’ factor was identified in the multidimensional risk analysis carried 
out, due to the lack of information available on the IL decomposition residues, 
bioaccumulation, biodegradation and biological activity (Figure 1.3). This highlighted 
not only the potential overlooked toxicity of the second generation of ILs (vide infra), 
but also the crucial need for the evaluation of IL toxicity and biodegradation. This work 
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was also able to demonstrate the use of quantitative structure–activity relationships 
(QSAR) as a methodology for predicting IL toxicity. 
 
 
 
 
 
 
 
Figure 1.3 5-Dimensional risk comparison of [BMIM][BF4] with acetone. Very high 
risk = 4 and very low risk = 1. R = Release, S = Spatiotemporal Range, B = 
Bioaccumulation, A = Biological activity, U = Uncertainty.
28
 Adapted from Ref. 28 
with permission from the Royal Society of Chemistry. 
 
Since this work, numerous toxicity and biodegradation studies have been carried out on 
the second generation of ILs, highlighting the need for the redesign of ILs for lower 
toxicity and increased biodegradation.
29-33
 It is now also known that the widely 
employed anions [BF4] and [PF6] readily hydrolyse to highly corrosive hydrogen 
fluoride (HF), especially in the presence of water and heat.
31,32
 [PF6] has also been 
shown to additionally release the toxic and corrosive hydrolysis products HPO2F2, 
H2PO3F and POF3.
34,35
 Consequently, there has been speculation that some of the early 
results of [BF4] and [PF6] IL catalysis may have been no more than catalysis by HF 
produced from IL breakdown.
16
 However, the main problem highlighted here is that the 
additional toxic and corrosive hydrolysis products generated from these ILs, which are 
often overlooked, clearly present a barrier to their widespread application in industrial 
processes. 
 
The series of ILs that have found the most applications to date are often referred to as 
the second generation of ILs.
36
 These ILs are oxygen and water stable with weakly 
coordinating anions such as [BF4], [PF6] or halides ([Cl], [Br] and [I]). The most 
common cations found in the second generation of ILs are imidazolium, pyridinium, 
ammonium and phosphonium. These ILs are designed to remain inert and are also the 
most studied and applied in the field of biocatalysts.
37
 Modifications to the structure of 
the second generation of ILs resulted in the production of a third generation of task 
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specific ILs (TSILs). These were designed with an anion or cation that would actively 
take part in chemical reactions. An example is the imidazolium ILs synthesised and 
utilised by Myles et al. that act as Brønsted acidic catalysts in the presence of protic 
additives.
38,39
 
 
However, research into the biodegradability and toxicity of the second generation ILs 
placed uncertainty over their ‘greenness’. Progress has been made towards increasing 
the biodegradability of the second generation of ILs, by introducing functionalities such 
as ester groups and ether linkages into the cation side chain, and by replacing the 
common halogenated anions with the biodegradable low toxicity counterion octyl 
sulfate.
40-42
 IL toxicity has also been reduced by the addition of ether linkages and the 
avoidance of long alkyl chains (> C6).
43
 However, the imidazolium ring has been shown 
to be highly resistant to biodegradation and therefore inappropriate for designing 
biodegradable ILs.
44
 
 
There has been a recent introduction of a fourth generation of ILs, based on more 
biodegradable, readily available, renewable and less toxic cations and/or anions. More 
hydrophobic stable anions prepared from sugars, amino acids, organic acids, and the 
cation choline have thus been employed. However, despite the introduction of these 
types of moieties into ILs, results still show that ILs designed in this way are not always 
readily biodegradable (> 60 % biodegradation over 28 days).
45,46
 It appears that 
incorporating both high biodegradation and low toxicity into an IL is still a challenge 
today and is an area that would clearly benefit from further research. 
 
A class of solvents with similar properties to ILs are the deep eutectic solvents (DES). 
These are mixtures of salts (e.g. choline chloride) and uncharged hydrogen bond donors 
(e.g. urea and glycerol).
47
 They have also been proposed as green alternatives to the 
second and third generations of ILs due to the non-toxic, renewable and biodegradable 
nature of their synthesis materials. They are also likely to be less expensive than 
previous generations of ILs with no purification required after the formation of the 
DES.
48
 Examples of low toxicity readily biodegradable DES have been identified in the 
literature.
49,50
 However, current research suggests that further work is still required to 
assess the full ecotoxicological profile and biodegradability of DES before they can be 
classed as ‘greener’ alternatives to the early generations of ILs.51,52 In addition, a study 
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on the identification of DES biodegradation breakdown products, and an evaluation of 
their toxicity, is currently not available in the literature. 
 
Toxicity and biodegradation tests on ILs are often carried out independently, yet it is 
important not to consider results from these tests as two unrelated datasets.
53
 IL toxicity 
can have a significant influence on the biodegradation test results, as the IL being tested 
may be toxic to the microorganisms necessary for biodegradation.
54,55
 If so, the 
microorganisms will not have the opportunity to biodegrade the IL. A low level of 
biodegradation will be observed in the test, even if the IL has many accessible 
breakdown pathways. To prevent erroneous biodegradation results, IL concentrations 
should not exceed, if possible, levels that are toxic to the microorganisms used in the 
test. Thus, to promote IL breakdown in the environment, the avoidance of high toxicity 
needs to be considered when designing an IL for enhanced biodegradability.  
 
A compound that breaks down too readily will not be useful for a wide range of 
applications with various conditions, such as high temperatures and a wide range of pH 
values. When investigating biological process in IL media, it is critical to establish that 
the IL will not be broken down by the reaction conditions or the enzymes used in the 
process. The resulting degradation products of the IL may hinder the reaction, react in a 
way that damages the process, or contaminate the final product.
56
 The IL would also no 
longer be able to be recycled in the process and additional costs for separation of 
contaminants from the product, purchasing of fresh IL and the disposal of the unusable 
degraded IL, would be incurred as a result.
57
 Thus, although counterintuitive, it is 
possible to design a compound that is potentially ‘too biodegradable’.  
 
The research groups directly related to the synthesis and study of ‘green’ ILs will likely 
have a different design approach to those synthesising task specific ILs, where ‘green’ 
properties of the ILs may be secondary to the IL application. The approach of a green 
chemist would be to design for biodegradation and low toxicity first, and to select an 
appropriate application afterwards. If no suitable application can be found the toxicity 
and biodegradation data can be fed back into the design of the next class of ‘green’ ILs 
(Figure 1.4). This is where one has to think about ‘greenness’ vs application, and which 
is more important and should be considered first during the IL design. Preferably 
fulfilling all three criteria of biodegradable, low toxicity and task specific would lead to 
an improved, potentially ‘ideal’, IL (Figure 1.5). 
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Figure 1.4 Design strategy for a ‘green’ IL. 
Figure 1.5 Properties of an ‘ideal’ IL. 
1.4.1 Toxicity of ILs 
IL toxicity has been studied using bacteria,
58-61
 fungi,
58
 algae,
62-68
 enzymes,
69-71
 and 
multicellular organisms including Daphnia magna,
72
 Danio rerio,
73
 soil invertebrates,
59
 
mammals,
74
 mammalian cells 
59,60,75-77
 and fish cells.
78
 A generalised overview of the 
current data available on the assessment of the second generation ILs (e.g. ILs with 
[BMIM], [MMIM] and [MPY] cations) shows they have toxicity in some cases, equal to 
or even one hundred to ten thousand times higher than conventional organic solvents 
such as benzene, methanol, dimethylformamide or propan-2-ol.
31,62,68,72
 The results are 
dependent on the structure of the IL (cation and anion pair) and the test system selected. 
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The toxicity of ILs is known to be much more affected by the structure of the cation 
than the anion.
77,79
 The cation alkyl chain length has been shown to be very important, 
with the longer alkyl chains (i.e. decyl vs ethyl) resulting in higher toxicity.
79
 This is 
directly related to the longer alkyl chains increasing the hydrophobicity of the IL, and 
thus lipophilicity. The increased lipophilicity increases the likelihood of an interaction 
with the phospholipid bilayers of cell membranes, and membrane protein hydrophobic 
domains. This interaction causes the cell membranes to rupture, leading ultimately to 
cell death.
31
 Polar groups, such as ether groups, introduced on the cation side chain have 
also been shown to reduce the toxicity of ILs.
43,75
 
 
In the following sections individual test systems and areas of IL toxicity are discussed. 
These include aquatic toxicity (1.4.1.1), bacterial and fungal toxicity (1.4.1.2), 
cytotoxicity (1.4.1.3), antimicrobial resistance (1.4.1.4) and acetylcholinesterase toxicity 
(1.4.1.5). 
1.4.1.1 Aquatic Toxicity 
When the environmental effects of ILs were initially considered around 2005 the 
aquatic toxicity of ILs was the first area to be investigated.
67
 This can be rationalised by 
the fact that if ILs were ever accidently released into the environment, it is likely that 
their first point of contact would be with the aquatic ecosystem. The majority of ILs 
have high water solubility and thus they are likely to move rapidly through the 
environment, interacting with a large range of aquatic organisms.  
 
Algae are primary producers of organic matter necessary to sustain the lives of many 
species in the freshwater food chain. They also have short life cycles, so they respond 
quickly to environmental change.
30
 Both these factors have led to the use of algae to 
assess the aquatic toxicity of ILs. In 2005, Latała et al. studied the effect of 
[EMIM][BF4], [BMIM][BF4], [HEXMIM][BF4], and [BZMIM][BF4] ILs on the growth 
inhibition of the green alga Oocystis submarina and the diatom Cyclotella 
meneghiniana from the southern Baltic Sea.
67
 The responses of both species were 
markedly different. O. submarina appeared to acclimatise to the lower IL concentrations 
and recovered their growing ability after ca five days. In contrast, the growth of C. 
meneghiniana was inhibited for the duration of the test at all IL concentrations. 
[BMIM][BF4] and [BZMIM][BF4] were shown to have a lower toxic effect on O. 
submarina at higher water salinity, which is an interesting result as the salinity of the 
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Baltic Sea varies greatly. At higher water salinity the likelihood of the IL cations pairing 
with the chloride ions, instead of the hydroxyl groups (green algae) or silanol groups 
(diatom) in algae cell wall functionalities, increases. This in turn reduces the 
permeability of the IL cations through the algal cell walls. The outcome is that the IL is 
less toxic to the algae.  
 
Since 2005, algae assays have been widely used to evaluate the aquatic toxicity of ILs. 
Further work has been conducted by Latała et al., studying the toxicity of 1-alkyl-3-
methylimidazolium ILs towards planktonic green algae (Chlorella vulgaris and O. 
submarina), diatoms (C. meneghiniana, Skeletonema marinoi and Bacillaria paxillifer), 
and blue-green algae (Geitlerinema amphibium).
64-66
 A pronounced alkyl chain effect 
was observed with all organisms studied and indicated that sensitivity towards ILs 
decreases in the order blue-green algae > diatoms > green algae. The main reason for 
this observed trend is the difference in cell wall structures. Blue-green algae have 
peptidoglycan cell walls, diatoms have silica based cell walls and green algae have 
cellulose based cell walls. [BF4] and [CF3SO3] anions were shown to increase IL 
toxicity due to either HF formation from [BF4] hydrolysis, or increased cell wall 
penetration with highly lipophilic [CF3SO3]. Cell size is also significant in determining 
the level of toxicity with a 10 times difference in cell size leading to a 100 % more 
sensitive reaction to ILs in green algae and diatoms.
65
 1-Alkyl-3-methylimidazolium 
chloride ILs also showed the same previously observed trend of lower toxicity at higher 
water salinities.
64
  
 
Additional studies on algae toxicity all followed the same observed alkyl chain trend of 
increasing IL toxicity with increasing chain length.
59,63,80
 Kulacki and Lamberti also 
stated that the EC50 values they reported suggested that the ILs tested were more, or just 
as toxic to the algae as many of the solvents they are intended to replace.
63
 Cho and 
Pham et al. also showed that imidazolium ILs comprising the anion [SbF6] were the 
most toxic of anions tested and found pyridinium ILs were more toxic than their 
imidazolium counterparts.
62,68
  
 
D. magna are a species of cladoceran freshwater water flea. They are widely used in the 
laboratory environment to examine the toxic effect a compound has on reproduction and 
life expectancy. The first IL toxicity studies on D. magna, undertaken in 2005 by Bernot 
et al., investigated the acute and chronic toxic effects of imidazolium ILs with various 
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anions such as [Cl], [Br], [BF4] and [PF6].
72
 Median lethal toxicity (LC50) values were 
more than an order of magnitude higher than the corresponding sodium salts, showing 
that the IL toxicity was related to the imidazolium cation and not the anion. Toxicity 
was comparable to that of common industrial solvents of the time, such as phenol and 
ammonia; however, they were two to three orders of magnitude more toxic than 
methanol or acetonitrile.
72
 Since this work, numerous studies on the toxicity of ILs 
towards D. magna have been undertaken.
55,81,82
 The overriding conclusion from this 
work is that imidazolium, pyridinium and quaternary ammonium ILs with increasing 
alkyl chain length have an increased toxicity towards D. magna. Again, the nature of the 
anion had a smaller effect on IL toxicity than the cation. Couling et al. used QSAR 
modelling to help identify the specific part of the IL responsible for the toxic effects 
towards D. magna.
82
 It was determined that ILs with longer alkyl residues attached to 
aromatic nitrogen atoms, and a higher number of aromatic nitrogen atoms, had 
increased toxicity. Addition of a methyl group on the aromatic carbons was shown to 
reduce the IL toxicity.  
 
The model vertebrate Zebrafish (Danio rerio) was used by Pretti et al. in 2006 to study 
the toxic effect of ammonium, imidazolium, pyridinium and pyrrolidinium ILs.
73
 The 
imidazolium, pyridinium and pyrrolidinium ILs gave LC50 values > 100 mg L
−1
 and 
were thus regarded as non-highly lethal towards zebrafish. In stark contrast, the 
ammonium ILs AMMOENG
TM
 100 and 130 were much more toxic, with LC50 values 
of 5.9 and 5.2 mg L
−1
 respectively. These LC50 values were remarkably lower than 
those for common organic solvents and tertiary amines. It was thus concluded that ILs 
may have a different effect on fish related to the IL chemical structure. However, it is 
important to note that the ammonium ILs used in the study were AMMOENG
TM
 100, 
110, 112 and 130. These acyclic ammonium salts are used industrially as cationic 
surfactants and contain poly(ethylene glycol) (PEG) and alkyl chains of various lengths 
on the cation.
83
 These PEG and alkyl chains are much longer than the ethyl and butyl 
chains on the imidazolium and pyridinium ILs used in the study. Long alkyl chain 
length has been shown to increase IL toxicity, and this should be taken into account 
when concluding that ammonium ILs were more toxic to fish than the imidazolium and 
pyridinium ILs. 
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1.4.1.2 Bacterial and Fungal Toxicity 
The short generation times of bacteria make them an ideal starting point for toxicity 
studies. Preliminary toxicity studies showed that compounds containing quaternary 
ammonium and pyridinium moieties have clinical inhibitory effects on a variety of 
bacteria and fungi.
30
  
 
Pernak et al. published a paper in 2003 on the anti-microbial properties of 3-
alkoxymethyl-1-methylimidazolium ILs with [Cl], [BF4] and [PF6] anions.
79
 Here they 
showed an increase in alkyl chain length increased the toxicity towards rods, cocci and 
fungi. ILs with 10, 11, 12 and 14 carbon atoms in the alkyl chain were shown to have 
the highest toxicity towards the screened bacteria. Additional work by Pernak et al. 
corroborated this trend with pyridinium salts.
84,85
 Pernak et al. also found that the 
stereochemistry of the anion in lactate ILs affected their toxicity towards bacteria. In 
general the L-lactate ILs gave lower minimum inhibitory concentration (MIC) values 
than the racemates.
84
 
 
In 2005, Docherty and Kulpa examined the antimicrobial effects of various alkyl chain 
length imidazolium and pyridinium ILs, at a concentration of 1000 ppm, on the growth 
of a Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Pseudomonas 
fluorescens and Saccharomyces cerevisiae.
58
 Increased antimicrobial activity was 
observed at increased alkyl chain lengths. Imidazolium and pyridinium bromide ILs 
with hexyl and octyl chains showed considerable antimicrobial activity towards pure 
cultures of the microorganisms, with ILs [OMIM][Br], [OPY][Br] and [HEXMIM][Br] 
having log EC50 values 0.07, 0.25 and 0.81 respectively. 
 
In general, studies on the microbial toxicity of imidazolium ILs have shown that the 
anion has a slight effect on activity.
58,79,81,84
 Whereas for alkyltrihexyl phosphonium 
ILs, both the anion type and cation structure have been shown to have a significant 
effect on the IL microbial toxicity.
85
  
 
The rod-shaped bacterium Vibrio fischeri is often used to measure IL toxicity using the 
acute bioluminescence assay (DIN EN ISO 11348).
59,80,82
 Gathergood et al. also used 
photobacterium phosphoreum for the same purpose.
81
 For both bacteria increasing alkyl 
chain length was again shown to increase the toxicity of the ILs. With V. fischeri the 
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same trend was observed by Docherty et al. for imidazolium and pyridinium IL using 
the Microtox assay.
58
 Ranke et.al showed IL toxicity was mainly due to the cationic 
portion of the IL; however, ILs containing the anion [PF6] were slightly more toxic. At 
concentrations below the ILs inhibitory concentration, slight hormesis was observed.
60
 
Couling et al. found that the same trend of increasing alkyl chain length leading to 
increased IL toxicity was apparent for the toxicity of ILs towards D. magna, with 
quaternary ammonium ILs being the least toxic of those studied.
82
 The same QSAR 
model and trends found for the toxicity of the ILs towards V. fischeri also applied to D. 
magna. 
 
Stolte et al. studied the effect of headgroups and side chains on the aquatic toxicity of 
ILs, and showed that short functionalised side chains reduce the lipophilicity and thus 
toxicity (by six to seven orders of magnitude).
80
 The morpholinium headgroup was 
recommended for use and the 4-dimethylaminopyridinium (DMAP) recommended for 
avoidance due to its effect on the aquatic organisms in the study. It was found that the 
halide anions ([Cl]
 
and [Br]) did not exhibit an intrinsic toxic effect; however, ILs 
containing the [NTf2] anion were more toxic to V. fischeri. This is in contrast to the 
work by Matzke et al. where [NTf2] showed no intrinsic toxicity to V. fischeri.
59
  
 
In 2006, Docherty et al. carried out the Ames test with Salmonella typhimurium strains 
TA98 and TA100 to assess the mutagenicity of ten ILs containing imidazolium, 
pyridinium and quaternary ammonium cations.
86
 The level that the ILs caused mutation 
in the bacteria was measured and related to higher organism carcinogenicity. None of 
the ILs tested fell under the US EPA classification for mutagenicity.
87
 However, 
imidazolium ILs [BMIM][Br] and [OMIM][Br] indicated the potential for mutagenicity 
at high doses (20 mg plate
−1
 for [BMIM][Br] and 1.0 mg plate
−1
 for [OMIM][Br]), 
suggesting that further testing is required before the mutagenic potential of ILs is fully 
understood. Based on this study alone, designing ILs based on pyridinium and 
quaternary ammonium cations instead of imidazolium cations is encouraged to reduce 
the potential for mutagenicity.  
1.4.1.3 Cytotoxicity 
Stolte et al. studied the cytotoxicity of ILs on the IPC-81 rat leukaemia cell line using 
the WST-1 cell viability assay.
75,88
 100 ILs containing various anions, cations and side 
chains were tested, and showed a low cytotoxicity compared to previous ILs tested. 
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Low cytotoxicity was linked to the polar ether, hydroxyl and nitrile functional groups in 
the IL side chains decreasing the IL lipophilicity and consequently cell uptake.
75
 The 
headgroup was shown to have little effect on cytotoxicity with the [NTf2] anion having 
a marked effect on cytotoxicity. The correlation between IL cation lipophilicity and 
cytotoxicity was also confirmed using a HPLC derived lipophilicity parameter. Further 
work by Ranke et al. on 74 ILs with comparatively small anions [Cl], [Br], [BF4] and 
[PF6]
 
demonstrated that the IL side chain has a greater influence on IL cytotoxicity than 
the IL headgroup or the anion, reinforcing the link between increased lipophilicity and 
increased IL cytotoxicity.
77
 
1.4.1.4 Antimicrobial Resistance 
It is important to consider what happens to ILs if they are released into the environment, 
where they are likely to come into contact with a plethora of different microorganisms. 
A major problem that has recently been highlighted in the media is that of antimicrobial 
resistance. This is described by the World Health Organisation (WHO) as an 
increasingly serious threat to global public health that requires action across all 
government sectors and society.
89
 
 
In 2014, Luo et al. investigated the ability of the IL [BMIM][PF6] to promote the 
proliferation and dissemination of antibiotic resistance genes in environmental 
bacteria.
90
 [BMIM][PF6] was found to increase the abundance of sulI (sulfonamide 
resistance gene) in freshwater microcosms by 500 times, when compared to untreated 
controls. The IL also significantly increased the abundance of class I integrons, which 
are particularly adapted to transfer and disseminate antibiotic resistance through 
horizontal gene transfer between different bacterial strains. Cell membranes in bacteria 
are hugely significant in preventing horizontal gene transfer. Results suggested that sulI 
propagation mediated by class I integrons was up to 88 times higher in the presence of 
the IL. This was concluded to be due to the presence of the IL causing an increase in 
cell membrane permeability. Flow cytometry results showed that in the presence of just 
0.5 g L
−1
 of the IL the bacterial cell membrane permeability increased by over 230 % 
when compared to untreated cells.  
 
This work by Luo et al. is the first to report that ILs can facilitate the proliferation of 
antibiotic resistant genes in environmental bacteria, and highlights ILs as a potential 
public health risk. Despite the clear merits of this work, it should be highlighted that 
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only one IL has been evaluated in this study. The IL [BMIM][PF6] is also a second 
generation IL, and various preceding work has already shown this IL has high levels of 
toxicity to certain bacteria and aquatic organisms. This IL also presents a high usage 
and release hazard, especially through the formation of degradation products. Thus a 
wider range of ILs needs to be evaluated, including non-toxic and biodegradable ILs, 
before a clear picture can be built up as to how concerned we should be over the ability 
of ILs to promote antimicrobial resistance.  
1.4.1.5 Acetylcholinesterase Inhibition 
A widely used test to study the molecular toxicity of ILs is the acetylcholinesterase 
(AChE) assay, where the purified enzyme from the electric eel (Electrophorus 
electricus) is most often used. This enzyme has a vital role in the nervous system of 
almost all higher organisms, including humans, as a neurotransmitter. Inhibition of 
AChE has been linked to various conditions such as muscular weakness, fatigue and 
heart disease.
70
  
 
Stock et al., in 2004, were the first to use the AChE assay to evaluate the toxicity of 
ILs.
69
 They give many reasons for their selection of the AChE assay, including that the 
active site of AChE has been widely studied and was the main target during extensive 
research into the design of insecticides based on phosphoric acid esters and 
carbamates.
91-93
 This work would help to facilitate a detailed quantitative structural 
activity relationship (QSAR) study linking IL structural features to enzyme inhibition. 
Previous work on pharmaceuticals showed that AChE inhibition was linked to a 
positively charged nitrogen, an electron deficient aromatic system, and a certain 
lipophilicity, all common features of ILs.
94
 The AChE active site has also been shown 
to be comparable between organisms, thus any QSAR conclusions drawn would be 
applicable to organisms other than those tested. 
69
 
 
Imidazolium, pyridinium and phosphonium ILs were chosen for AChE inhibition assays 
in particular because the chemical structures of the IL cations and acetylcholine 
(substrate for acetylcholinesterase enzyme) are similar.
69
 Both are cationic and the 
positive charge is masked by the lipophilic residues.
95
 Inhibition was shown to be 
dependent on the cationic structure and alkyl side chain with 1-butyl-2-
methylpyridinium, [OMIM] and [DECMIM] ILs all showing pronounced AChE 
inhibition only 3–10 times weaker than a potent inhibiting insecticide Aldicarb.35 ILs 
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with short alkyl chains gave less inhibition correlating to results in V. fischeri and 
leukaemia cells. When considering only AChE inhibition phosphonium < pyridinium < 
imidazolium thus phosphonium IL use is preferred.
69
 The influence of the anion was 
shown to not dominate the toxicity of the IL. 
 
A further study by Arning et al. in 2007 identified a positively charged nitrogen atom, a 
widely delocalised aromatic system and the lipophilicity of the cation alkyl chain as key 
structural elements of IL binding to the AChE active site.
70
 The DMAP, quinolinium 
and pyridinium headgroups were listed as having a very strong inhibitory potential, 
whereas the polar and non-aromatic morpholinium headgroup was only weakly 
inhibiting. The inhibitory potential was shown to be lowered when ether, nitrile or polar 
hydroxyl groups were introduced to the alkyl side chain. A wide range of commonly 
used anions were tested with most showing no inhibitory potential. Only fluorine and 
fluoride containing anions which readily undergo hydrolytic cleavage showed any 
inhibitory potential. The ‘side chain’ effect was observed in this study with increased 
lipophilicity of the cation alkyl side chain increasing enzyme inhibition.  
 
A review in 2007 by Ranke et al. listed the AChE inhibition (log EC50) values for 292 
compounds, including a large number of ILs and closely related salts.
35
 The review 
compiled into one table the largest selection of ILs tested in a single biological test to 
date. The AChE inhibitory concentrations spanned more than three orders of magnitude 
and followed the trends of potent IL AChE inhibitors having a positively charged 
nitrogen centre, a broadly delocalised aromatic ring system and a certain lipophilicity.  
 
The results obtained in the aforementioned AChE inhibition studies were often 
rationalised using QSAR.
69,70
 QSAR analysis aims to relate the chemical structures of 
molecules to their biological activity, thus enabling a prediction about the toxicity of 
novel molecules to be made. QSAR modelling is currently being used more readily in 
the area of predicting IL toxicity, although it is still rare for the prediction of AChE 
inhibition.
96,97 
Recently, work has been published by Das et al. on the in silico 
modelling of ILs towards inhibition of AChE.
98
 In this study the chemical attributes of a 
broad range of 292 ILs were investigated using predictive regression and classification-
based quantitative mathematical models. Topological features and electronic parameters 
of the ILs were considered in the model. The results showed that the main contributors 
to IL toxicity were positively charged nitrogen species, branching, hydrophobicity and 
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hydrophilicity as summarised in Figure 1.6. These conclusions were additionally 
supported by molecular docking studies, carried out for the first time in this area, which 
investigated the structural features responsible for IL binding to the AChE enzyme 
cavity.  
Figure 1.6 Features of ILs for toxicity towards E. electricus derived using discernment, 
regression and docking analysis carried out by Das et al.
98
 Reprinted with permission 
from R. N. Das and K. Roy, Ind. Eng. Chem. Res., 2014, 53, 1020. Copyright 2014 
American Chemical Society. 
 
A paper in 2013 by Hou et al. evaluated a series of cholinium amino acid ILs, 
composed entirely of renewable biomaterials, for acetylcholinesterase inhibition. 
99
 The 
cholinium ILs had much lower toxicity towards AChE with inhibitory potentials 
approximately an order of magnitude lower than [BMIM][BF4]. They also displayed 
low toxicity towards the bacteria tested against. For several ILs lengthening the amino 
acid side chain increased the AChE inhibition. This is due to an increased anion 
lipophilicity resulting in stronger hydrophobic interactions with the lipophilic amino 
acid residues in the AChE enzyme cavity. However, for amino acids with hydrophobic 
aliphatic side chains, increasing the size of the side chain beyond valine (-CH(CH3)2) 
resulted in lower AChE inhibition. This is likely due to steric hindrance preventing the 
amino acid entering the active site of the enzyme. The introduction of hydrophilic 
groups such as hydroxyl, carboxyl and amino into the amino acid generally decreased 
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the IL AChE inhibition. Aromatic systems introduced into the cation side chains also 
led to greater AChE inhibition. 
1.4.2 Biodegradation of ILs 
Biodegradation is classified as the breakdown of a compound by microorganisms via 
enzymatic processes. This breakdown pathway is preferred over chemical degradation, 
especially if the release of the compound into the environment is a possibility. The 
ultimate biodegradation of a compound (total breakdown of the test compound by 
microorganisms) can be studied by several methods. The most widely used today are 
those carried out following OECD Guidelines for chemical testing and include the 
dissolved oxygen content (DOC) die-away test (OECD 301 A),
100
 the CO2 
evolution/modified Sturm test (OECD 301 B),
100
 the closed bottle test (OECD 301 
D),
100
 the manometric respirometry test (OECD 301 F),
100
 and the CO2 headspace test 
(OECD 310/ISO 14593).
101,102
  
 
There are many classifications for evaluating the level of biodegradation of a 
compound. The term readily biodegradable is most often used when evaluating the 
ultimate biodegradation of an IL. If an IL passes a specified level of degradation in a 
certain amount of time, as determined by the particular ultimate biodegradation test 
used, the IL can be classed as readily biodegradable. For the OECD tests 301 A, B, D 
and F a removal of at least 70 % dissolved organic carbon or a production of 60 % 
theoretical oxygen demand/theoretical carbon dioxide, during the 28 day test period, 
classifies a compound as readily biodegradable.
100
 There is also a 10-day window for 
biodegradation following attainment of 10 % biodegradation, in which the compound 
must biodegrade to the specified level to be classified as readily biodegradable. For the 
CO2 headspace test (OECD 310) production of > 60 % theoretical inorganic carbon 
within the 10-day window demonstrates that the test substance is readily biodegradable 
under aerobic conditions.
101
  
 
The biodegradation of ILs was first reviewed by Coleman and Gathergood
7
 in 2010 and 
subsequently by Stolte et al.
27 
in 2011. Most recently the biodegradation of ILs has been 
critically reviewed by Jordan and Gathergood in 2015.
33
 All three reviews provide a 
detailed explanation of IL biodegradation assays, and the links found between IL 
structure and biodegradation are discussed. In this section, an overview as to how to 
 20   
best design a biodegradable IL, based on the research contained in the reviews, will be 
presented. Recent examples of interest in the literature will be highlighted.   
1.4.2.1 Designing for Biodegradation 
Gathergood and Scammells were the first to study the biodegradation of ILs in 2002.
103
 
They introduced functional groups susceptible to enzymatic hydrolysis to increase IL 
biodegradation. Incorporating ester groups into the IL side chain significantly improved 
IL biodegradation; however, ILs with additional amide groups were poorly 
biodegradable.
40
 Further work by Gathergood et al. focused on the effect of the anion on 
IL biodegradation, leading to a series of results where imidazolium ester ILs combined 
with octyl sulfate anions (first used in ILs by Wasserscheid et al.)
42
 showed high levels 
of biodegradation.
81
 Readily biodegradable ILs of this type were identified using the 
CO2 headspace test.
41
 ILs prepared from pyridine or nicotinic acid with an ester side 
chain moiety by Harjani et al. in 2009 also showed high levels of biodegradation in the 
CO2 headspace test and were classed as readily biodegradable.
104
 In 2009 Morrissey et 
al. incorporated ether and poly ether side chains into imidazolium ester ILs.
43
 Six of the 
ILs were classed as readily biodegradable by the CO2 headspace test, all containing the 
octyl sulfate anion, with amide ILs again shown to be less biodegradable than ester ILs. 
The introduction of ether and poly ether side chains was also shown to reduce IL 
bacterial toxicity compared to long alkyl chain derivatives.  
 
Further research in the area of biodegradable ILs led to investigating the biodegradation 
pathways of ILs and the resulting metabolites.
7
 It is of paramount importance to identify 
the resultant metabolites of IL biodegradation, especially if a compound is not 
ultimately biodegradable. HPLC-MS is widely utilised by research groups to determine 
the structure of metabolites. It is vital to know which metabolites are recalcitrant, so 
further generations of ILs can be designed which only form biodegradable metabolites 
during biodegradation. Analysis of the toxicity of metabolites is also recommended. A 
concern is that metabolites, especially persistent metabolites, may be more toxic than 
the IL.  
 
Recent work on the biodegradation of ILs has included the evaluation of cholinium 
amino acid ILs based on renewable resources.
99
 The choline cation was paired with 18 
different amino acids as anions and each IL was evaluated for aerobic biodegradability 
via the closed bottle and CO2 headspace test. The ILs were compared to choline acetate 
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and the reference sodium benzoate. Biodegradability was > 60 % after 28 days for all 
ILs in both tests, so all can be classed as readily biodegradable. The high level of 
biodegradation for the cholinium amino acid ILs was attributed to the cholinium cation, 
and the presence of the carboxyl and primary amino groups in the anion. The addition 
of branched side chains decreased the levels of biodegradation, and the addition of 
hydroxyl groups increased IL biodegradation. The ILs with carboxylic acid and primary 
amide groups gave very high levels of biodegradability (> 86 %). Particularly 
interesting to note from this work is that previous problems with designing ILs for both 
low toxicity and biodegradation were not present in this study. With relatively few 
exceptions, the cholinium amino acid ILs with lower toxicity had a higher level of 
biodegradability. 
 
The toxicity of an IL can have an effect on biodegradation test results. Recent work by 
Markiewicz et al. showed this to be the case for ILs with highly hydrophobic cations 
and anions.
54
 It was recommended that for such ILs lower than normal IL test 
concentrations should be used to avoid false negative biodegradation results. This work 
also showed that the type of inoculum used in the biodegradation test had a strong 
influence on the test result. However, when considering toxicity, no significant 
differences in sensitivity/tolerance of the activated sludge could be determined.  
 
Neumann et al. recently published a paper on the biodegradability of 27 pyrrolidinium, 
morpholinium, piperidinium, imidazolium and pyridinium IL cations under aerobic 
conditions.
44
 The ILs contained different alkyl chains and halide counterions and were 
assessed for ultimate biodegradability using the manometric respirometry test (OECD 
301 F). ILs classed as readily biodegradable were assessed for full mineralisation 
through BOD measurements. For all five headgroups ILs that were readily or inherently 
(20–70 %) biodegradable were identified, with biodegradation being solely attributed to 
the cation. The headgroup influenced the biodegradation level with pyrrolidinium and 
pyridinium cations having higher levels of biodegradation than piperidinium and 
morpholinium cations. The imidazolium cation was classified as the least biodegradable 
headgroup, and as in previous work presented as recalcitrant. Side chain type also 
influenced biodegradation levels with hydroxyl substitution and longer chain length 
both increasing biodegradation. This work also corroborated previous work stating that 
the level of biodegradation was dependent on the inoculum used and the conditions of 
the test.  
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When analysing the structural attributes of an IL that influence biodegradability, 
increased biodegradability has been observed in pyridinium, imidazolium and DMAP 
ILs with elongated alkyl side chains.
7
 However, this design strategy is directly opposed 
to creating a low toxicity IL, where long alkyl side chains have been shown to increase 
IL toxicity. It has also been shown that introducing ester groups into the IL side chains 
can increase IL biodegradation.  
 
ILs with pyridinium headgroups generally have a higher degree of biodegradation than 
imidazolium and DMAP ILs. The literature reports many examples of readily 
biodegradable pyridinium ILs, even when linked to short alkyl chains and when tested 
under stringent readily biodegradable analysis conditions. For imidazolium ILs, only the 
alkyl side chain has been shown to degrade under the same readily biodegradable test 
conditions, with the imidazolium core remaining resistant to biodegradation. However, 
the use of industrial inocula has indicated that degradation of the imidazolium core is 
possible under certain conditions.
7
  
 
Anions that have been used to increase the biodegradation of ILs include alkyl sulfates 
(such as methyl sulfate or octyl sulfate), linear alkyl sulfonates (such as methyl 
sulfonate), linear alkylbenzyl sulfonates (such as p-toluenesulfonate) and carboxylates 
(such as acetate or lactate). These anions are also recommended for use when designing 
low toxicity ILs. Fluorine containing anions (such as [NTf2] and [(C2F5)3PF3)]) should 
be avoided as they are likely to be recalcitrant in the environment, and accumulate in the 
tissues of living organisms due to their high hydrophobicity. 
 
Modelling and predicting the biodegradation of ILs is important. It can be costly and 
time consuming to substitute an IL at a late stage of project. This would be advisable if 
the IL was determined to be unsuitable for use due to unacceptably high toxicity and 
poor biodegradation. Thus, it would be a major benefit to have QSAR models that were 
used widely and highly reliable for the prediction of an ILs biodegradation. 
Unfortunately, we are not there yet and a review from 2012 by Rücker and Kümmerer 
details some of the reasons why.
105
 A particular problem highlighted was the slow 
progress of QSAR model development due to the poor reproducibility of experimental 
data. However, a large part of this is unavoidable due to the variation in bacterial 
populations. Also noted was the dearth of high quality experimental data which often 
remains confidential in industry, and the need for it to be made publicly available. The 
 23   
conclusion was that models need to be published in detail, including all the data a model 
is built on and any corresponding software, to facilitate the wider use and enhancement 
of such models for predicting biodegradation.  
 Conclusion  1.5
It can be concluded from reviewing the literature that there is a long way to go before 
the design of low toxicity and biodegradable ILs is a priority for researchers 
synthesising and using ILs for specific applications. Certain features have been 
identified with the potential to increase IL toxicity, such as long lipophilic alkyl chains 
on the cation, positively charged nitrogen atoms and a widely delocalised aromatic 
system, and would best be avoided when designing ILs for low toxicity. The IL cation 
has been found to have a more marked effect on toxicity than the anion, with 
phosphonium, ammonium and morpholinium in many cases preferred over 
imidazolium, pyridinium and DMAP cations. The stereochemistry of the cation has also 
been noted to affect IL toxicity. Anions containing fluorine atoms, particularly those 
prone to hydrolysis such as [BF4] and [PF6], are also best avoided when designing low 
toxicity ILs, and also for biodegradability. The introduction of ether, hydroxyl and 
nitrile groups to alkyl side chains have also been shown to be promising in reducing IL 
toxicity.  
 
Increasing the alkyl chain lengths in IL cations has been shown to increase IL 
biodegradability, but also to increase IL toxicity. This increase in toxicity was reduced 
by the introduction of ether groups to the alkyl chains. ILs with hydroxyl groups and 
hydrolysable ester groups in the alkyl chains showed higher levels of biodegradability. 
Branching of alkyl chains, amides moieties and imidazolium headgroups were all 
shown to reduce IL biodegradability. The use of alkyl sulfate and alkyl sulfonate groups 
has been employed successfully to increase the overall biodegradation of ILs. ILs with 
pyrrolidinium, pyridinium and nicotinic acid headgroups were often more 
biodegradable than those containing imidazolium and morpholinium headgroups.  
 
Each IL will have a new distinct environmental profile. With numerous cation and 
anion pairs available, it is not possible to evaluate the toxicity and biodegradation of 
each and every IL before its use. Thus the use of QSAR models for the prediction of IL 
toxicity for future generations of ILs is recommended, and they have so far proved to be 
very promising in predicting the toxicity of various IL classes. However, as previously 
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mentioned, the use of QSAR for predicting IL biodegradation is an area that needs 
further work if the future generations of ILs can be assessed in this way. The 
implementation of a highly applicable QSAR model is most likely being held back by 
the fact that biodegradation assays are highly dependent on the type of inoculum used 
and the test conditions employed.   
 
Incorporating functional groups known to promote biodegradation into IL and pairing 
cations with biodegradable anions can yield ILs which are classed as readily 
biodegradable. However, uncertainty exists about whether these readily biodegradable 
ILs are ultimately biodegradable ILs. If the breakdown products of the parent IL are not 
biodegradable they will persist in the environment unable to further biodegrade. Thus, 
we should be using the information gathered from the studies discussed herein to help 
design ultimately biodegradable IL from the ground up. In this way, we can prevent the 
build-up of recalcitrant IL components in the environment should their release ever 
occur.  
 
It is envisaged that by carrying out IL toxicity and biodegradation analysis in tandem 
with performance analysis, we can promote the use of ‘greener’ IL alternatives. The 
appeal of ILs to industry has often been in their ability to solve complex problems due 
to their multifaceted properties, with the ‘greenness’ of the ILs often considered to a 
lesser extent. However, if given the choice of two ILs with identical performance 
capabilities but different toxicological profiles, the ‘greener’ IL would likely be chosen. 
Thus, by collecting IL toxicity and biodegradation data alongside performance data, the 
use of green ILs in industry may indeed become a reality. We need to be sensitive to 
industry requirements whilst still promoting the Gathergood group's philosophy that the 
‘greenest’ possible solution to these problems should be targeted.  
 Thesis Aims and Objectives 1.6
The first aim of this thesis (chapter 2) was targeted towards the synthesis of a new class 
of low toxicity readily biodegradable ILs, utilising the design strategy discussed in the 
preceding sections. This body of work builds on a previous study undertaken in the 
Gathergood group where a series of low toxicity mandelic acid ILs were synthesised.
106
 
There was a significant opportunity to expand on this work by synthesising a new series 
of mandelic acid IL directly from the renewable resource in a shorter and more efficient 
synthesis. In addition, by carrying out toxicity screening under identical conditions to 
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the previously published work a direct comparison of IL toxicity between the two series 
would be possible. An insight into the effect of the new IL structures on IL toxicity 
would be gained. This work also expands on the previous study by aiming to provide an 
evaluation of the biodegradability of the newly synthesised ILs. 
 
As discussed in the introduction to this thesis, it is highly important to facilitate the 
introduction of ‘green’ ILs into industry. If ILs with performance capabilities 
comparable to the current state of the art can be identified, the goal of introducing green 
ILs into industry could indeed become a reality. One area where ‘green’ ILs could be 
commercially applied is as replacements to the current chemicals used as plasticisers. 
Plasticisers are often required for a variety of materials, most notably plastics, where 
they are introduced to increase material ductility and softness
107
 and in turn widen the 
applicability of the material. Currently the most highly used phthalate plasticisers are 
coming under increasingly stringent regulation (i.e. REACH)
108
 due to concerns about 
their toxicity,
109-111
 thus replacing them with more environmentally friendly alternatives 
is highly industrially relevant. In this thesis (chapter 3) the use of a series of 1-
methylimidazolium ester ILs as plasticisers for poly(L-lactic acid) (PLLA) is proposed. 
These ILs have been previously evaluated for their toxicity and biodegradability, with 
low toxicity readily biodegradable examples identified.
43
 A significant aim of this work 
was to utilise the ‘green’ ILs as PLLA plasticisers to overcome a number of the 
limitations of current PLLA plasticisers such as low thermal stability, poor 
biocompatibility, plasticiser leaching and the requirement for increased ductility and 
material performance.
112
 Preventing the physical aging of PLLA through IL 
plasticisation was also an important goal (see chapter 3, section 3.1.5). In this chapter 
the mechanical properties of the IL plasticised PLLA films were evaluated along with a 
thermal analysis study to investigate both plasticiser efficiency and the thermal stability 
of the materials. This work was designed as a proof of concept study where a number of 
prototype materials were synthesised. It is envisaged that this work will be further 
progressed in the future by utilising functionalised and task specific ILs as plasticisers, 
with the aim of creating plasticised materials targeted to specific applications.  
 
The importance of evaluating the ‘greenness’ of ILs alongside performance analysis 
was previously discussed in section 1.5. In chapter 4 of this thesis the dielectric 
properties of a number of the mandelic acid and 1-methylimidazolium ester ILs, 
designed for low toxicity and high biodegradability, were evaluated with the aim of 
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facilitating the utilisation of these ILs in an industrial setting. Highly polar materials can 
be heated by microwaves based on their dielectric constants.
113
 Thus, evaluating the 
dielectric constant of ILs provides an insight into their polarity and their applicability as 
solvents and as electrolytes,
114
 where increased polarity is a desirable feature. In this 
work the dielectric constants of the ILs were evaluated using microwave dielectric 
spectroscopy (see chapter 4). It was desired that this study will help to facilitate the 
utilisation of ‘green’ ILs with microwaves in industry, so reactions with safer solvents 
(replacement of VOCs with ‘green’ ILs) and increased energy efficiency (shorter 
reaction times, and lower temperatures) can be employed, fulfilling the 5
th 
and 6
th
 
principles of green chemistry respectively. It is expected that the ILs studied in this 
work will possess a wide range of dielectric constants, due to the impact of the differing 
nature of the cations and anions and physical state of the ILs.
115
 It is also widely known 
that dielectric constants are affected by both frequency and temperature;
116
 thus, it was 
desired to study both the impact of temperature and frequency on the dielectric 
properties of the ILs.  
 
The work in this thesis aims to fulfil the 4
th
, 7
th
 and 10
th
 principles of green chemistry 
(outlined in section 1.3.1); designing safer chemicals, the use of renewable feedstocks 
and designing for degradation (respectively). The use of renewable feedstocks is 
addressed by the synthesis of a novel series of ILs directly from the renewable resource 
mandelic acid. The IL backbone of mandelic acid was chosen with the aim of increasing 
IL degradation (see chapter 2, section 2.1), without significantly increasing IL toxicity 
compared to the previous class of mandelic acid ILs. The overarching theme of 
designing low toxicity biodegradable ILs also directly addresses the 4
th
 principle of 
green chemistry (designing safer chemicals). The ILs utilised in chapter 3 for the 
plasticisation of PLLA were also chosen because they were originally designed for low 
toxicity and high biodegradability, again meeting the 4
th
 green chemistry principle of 
designing safer chemicals. 
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2.0 Mandelic Acid ILs – Synthesis, Toxicity and Biodegradation 
 Introduction 2.1
The necessity to use renewable feedstocks to design chemicals for use in today’s 
society, and to promote low toxicity and high biodegradation in chemical design, was 
discussed in depth in the literature review in chapter 1. This section of work is intended 
to outline and discuss the synthesis of ILs from the renewable feedstock mandelic acid 
(1) (Figure 2.1). The ILs were designed to optimise biodegradation properties and to 
exhibit low antimicrobial and antifungal activity.  
 
 
Figure 2.1 Renewable resource mandelic acid (1). 
 
Mandelic acid is an aromatic α-hydroxy acid that is found naturally in small quantities 
in plant tissues such as wheat leaves and grapes.
1
 A wide range of organisms (e.g. 
Penicillium chrysogenum
2
 and phytoplankton
3
) can convert the naturally occurring 
compounds L-phenylalanine and phenyl acetic acid into mandelic acid.
1
 Mandelic acid 
can be obtained by heating the glycoside amygdalin with concentrated hydrochloric 
acid.
4
 Amygdalin can be isolated from the seeds of the bitter almond tree
5,6
 and is also 
found in apricots
6,7
 and peach pits.
1
 In industry mandelic acid is made from the acid or 
enzyme catalysed hydrolysis of mandelonitrile.
8
 Optically pure (R)- and (S)-mandelic 
acid has also been produced from the renewable feedstock glucose using a genetically 
modified strain of E. Coli.
9
  
 
Two routes that mandelic acid can enter the environment are through excretion in the 
urine, where it is detected due to its use to treat urinary tract infections,
10
 and as a key 
metabolite of the widely used polymer precursor styrene, which is known to enter the 
bodies of plastic industry workers through inhalation.
11,12
 Despite its release into the 
environment, there have been no reports of its concentration in soil.
1
 This, coupled with 
the fact that numerous metabolic breakdown pathways of mandelic acid by 
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microorganisms have been described over the years,
1,13
 suggests that it is rapidly 
metabolised in the environment.
1
 
 
The most widely accepted degradation pathway of mandelic acid (1) is via 
benzoylformic acid (2) and benzaldehyde (3) to benzoic acid (4) (Scheme 2.1).
14
 Further 
degradation occurs by bacteria (e.g. Pseudomonas putida)
15
 to catechol (5), which is 
further metabolised via the catechol branch of the β-ketoadipate pathway.16 
Alternatively, degradation of (4) occurs by fungi (e.g. Aspergillus niger)
17 
to 4-
hydroxybenzoic acid (6) and 3,4-dihydroxybenzoic acid (7), which is further 
metabolised via the protocatechuate branch of the β-ketoadipate pathway.16  
 
 
Scheme 2.1 Microbial metabolic pathway for the degradation of mandelic acid (1). 
Enzymes: a) mandelate dehydrogenase; b) phenylglyoxylate decarboxylase; c) 
benzaldehyde dehydrogenase; d) benzoate oxidase; e) benzoate 4-hydroxylase; f) 4-
hydroxybenzoate 3-hydroxylase. The β-ketoadipate pathway: g) catechol branch; h) 
protocatechuate branch. 
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A series of ILs based on mandelic acid (8–15) (Figure 2.2) was previously described in 
the literature and evaluated for their bacterial and algal toxicity.
18
 The majority of the 
ILs were derived from 3,4-methylenedioxymandelic acid (8–11 and 13–15), with the 
exception of IL 12 which was derived from 3,4-dimethoxymandelic acid. IL 12 was 
included in this study as it was envisaged that the group would be more stable to a wider 
set of conditions (less susceptible to nucleophilic attack), thus leading to a greater scope 
of applications. All the ILs (8–15) incorporated a high oxygen content (e.g. ether, 
phenol and catechol groups are present), and had low toxicity to the bacterial (e.g. IL 9, 
IC50 = 100–200 mM against P. putida) and algae (e.g. IL 9, EC50 = 1670 µM against C. 
vulgaris) strains they were screened against.  
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Figure 2.2 Previously published mandelic acid derived ILs from the Gathergood group 
(8–15).18  
 
The low antimicrobial activity of the previous class of compounds (8–15) was 
postulated to be due to the aromatic ring of the IL backbone, in contrast to a linear alkyl 
chain, and also the oxygen atoms present on the aromatic ring. However, the importance 
of the aromatic ring oxygen atoms towards the resultant low toxicity was not established 
in the previous work. To evaluate the impact of the aromatic ring oxygen atoms on IL 
toxicity, a target series of ten mandelic acid ILs (16–25) (Figure 2.3) was proposed. 
These ILs were designed to include and exclude specific structural motifs to allow for 
the investigation of their effect on IL toxicity and biodegradation. These structural 
features included: 
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- Three alkyl chain lengths – butyl, ethyl and methyl 
- Phenyl ring – C6H5 
- Ester or amide functional groups 
- Halide anion – bromide 
- Four N-heterocyclic cation headgroups – 1-methylimidazolium, pyridinium, 3-
methoxypyridinium and 3-(ethoxycarbonyl)pyridinium 
 
Figure 2.3 Target mandelate and mandelamide ILs (16–25). 
 
The toxicity of the new series of ILs (16–25) was anticipated to increase on removal of 
the aromatic ring oxygen atoms. However, as ILs (8–15) from the previous study had 
very low antimicrobial activity,
19
 synthesis and evaluation of this new class of ILs was 
considered worthwhile. The previous ILs (8–15) were synthesised from mandelic acid 
derivatives, with an additional synthetic step required to make the derivative.
18
 Thus, 
the synthesis of the ILs described herein satisfies the 8
th
 principle of green chemistry by 
reducing the number of derivatives in the synthesis from the previously published 
work.
18
 The new target series of ILs (16–25) were designed with a synthesis route 
directly from mandelic acid; therefore, they have a shorter synthesis directly from the 
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renewable resource. This satisfies the 3
rd
 principle of green chemistry where a less 
hazardous chemical synthesis to the previous published work was utilised.
18
 This work 
also goes further than the previously published work by providing a biodegradation 
evaluation of the newly synthesised ILs. Overall, this section of work aims to satisfy the 
4
th
, 7
th
 and 10
th
 principles of green chemistry (outlined in section 1.3.1); designing safer 
chemicals, the use of renewable feedstocks and designing for degradation (respectively). 
 Synthesis 2.2
The ten target mandelic acid ILs (16–25) (Figure 2.3) were all synthesised from the 
starting material (R,S)-mandelic acid. Although both the (R)- and (S)-isomers are known 
to occur in nature,
14
 the racemate was selected as the starting material due to the 
expected loss of defined stereochemistry during the proposed synthesis. The synthesis 
of the ILs consisted of three parts (Scheme 2.2 and 2.3): 
 
1. Esterification or amidation of mandelic acid 
2. Halogenation of the α-position of the ester/amide with thionyl bromide 
3. Nucleophilic substitution reaction of the α-halo ester with aromatic N-heterocycle 
 
Full procedural detail for the preparation of the mandelic acid ILs is provided in the 
experimental section of this work (chapter 6, section 6.2). 
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Scheme 2.2 General synthesis of mandelate ILs (16–23) with percentage yields. 
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Scheme 2.3 General synthesis of mandelamide ILs (24 and 25) with percentage yields. 
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2.2.1 Synthesis of Mandelic Acid Esters 
Esterification of mandelic acid (1) was carried out by the well-known Fischer-Speier 
method
20
 to produce the methyl (26), ethyl (27) and butyl (28) mandelic acid esters 
(Figure 2.4). 
 
 
Figure 2.4 Percentage yields for mandelic acid methyl (26), ethyl (27) and butyl (28) 
esters synthesised from mandelic acid (1). 
 
The esterification of mandelic acid was carried out with thionyl chloride (SOCl2) in the 
solvent alcohol of the required alkyl chain length. The SOCl2 reacts with the alcohol 
releasing 2 eq. of HCl for every 1 eq. of SOCl2, which promotes the reaction (Scheme 
2.4). Mandelic acid was dissolved in an excess of alcohol and SOCl2 (0.5 eq.) was 
added dropwise at 0 °C. The reaction was stirred at rt for 4 h and reaction completion 
was confirmed by TLC. After reaction work-up no further purification was required to 
give esters 26–28 in excellent yields (92–97 %) (Figure 2.4).  
 
 
Scheme 2.4 Generation of 2 eq. of HCl in situ from the reaction of thionyl chloride with 
alcohol. 
 
(93 %) 
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In the 
1
H NMR of the mandelic acid methyl ester (26) in CDCl3 the proton at the α-
position to the carbonyl group (H4) forms a doublet at 5.18 ppm by coupling to the 
alcohol proton (OH) with J = 5.1 Hz (Figure 2.6). The alcohol proton on the mandelic 
acid ester (H5) thus gives a doublet in the 
1
H NMR at 3.44 ppm, when the spectra is 
highly resolved, due to coupling to the proton on the α-position with J = 5.1 Hz (Figure 
2.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 
1
H NMR of mandelic acid methyl ester (26) in CDCl3 showing the doublets 
for proton H4 at the stereogenic centre (left) and the alcohol proton H5 (right). 
 
In the 
1
H NMR of the mandelic acid ethyl ester (27) in CDCl3 the two protons of the 
CH2 group attached to the ester oxygen (H6) are diastereotopic and thus couple. They 
also couple to the adjacent CH3 protons (H7). This forms two separate doublets of 
quartets at 4.27 and 4.17 ppm, each with eight peaks and coupling constants J = 10.8 
and 7.1 Hz (Figure 2.6).  
 
 
 
 
 
 
 
 
4 5  
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Figure 2.6 
1
H NMR of mandelic acid ethyl ester (27) in CDCl3 showing the two 
doublets of quartets of the H6 protons (H6’ and H6”). 
2.2.2 Synthesis of Mandelic Acid Amides 
Two procedures with green reaction conditions were initially selected to synthesise a 
mandelic acid amide. The first was a thermal amidation procedure which required no 
solvent, was waste minimal, and good yields were reported for a variety of carboxylic 
acid substrates.
21
 A reaction was carried out with mandelic acid (1), n-butylamine (1.0 
eq.) and 3 Å molecular sieves at reflux under an N2 atmosphere. After 24 h the TLC 
showed no remaining mandelic acid, but three spots on the plate with a 94 % crude 
yield. Product purification by recrystallisation was unsuccessful, and column 
chromatography also proved problematic yielding only 9 % of the desired product.  
 
The second procedure was a tert-butoxide assisted amidation of esters carried out under 
mild conditions, reported to be a rapid (≤ 60 min) and versatile reaction (Scheme 2.5).22 
Mandelic acid ethyl ester (27) was reacted with n-butylamine (1.0 eq.) in the presence 
of potassium tert-butoxide (2.0 eq.) in THF at rt in air to synthesise the target butyl ester 
of mandelic acid (29) (Scheme 2.6). After 2 h TLC confirmed no unreacted ester or 
amine remained. However, after work-up only a very small amount of material was 
recovered (2 %), which 
1
H NMR confirmed was not the desired product. Further 
inspection of the literature showed that a substrate similar to mandelic acid, with a 
hydroxyl group at the carbon α to the ester group, gave a very poor yield with this 
procedure (4 %) (Scheme 2.5).
22
 
 
6’ 6’’
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Scheme 2.5 tert-Butoxide assisted amidation of ethyl esters alkanoates with amines.
22
 
 
 
Scheme 2.6 tert-Butoxide assisted amidation of methyl ester of mandelic acid (27) with 
n-butylamine. 
 
Coupling reagents are widely employed in synthetic chemistry to activate carboxylic 
acids and facilitate the formation of an amide bonds.
23,24
 A coupling reaction was 
undertaken to obtain the butyl amide of mandelic acid (29) using 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) (1.1 eq.), N-hydroxysuccinimide (HOSu) 
(1.1 eq.) and n-butylamine (1.0 eq.). After 2 days of stirring at rt no unreacted mandelic 
acid was detected by TLC. The crude product was purified by column chromatography 
to give 29 as a white crystalline solid in moderate yield (45 %).  
 
Alongside the coupling method, a reaction to produce amide 29 was undertaken with 
acetyl chloride according to a modified version of a the literature procedure (Scheme 
2.3).
25
 Mandelic acid (1) was dissolved in methanol and acetyl chloride (1.02 eq.) was 
added dropwise at 0 °C. The reaction was stirred overnight at rt and a complete reaction 
of mandelic acid was confirmed by TLC. The reaction was cooled to 0 °C and n-
butylamine (4.0 eq.) was added and the reaction was placed in the fridge (< 5 °C) 
overnight. TLC confirmed reaction completion and 29 was isolated as a white 
crystalline solid in excellent yield (89 %). The 
1
H NMR of the 29 in CDCl3 clearly 
shows the presence of both the NH (H10) and OH (H5) protons as broad singlets at 6.12 
and 3.77 ppm respectively (Figure 2.7). A D2O shake was carried out on the NMR 
sample and led to a disappearance of the NH and OH peaks from the subsequent 
1
H 
NMR spectra, further confirming the identity of these peaks. 
 46   
 
 
 
 
 
 
 
 
 
 
Figure 2.7 
1
H NMR of butyl amide of mandelic acid (29) in CDCl3 with the NH (H10) 
and OH (H5) peaks clearly visible at 6.1 and 3.8 ppm respectively.  
 
To deduce the mechanism of the acetyl chloride reaction, a sample was removed on 
completion of the reaction between mandelic acid (1) and acetyl chloride, confirmed by 
TLC, before the addition of n-butylamine. Analysis of the sample by 
1
H and 
13
C NMR 
showed that the intermediate produced in the reaction was the methyl ester of mandelic 
acid. The 
1
H NMR spectra was identical to the previously prepared mandelic acid 
methyl ester 26. This confirmed that the mechanism of the reaction was by HCl 
generation through the reaction of acetyl chloride with methanol, followed by acid 
catalysed Fischer-Speier esterification of mandelic acid. In the second stage of the 
reaction, a nucleophilic substitution reaction of n-butylamine with the methyl ester 
produced amide 29. 
 
There are several benefits to the acetyl chloride procedure over the coupling procedure 
to produce amide 39. The procedure with acetyl chloride does not require column 
chromatography to be undertaken and is a much higher yielding procedure than the 
coupling reaction (89 and 45 % respectively) (Table 2.1).  
 
  
 
 
 
 
 
1, 2, 3 
6 
4 
5 
7 
9
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CHCl3 
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Table 2.1 Comparison of the coupling and acetyl chloride methods used to synthesise 
the butyl amide of mandelic acid (29). 
Compound Structure 
Synthesis 
method 
Yield 
(%) 
Column 
purification  
29 
 
EDC 
coupling  
45 Yes 
Acetyl 
chloride  
89 No 
 
The overall duration of each reaction method is the same two-day length. However, the 
reaction with acetyl chloride is carried out with a large excess of n-butylamine (4 eq.), 
which is necessary to force the reaction to completion. Some n-butylamine is also used 
to neutralise any HCl remaining from the esterification step. Knowing that the reaction 
mechanism proceeds through the methyl ester of mandelic acid (26), a reaction was 
carried out directly between 26 and n-butylamine in methanol to see if amide 27 could 
be synthesised using less n-butylamine. Despite requiring a lower amount of n-
butylamine (1.55 eq.) and giving a good yield (78 %), the reaction took 6 days to reach 
completion, including 3 days at reflux. Due to this long reaction time and the 
requirement to initially synthesise 26 to undertake the reaction, the acetyl chloride 
procedure was preferred for the synthesis of amide 27.  
2.2.3 Synthesis of Mandelic Acid Alkylating Regents 
The synthesis of α-bromoester and α-bromoamide alkylating reagents 30–33 (Figure 
2.8) was carried out by the addition of thionyl bromide (SOBr2) to the mandelic acid 
esters 26–28 and amide 29. The reaction occurs via a meso substitution of the alcohol 
by bromine (Scheme 2.6).  
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Figure 2.8 Percentage yields for mandelic acid α-bromoester and α-bromoamide 
alkylating reagents (30–33), synthesised from mandelic acid esters 26–28 and amide 29.  
 
In a typical reaction, the mandelic acid ester/amide was dissolved in dry 
dichloromethane (DCM) with triethylamine (TEA) (1.5 eq.) under N2. SOBr2 (1.2 eq.) 
was added dropwise at 0 °C and the reaction was stirred at rt for 4 h. The crude product 
was purified by column chromatography (SiO2, EtOAc:hexane) to give 30–33 in 
moderate yields (51–67 %). 
 
The mechanism of the reaction occurs through the alcohol of mandelic acid, which acts 
as a nucleophile towards SOBr2 on its addition. This reaction converts the alcohol into a 
good leaving group, and subsequent reaction of the resultant bromide at the benzylic 
position on the mandelic acid results in the removal of SO2 and the formation of either 
the desired α-bromoester or α-bromoamide product (Scheme 2.7). 
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Scheme 2.7 Reaction mechanism of α-bromoester and α-bromoamide formation. 
2.2.4 Synthesis of Mandelic Acid ILs 
Ten mandelate and mandelamide bromide ILs (16–25) were synthesised via a 
nucleophilic substitution reaction between an N-heterocycle and the α-bromoester or α-
bromoamide of mandelic acid (30–31), as previously described in the literature (Scheme 
2.2 and 2.3).
26
 This type of reaction is more specifically called a Menschutkin reaction, 
with the reaction mechanism being either a bimolecular SN2 process or a unimolecular 
SN1 process, dependent on the nature of both the solvent and the reactants.
27,28
 
However, extensive mechanistic studies of the reactions between benzylic systems and 
aromatic tertiary amines have shown that the reactions occur simultaneously through 
independent SN1 and SN2 mechanisms,
29-32
 with the rate of the reaction dependent on 
the reaction conditions.
33
 The N-heterocycles selected for the IL synthesis of ILs (16–
25) were 1-methylimidazole, pyridine, 3-methoxypyridine and ethyl nicotinate (Figure 
2.9). When using ethyl nicotinate as the N-heterocycle the resultant IL was the 3-
(ethoxycarbonyl)pyridinium IL, which can also be described as a nicotinic acid derived 
IL. 
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Figure 2.9 N-Heterocycles used for synthesis of ILs 16–25: 1-methylimidazole, 
pyridine, 3-methoxypyridine and ethyl nicotinate. 
 
In addition to the research carried out on this particular class of compounds directly 
preceding this work, and previously discussed in section 2.1,
18
 there have been several 
mentions of this class of compounds in the literature.
34-36
 However, the only exact 
compound match for this new series that could be found in the literature was for the 
pyridinium butyl ester IL (19), where compound characterisation could be found, but 
not biodegradation and toxicity analysis.
37
  
 
ILs 16–18 and 20–25 were synthesised by the addition of the N-heterocycle to the 
appropriate α-bromoester or α-bromoamide (1.02–1.05 eq.) dissolved in diethyl ether. 
The reaction was stirred for 2 days and completion was confirmed by TLC. Trituration 
was carried out with diethyl ether before removal of the solvent to give the desired ILs 
as solids in good to excellent yields (56–99 %). IL 19 was synthesised by the addition of 
the N-heterocycle (0.98 eq.) directly to the neat α-bromoester, as the reaction was found 
to proceed very slowly in diethyl ether (> 2 weeks to reach 95 % yield). Trituration was 
carried out with diethyl ether before removal of the solvent to obtain the IL as white 
solid in excellent yield (98 %). 
 
Seven of the ILs were produced in excellent yields (16–20, 24 and 25) (84–99 %) with 
the three butyl esters with pyridinium (21), 3-methoxypyridinium (22) and 3-
(ethoxycarbonyl)pyridinium (23) headgroups produced in moderate yields (56, 74 and 
63 % respectively) (Figure 2.10). For the methyl ester (16 and 17), butyl ester (20 and 
21) and butyl amide (24 and 25) ILs, higher percentage yields were obtained for the ILs 
with a 1-methylimidazolium headgroup (e.g. 16 at 95 % vs 17 at 86 %). The opposite 
was observed for the ethyl ester ILs (18 and 19) with both 1-methylimidazolium and 
pyridinium IL having similar percentage yields (94 and 98 % respectively). For the 
butyl esters (13–16) the percentage yields were in the order, pyridinium < 3-
(ethoxycarbonyl)pyridinium < methoxypyridinium < 1-methylimidazolium. It is clear 
that substitution on the pyridine ring influenced the reaction rate. 
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Figure 2.10 Percentage yields for mandelate and mandelamide bromide ILs (16–25). 
 
All ten ILs were obtained as crystalline solids with a wide range of melting points 
observed (48–169 °C) (Table 2.2). It is anticipated that these ILs will be used in 
applications above their melting points, exploiting the potential solvent properties of the 
ILs. ILs 16 and 21 had the lowest melting points (61–63 and 48–50 °C respectively) 
despite any similar structural features. The highest melting points were observed for the 
pyridinium ILs 19 and 25 (161–162 and 167–169 °C respectively). ILs 17 and 24 had 
melting points around 140 °C (140–142 and 143–145 °C respectively), again with no 
similar structural features. ILs 18 and 20 had moderately high melting points (101–102 
and 99–101 °C respectively), both with 1-methylimidazolium headgroups. ILs 22 and 
23 had moderately high melting points (127–128 and 112–113 °C respectively), both 
butyl esters with 3-methoxypyridinium (22) and 3-(ethoxycarbonyl)pyridinium (23) 
headgroups. In conclusion, the headgroup has a more marked effect on the IL melting 
points than the alkyl chain length. In all but one case the pyridinium ILs had higher 
melting points than the 1-methylimidazolium ILs with the same ester/amide alkyl chain, 
with this trend only reversed for the butyl ester ILs 20 and 21. The butyl amides ILs 24 
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and 25 had higher melting points than the butyl ester ILs, which can be expected due to 
their high hydrogen bonding ability.  
 
Table 2.2 Physical appearance and melting points of mandelate and mandelamide 
bromide ILs (16–25).  
IL Appearance mp (°C)  
16 White solid 61–63 
17 White solid 140–142 
18 White solid 101–102 
19 White solid 161–162 
20 White solid 99–101 
21 Brown solid 48–50 
22 White solid 127–128 
23 Light pink solid 112–113 
24 White solid 143–145 
25 White solid 167–169 
 
The 
1
H NMR spectra of the 3-methoxypyridinium (22) and 3-
(ethoxycarbonyl)pyridinium (23) ILs in CDCl3 give distinct coupling patterns with 
characteristic J values of ortho and meta coupling for the N-heterocyclic rings (Figure 
2.11). Ortho and meta coupling constants in pyridines are typically 6–9 and 1–3 Hz 
respectively.
38
 The 3-methoxypyridinium IL (22) H9 proton gives a doublet of doublets 
(dd) at 9.81 ppm with J = 2.6 and 1.3 Hz due to coupling to protons H12 and H10 
respectively, which are meta to H9. The H10 proton gives a doublet of doublet of 
doublets (ddd) at 8.63 ppm with J = 6.0, 1.3 and 1.1 Hz due to coupling to proton H11 
which is ortho to H10, and to protons H9 and H12 respectively, which are meta to H10. 
A ddd is also observed at 7.99 ppm for the H12 proton with J = 8.8, 2.6 and 1.1 Hz due 
to coupling to proton H11 which is ortho to H12, and to protons H9 and H10 
respectively, which are meta to H12. Finally, the H11 proton gives a dd at 7.87 ppm 
with J = 8.8 and 6.0 Hz due to coupling to protons H12 and H10 respectively, which are 
ortho to H11.      
 
Two-dimensional NMR was also used to facilitate the assignment of protons H10 and 
H12 in IL 22. Heteronuclear multiple-bond correlation (HMBC) spectroscopy can be 
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used to detect heteronuclear through-bond correlation over 2−3 bonds.39 The HMBC 
spectrum of IL 22 shows that proton H10 correlates to C4 (3 bonds away), whereas 
proton H12 does not correlate to C4 (5 bonds away) (Appendix A1). This information 
allows for the unambiguous assignment of protons H10 and H12. The full HMBC 
spectrum of IL 22 is provided in Appendix A2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 N-Heterocyclic region of the 
1
H NMR for 3-methoxypyridinium IL (22) 
(top) and 3-(ethoxycarbonyl)pyridinium IL (23) (bottom) in CDCl3.  
 
The 3-(ethoxycarbonyl)pyridinium IL (23) H10 proton gives a ddd at 10.41 ppm with 
J = 6.3, 1.4 and 1.4 Hz due to coupling to proton H11 which is ortho to H10, and to 
protons H9 and H12 which are meta to H10. The H9 proton gives a broad singlet at 
9.43 ppm. A ddd is observed at 8.96 ppm for the H12 proton with J = 8.0, 1.4 and 
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1.4 Hz due to coupling to proton H11 which is ortho to H12, and to protons H9 and H10 
which are meta to H12. Finally, the H11 proton gives a dd at 8.23 ppm with J = 8.0 and 
6.3 Hz due to coupling to protons H12 and H10 which are ortho to H11. HMBC 
spectroscopy was again used to facilitate the unambiguous assignment of protons H10 
and H12. The HMBC spectrum of IL 23 shows that proton H10 correlates to C4 (3 
bonds away), whereas proton H12 does not correlate to C4 (5 bonds away) (Appendix 
A3). The full HMBC spectrum of IL 23 is provided in Appendix A4.  
2.2.4.1 Synthesis of Monofluoro Mandelic Acid ILs     
In certain applications where the mandelic acid ILs will find use, it is possible that they 
may be exposed to harsh reaction conditions such as acidic, basic or photochemical 
reactions. Under basic conditions it is possible for α-protons to be abstracted, as was 
observed in the case of acetate ILs (pKa = 4.76),
19
 therefore it is possible that the α-
proton in the mandelic acid ILs may be abstracted under basic conditions. This may lead 
to breakdown of the IL, rendering it unsuitable for its given application.  
 
To increase the chemical stability of the mandelate bromide ILs, and in turn widen their 
applicability, replacement of the α-proton in the ILs with a fluorine atom was proposed 
(Figure 2.12). Fluorine is often found in IL structures, most commonly in BF4, PF6 and 
NTf2 anions, but also as alkyl fluorides, such as in the highly fluorinate phosphonium 
ILs.
40
 Whilst the use of BF4 and PF6 is best avoided due to hydrolysis to toxic HF,
41
 the 
incorporation of fluorine atoms into the alkyl structure of ILs is still widely 
employed.
42-45
 In this work, the introduction of only one fluorine atom into the structure 
of the mandelic acid ILs, to give target IL 34 (Figure 2.12), was proposed. 
Biodegradation and antimicrobial activity analysis of any new fluorine ILs synthesised 
would ideally be carried out in line with the project aim of designing low toxicity 
biodegradable ILs.  
 
 
Figure 2.12 Target monofluoro mandelate IL (34). 
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The general route to synthesise the monofluoro mandelate bromide IL (34) consisted of 
three parts (Scheme 2.8). 
 
 
Scheme 2.8 General synthesis route to monofluoro mandelate bromide IL (34). 
 
Compound 35 (Figure 2.13) was synthesised by reacting mandelic acid ethyl ester (27) 
and diethylaminosulfur trifluoride (DAST) according to the literature procedure.
46
 
DAST (1.8 eq.) was added dropwise to 27 in DCM at 0 °C and the reaction was stirred 
for 1 day at rt. After quenching, work-up and subsequent column chromatography 
(SiO2, EtOAc:hexane) the α-fluoroester 35 was obtained as a yellow oil in 64 % yield.  
 
 
Figure 2.13 Percentage yields for the monofluoro intermediates (35 and 36), and the 
monofluoro mandelate IL (37). 
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The reaction of 27 with DAST is a nucleophilic meso substitution reaction where 
fluoride acts as a nucleophile. The 
1
H NMR spectrum of 35 in CDCl3 shows a doublet at 
5.78 ppm for H4 with J H-F = 47.8, due to coupling to the fluorine atom (Figure 2.14). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14 
1H NMR of α-fluoroester of mandelic acid (35) in CDCl3.  
 
In the 
13
C NMR spectrum of 35 in CDCl3 coupling of the fluorine atom to the adjacent 
carbon atom (C7) gives a doublet at 89.45 ppm with J = 185.3 Hz (Figure 2.15). This is 
a typical coupling constant for one bond C-F coupling in ester containing mono-fluoro 
compounds.
47
 Coupling of the C7, C8, C3 and C1 carbons to the fluorine atom is also 
observed with J = 27.4, 20.4, 6.0 and 2.3 Hz respectively. Such long range coupling 
(≥ 4, 5 and 6 bonds) is frequently observed in the NMR of fluorinated compounds.48 In 
the 
19
F NMR spectrum of 35 in CDCl3 a doublet is observed at −179.77 ppm due to two 
bond coupling of the fluorine atom to proton H4 with J = 47.9 Hz (Figure 2.14).   
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Figure 2.15 NMR doublets observed for the coupling of fluorine to carbon C7 in 35, as 
observed in the 
13
C NMR (left) and the 
19
F NMR (right) in CDCl3.  
 
Compound 36 (Figure 2.13) was synthesised by a photochemical reaction of 35 with N-
bromosuccinimide (NBS) in CCl4 at reflux. The literature describes α-bromination of α-
fluoro ketones to give gem-bromohalo analogues by irradiation with a 300 W tungsten 
lamp in the presence of NBS.
49
 In DCU a tungsten lamp was not available; however, a 
mercury lamp was accessible and was tested as an alternative lamp source. A solution of 
35 and NBS (1.8 eq.) was irradiated with a 300 W mercury lamp at reflux for 19 h. On 
reaction completion, confirmed by TLC, the solvent was removed and the crude product 
was purified by column chromatography (SiO2, EtOAc:hexane) to give the α-bromo-α-
fluoroester 36 as a colourless viscous liquid in 85 % yield. Thus, in our labs the 
literature procedure was successfully applied to give compound 36 using a mercury 
lamp.   
  
The 
1
H NMR spectrum of 36 in CDCl3 shows the disappearance of the doublet observed 
at 5.7 ppm for the proton at the stereogenic centre in compound 35 (Figure 2.16), 
confirming successful bromination at the α-position. The 19F NMR of compound 36 in 
CDCl3 shows a large downfield shift of the fluorine doublet from −179.77 to −144.41 
ppm (Figure 2.17). This further confirms α-bromination as the downfield shift is caused 
by a deshielding of the fluorine nucleus by the bromine atom.
47
 A doublet is observed 
for this peak due to four bond coupling of the fluorine atom to proton H3 with 
4
JF-H = 
8.2 Hz.  
 
4 F 
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Figure 2.16 
1
H NMR of the α-bromo-α-fluoroester of mandelic acid (36) in CDCl3. 
  
 
 
 
 
 
 
 
  
 
Figure 2.17 
19
F NMR of the α-bromo-α-fluoroester of mandelic acid (36) in CDCl3. 
 
Compound 37 (Figure 2.13) was synthesised by a nucleophilic substitution reaction 
between 1-methylimidazole and compound 36. 1-Methylimidazole was added dropwise 
to compound 36 (1.0 eq.) and the reaction was stirred for 2 days. Completion was 
confirmed by TLC. Trituration was carried out with diethyl ether, the solvent removed, 
and the crude product was purified by column chromatography (SiO2, MeOH/DCM), 
where transesterification to the methyl ester occurred to give compound 37 as an off-
white solid in 17 % yield. The target compound for the nucleophilic substitution 
reaction of 1-methylimidazole with compound 36 was IL 34 (the ethyl ester derivative 
of compound 37), as shown in Figure 2.12 and in the general synthesis route to 
monofluoro mandelate bromide ILs (Scheme 2.8). However, the 
1
H NMR in DMSO-d6 
obtained after column purification of the crude reaction product clearly shows that a 
methyl ester (37) was isolated, with the CH3 protons (H4) for the methyl ester seen 
F 
4 
5 
 
2 
1, 3 
CHCl3 
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clearly as a singlet at 3.35 ppm (Figure 2.18). The reason for isolation of the methyl 
ester is likely due to transesterification of the ethyl ester crude product on the silica 
column, caused by the use of methanol in the column solvent and the fact that the silica 
gel (silicon dioxide) has weakly acidic sites.
50
 Purification on the column was difficult 
(low yield of 17 %) despite a solvent gradient of 5–10 % MeOH:DCM being employed 
to increase the separation of the product and the impurities. However, the use of a 
solvent gradient increased the time that the compound remained on the column, likely 
facilitating the transesterification. Thus, purification of the IL would be reconsidered if 
the reaction were repeated. A shorter column time and the use of ethanol instead of 
methanol to prevent transesterification are recommended. Unfortunately, there was not 
enough time to investigate this work in more detail as success in other areas of the 
project moved the focus and dedication of time away from this area of work.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18 
1
H NMR of the monofluoro mandelate IL (37) in DMSO-d6. 
2.2.5 Critique on the ‘Greenness’ of the Synthesis 
The aim of this section of work was to synthesise a series of ‘green’ ILs from the 
renewable resource mandelic acid. Thus, it is necessary to evaluate the ‘greenness’ of 
all stages of the synthesis of the mandelic acid ILs (scheme 2.2). Herein a preliminary 
critique of the ‘greenness’ of the synthetic methodologies is presented.  
 
Firstly, the synthesis of the mandelic acid esters (26–28) employs the use of the reagent 
SOCl2. SOCl2 has been classified as a reagent with ‘some issues’ in a publication by 
5 
1, 2, 3 
8 
4 
DMSO-d5 
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GlaxoSmithKline (GSK), which presents a reagent guide and discusses reagent 
selection based on sustainability.
51
 SOCl2 is also a lachrymator.
51
 Alternative reagents 
that could be employed for this synthesis include acetyl chloride, sulfuric acid or 
hydrochloric acid. However, SOCl2 is required at lower equivalents than HCl as it 
releases 2 eq. of HCl for every 1 eq. of SOCl2. HCl is used only as a catalyst in the 
reaction, thus it is highly probable that the equivalents of SOCl2 necessary for 
successful reaction completion could be further reduced if investigated. Utilising the 
alcohol of the required alkyl chain length as both the solvent and reagent in the reaction 
enhances the ‘greenness’ of this synthesis, with no extra unnecessary solvents required 
(5
th
 principle of green chemistry). The reaction is also carried out at room temperature 
for only 4 h which is an energy efficient process (6
th
 principle of green chemistry). 
 
The synthesis of the mandelic acid amide (29) employed acetyl chloride and n-
butylamine (4 eq.) in the reaction. Two ‘green’ methods were trialled for this reaction 
but they were unsuccessful (see section 2.2.2).
21,22
 Despite the fact that a high 
equivalence of n-butylamine was required to reach reaction completion (see section 
2.2.2), the alternative EDC coupling method that was investigated is far less desirable 
from a green chemistry perspective. Coupling reactions with carbodiimides are known 
to produce a lot of waste and have very poor atom economy (contravening the 3
rd
 
principle of green chemistry).
52
 Recently, the American Chemical Society Green 
Chemistry Institute (ACS GCI) Pharmaceutical Roundtable identified direct amide 
formation avoiding poor atom economy a research area of high priority for sustainable 
synthetic method development.
52
 The coupling reaction also required column 
purification. Alternative reagents that could be proposed for this synthesis include 
enzymes (satisfying the 9
th
 principle of green chemistry), N,N'-Carbonyldiimidazole 
(side products of CO2 and imidazole are relatively innocuous)
53
 and isobutyl 
chloroformate (side products of isobutanol and CO2 are relatively harmless)
54
.     
 
The synthesis of the mandelic acid α-bromoester and α-bromoamide alkylating reagents 
(30–33) employs the use of SOBr2, DCM and TEA. DCM poses significant human and 
environmental toxicity issues.
55
 Thus, the reactions would be improved by the 
replacement of the chlorinated solvent DCM, which could be facilitated by using the 
GSK solvent sustainability guides.
56,57
 2-Methyltetrahydrofuran (2-MeTHF) could be 
investigated for use as an alternative to DCM and can be produced from renewable 
resources such as furfural or levulinic acid (addressing the 7
th
 principle of green 
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chemistry).
58
 Compounds 30–33 were all purified by column chromatography, an 
additional step in the synthesis that further increased the use of solvents and auxiliaries 
(SiO2). However, it is important to note that the solvent system used to purify 30–33, 
EtOAc:hexane, is a much ‘greener’ choice than a solvent system using DCM. 55 The use 
of SOBr2 is also undesired from a green chemistry perspective as the reaction produces 
the toxic gases SO2 and HBr. However, the use of TEA prevents the gaseous release of 
HBr from the reaction. An alternative to SOBr2 may be the use of HBr and a bromide 
IL, as a similar process for the chlorination of alcohols using HCl and a chloride IL 
(without the formation of by-products) has been commercialised by BASF.
59
  
 
Synthesis of the mandelic acid ILs 16–18 and 20–25 was carried out in diethyl ether via 
a nucleophilic substitution reaction. Diethyl ether is highly undesired as a reaction 
solvent in industry as it has a low boiling point, high volatility, high flammability and 
presents an explosion risk.
57
 A more sustainable and safer solvent for the synthesis, such 
as 2-MeTHF, could be selected by consulting the GSK solvent sustainability guides
56,57
 
Mandelic acid IL 21 was synthesised in a solventless synthesis, satisfying the 5
th
 
principle of green chemistry (no unnecessary use of auxiliary substances). Therefore, an 
investigation into the solventless synthesis of ILs 16–20 and 22–25 may result in a 
reduction of the amount of diethyl ether necessary for successful reaction completion. 
 
There are several areas that could be addressed in the synthesis of the target monofluoro 
mandelic acid ester IL (34) to increase the ‘greenness’. The α-fluoroester (35) was 
synthesised using the reagents DAST and DCM. As previously discussed, replacement 
of the chlorinated solvent DCM is advisable. In addition, DAST is known to be 
converted to extremely toxic and corrosive SF4 and explosive bis(diethylamino)sulfur 
difluoride when heated.
60
 Aminodifluorosulfinium salts have been shown to be a safer 
alternative to DAST (increased thermal stability, more easily handled, do not generate 
highly toxic and corrosive HF) and could be considered for the synthesis of 35.
60
 The 
synthesis of the α-bromo-α-fluoroester (36) was carried out with NBS and CCl4 in a 
photochemical reaction. CCl4 has a relatively high toxicity, is carcinogenic and its use is 
restricted under the Montreal Protocol due to its ozone depleting effects.
61
 
Consequently, replacement of CCl4 is highly recommended. (Trifluoromethyl)-benzene 
has been shown to be a suitable alternative to CCl4 in photochemical reactions with 
NBS, and its inertness and low toxicity make it a much ‘greener’ replacement.62 The use 
of NBS is undesired as the reaction has poor atom economy; however, it is a much safer 
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and more easily handled alternative to Br2 which is corrosive and fumes at room 
temperature releasing toxic bromine gas.
63
 A solvent free reaction was carried out to 
produce IL 34 from 36, yet purification by column chromatography was required 
(MeOH:DCM). The use of a greener solvent system, without DCM, could potentially be 
investigated for the purification.  
  
The environmental impact of solvents can be reduced in two ways; by identifying and 
replacing with greener solvents and by minimising solvent use.
64
 However, the only 
way to truly find the best solvent for the synthesis is by carrying out a full life cycle 
analysis on the solvent in a specific application.
64
 
 Antimicrobial Activity 2.3
The antimicrobial activity of the ten mandelate and mandelamide bromide ILs (16–25) 
was evaluated in three separate toxicity tests. 
2.3.1 Antibacterial Activity – High Concentrations 
The antibacterial activities of ILs 16–25 (Table 2.3) were evaluated against one Gram-
positive bacterial strain: Bacillus subtilis (B. subtilis; DSMZ 10), and four Gram-
negative bacterial strains: Escherichia coli (E. coli; DSMZ 498), Pseudomonas 
fluorescens (P. fluorescens; DSMZ 50090), Pseudomonas putida (P. putida; CP1), and 
P. putida (KT 2440). The bacterial toxicity of the ILs was determined by a 24 h 
bacterial growth inhibition assay and are expressed as IC50 values. Stock solutions of the 
ILs were prepared in deionised water to a maximum concentration of 2 M. The 
concentration of each stock solution was determined by the maximum aqueous 
solubility of each IL up to 2 M (Table 2.4). ILs 17, 19, 22 and 24 had a solubility limit 
lower than the maximum stock solution concentration of 2 M. The maximum test 
concentration of the IL was a factor of 10 dilution of the IL stock solution (see chapter 
6, section 6.5.1). This work was carried out in collaboration with Dr Brid Quilty from 
the School of Biotechnology in DCU.  
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Table 2.3 Antibacterial screening results for ILs 16–25 (IC50).  
IL 
IC50 (mM) 
E. coli B. subtilis P. fluorescens 
P. putida 
(CP1) 
P. putida 
(KT 2440) 
16 50–100 50–100 50–100 50–100 100–200 
17 25–50 25–50 25–50 25–50 50–100 
18 25–50 50–100 25–50 25–50 50–100 
19 25–50 50–100 50–100 50–100 > 100
a 
20 6.25–12.5 12.5–25 12.5–25 6.25–12.5 12.5–25 
21 12.5–25 25–50 25–50 12.5–25 25–50 
22 12.5–25 12.5–25 12.5–25 12.5–25 25–50 
23 12.5–25 25–50 25–50 12.5–25 25–50 
24 6.25–12.5 12.5–25 12.5–25 12.5–25 25–50 
25 6.25–12.5 12.5–25 6.25–12.5 12.5–25 12.5–25 
a
Solubility limit; IC50 value greater than solubility in media. 
 
Table 2.4 Aqueous solubility of ILs 16–25 up to a maximum concentration of 2 M.  
IL Solubility (M) 
16 2.00 
17 0.89 
18 2.00 
19 1.00 
20 2.00 
21 2.00 
22 0.89 
23 2.00 
24 1.00 
25 2.00 
 
The majority of the ILs had low toxicity towards the bacterial strains they were screened 
against, with the lowest toxicity observed for the pyridinium ethyl ester IL (19) against 
P. putida (KT 2440) (IC50 > 100 mM) (Table 2.3). The highest levels of inhibition were 
observed for the 1-methylimidazolium butyl ester IL (20) which inhibited E. coli and P. 
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putida (CP1) with IC50 values of 6.25–12.5 mM, the butyl amide pyridinium IL (25) 
which inhibited E. coli and P. fluorescens with IC50 values of 6.25–12.5 mM, and the 1-
methylimidazolium butyl amide (24) which inhibited E. coli with IC50 values of 6.25–
12.5 mM. A general trend of increasing IL toxicity with increasing alkyl chain length 
was observed across all bacterial strains in the order methyl ester < ethyl ester < butyl 
ester/amide. In general, the methyl ester ILs 16 and 17 had lower toxicity (IC50 = 25–
200 mM) than the ethyl ester ILs 18 and 19 (IC50 = 25–100 mM), which in turn had 
lower toxicity than the butyl ester/amide ILs 20–25 (IC50 = 6.25–50 mM). This observed 
trend is expected as the literature shows that ILs with longer alkyl chain lengths have 
increased levels of toxicity.
65
 The ILs with longer alkyl chains have a higher 
lipophilicity, which increases their ability to permeate through the cell membrane and 
disrupt it, leading ultimately to cell death.
66
 There was no observed trend for the level of 
bacterial inhibition between 1-methylimidazolium ILs and pyridinium ILs across the 
various alkyl chain lengths. When comparing the IC50 values of the butyl ester ILs with 
pyridinium (21), 3-methoxypyridinium (22) and 3-(ethoxycarbonyl)pyridinium (23) 
headgroups, a difference in inhibition was only observed for IL 22 which showed the 
same increase in inhibition towards B. subtilis and P. fluorescens (IC50 = 12.5–25 mM). 
When comparing the inhibition of the Gram-positive bacteria E. coli with the Gram-
negative bacteria B. subtilis, seven ILs (18–21 and 23–25) inhibited E. coli to a greater 
extent than B. subtilis. The remaining ILs (9, 10 and 15) inhibited both E. coli and B. 
subtilis to the same extent.  
 
It is necessary to compare the IC50 values of the 1-methylimidazolium and pyridinium 
methyl and butyl ester ILs (16, 17, 20 and 21) (Table 2.3) to the previously published 
mandelic acid derived ILs with the same ester alkyl chain length and headgroup (8–11) 
(Figure 2.19 and Table 2.5).
18
 IL 8 has been included here for comparison purposes 
despite containing a chloride anion, as the halide anions bromide and chloride have 
previously been reported to have similar toxic effects in imidazolium IL.
67
 In all cases 
the previous class of ILs (8–11) had lower levels of inhibition for every bacterial strain 
that was screened against. Despite the maximum inhibition for the previous class of ILs 
being lower than the new class (maximum IC50 = 25–50 mM for IL 11 across all 
bacterial strains), the new class of ILs do not represent a large increase in the level of 
inhibition (maximum IC50 = 6.25–12.5 mM for IL 20, 24 and 25 to several bacterial 
strains). A lower level of inhibition is expected for the previous ILs (8–11) due to the 
presence of the oxygen functionality on the aromatic ring. The increased oxygen content 
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decreases the lipophilicity of the ILs and increases their hydrophilicity, in turn 
decreasing the toxicity of the ILs towards the bacterial strains for reasons previously 
described (see chapter 1, section 1.4.1).
66
  
 
 
Figure 2.19 Previously published mandelic acid derived ILs (8–11).18  
 
Table 2.5 Antibacterial screening results for ILs 8–11 (IC50).
18
 
IL 
IC50 (mM) 
E. coli B. subtilis P. fluorescens 
P. putida 
(CP1) 
P. putida 
(KT 2440) 
8 50–100 50–100 100–200 100 –200 100–200 
9 100–200 50–100 100–200 100–200 100–200 
10 50–100 50–100 100–200 100–200 100–200 
11 25–50 25–50 25–50 25–50 25–50 
2.3.2 Antibacterial Activity – Low Concentrations 
The in vitro antibacterial activities of ILs 16–25 (Table 2.5) were evaluated against 
three ATTC strains: Staphylococcus aureus (SA; ATTC 6538), Escherichia coli (EC; 
ATTC 8739), Pseudomonas aeruginosa (PA; ATTC 9027) and five clinical isolates: 
Staphylococcus aureus MRSA (MRSA; HK5996/08), Staphylococcus epidermidis (SE; 
HK6966/08), Enterococcus sp. (EF; HK14365/08), Klebsiella pneumoniae (KP; 
HK11750/08) and Klebsiella pneumoniae ESBL (KP-E; HK14368/08). The ATCC 
strains were also used as the quality control strains. MIC values were calculated after 24 
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and 48 h. The MICs were defined as 95 % inhibition (IC95) of the control growth. The 
maximum test concentration of the IL was dependent on the IL aqueous solubility, with 
the highest IL concentration in the test being 2000 M. All the isolates were maintained 
on Mueller-Hinton dextrose agar prior to being tested. This work was carried out in 
collaboration with Dr Marcel Špulák from the Department of Organic and Inorganic 
Chemistry in the Faculty of Pharmacy at Charles University in Hradec Králové, Czech 
Republic. 
 
Table 2.6 Antibacterial screening results for ILs 16–25 (MIC, IC95). 
Strain 
Time 
(h) 
IL MIC (M) 
16 17, 23 18 19, 22 20 21 24 25 
SA 
24h 2000 >2000 500 >1000 2000 500 >2000 2000 
48h 2000 >2000 500 >1000 >2000 2000 >2000 2000 
MRSA 
24h >2000 >2000 500 >1000 >2000 2000 >2000 >2000 
48h >2000 >2000 500 >1000 >2000 >2000 >2000 >2000 
SE 
24h 2000 2000 250 >1000 2000 500 >2000 2000 
48h 2000 2000 250 >1000 >2000 1000 >2000 2000 
EF 
24h >2000 >2000 500 >1000 >2000 >2000 >2000 >2000 
48h >2000 >2000 500 >1000 >2000 >2000 >2000 >2000 
EC 
24h >2000 >2000 2000 >1000 >2000 >2000 >2000 >2000 
48h >2000 >2000 2000 >1000 >2000 >2000 >2000 >2000 
KP 
24h >2000 >2000 2000 >1000 >2000 >2000 >2000 >2000 
48h >2000 >2000 2000 >1000 >2000 >2000 >2000 >2000 
KP-E 
24h 2000 >2000 1000 >1000 1000 >2000 >2000 >2000 
48h 2000 >2000 1000 >1000 >2000 >2000 >2000 >2000 
PA 
24h >2000 >2000 >2000 >1000 >2000 >2000 >2000 >2000 
48h >2000 >2000 >2000 >1000 >2000 >2000 >2000 >2000 
 
The majority of the ILs did not have high toxicity towards the bacterial strains they 
were screened against. The pyridinium ethyl ester IL (19) and the 3-methoxypyridinium 
butyl ester (22) did not have high toxicity, up to the maximum IL concentration limit, 
with IC95 values > 1000 M. The 1-methylimidazolium butyl amide IL (24) also did not 
have high toxicity with IC95 values > 2000 M. The 1-methylimidazolium and 
pyridinium methyl ester ILs (16 and 17), the 3-methoxypyridinium butyl ester IL (16) 
and the pyridinium butyl amide IL (25) all inhibited S. epidermidis at a concentration of 
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2000 M, with IL 25 aditionally inhibiting S. aureus at 2000 M and IL 16 aditionally 
inhibiting S. aureus and K. pneumoniae ESBL at 2000 M. The 1-methylimidazolium 
butyl ester IL (20) inhibited S. aureus and S. epidermidis at 2000 M and K. 
pneumoniae ESBL at 1000 M after 24 h, but after 48 h no longer inhibited S. aureus, 
S. epidermidis and K. pneumoniae ESBL up to the test concentration of 2000 M, 
suggesting that the bacterial strains were able to overcome the initial observed 
inhibition after 24 h and recover. The pyridinium butyl ester IL (21) inhibited S. aureus 
MRSA at 2000 M after 24 h, but after 48 h no longer inhibited S. aureus MRSA up to 
the test concentration of 2000 M. IL 21 also inhibited S. aureus and S. epidermidis at 
500 M after 24 h, which reduced to inhibition at 2000 M to S. aureus and 1000 M 
to S. epidermidis after 48 h. The 1-methylimidazolium ethyl ester IL (18) showed the 
greatest level of inhibition to the bacterial strains across the board with the highest level 
of inhibition observed against S. epidermidis (IC95 = 250 M) and against S. aureus, S. 
aureus MRSA and Enterococcus sp. (IC95 = 500 M). Ils 18 and 21 generally showed 
greater inhibition towards the Gram-positive bacterial strains (S. aureus, S. aureus 
MRSA, S. epidermidis and Enterococcus sp.) than towards the Gram-negative bacterial 
strains (E. coli, K. pneumoniae, K. pneumoniae ESBL and P. aeruginosa). This 
observation was most pronounced for IL 18 where the greatest level of inhibition 
towards a Gram-negative bacterial strain was observed against K. pneumoniae ESBL 
(IC95 = 500 M), and the greatest level of inhibition towards a Gram-positive bacterial 
strain was observed against S. epidermidis (IC95 = 250 M). IL 18 did not present the 
same inhibition towards E. coli as observed in the previous high concentration bacterial 
toxicity screening (Table 2.4), and this is attributed to the use of two different strains of 
E. coli. The overall findings are that none of the ILs demonstrated high toxicity to the 
various bacterial strains screened against, with moderate toxicity observed for IL 18 
against several of the bacterial strains.  
 
It is again necessary to compare the IC95 values of the 1-methylimidazolium and 
pyridinium methyl and butyl ester ILs (16, 17, 20 and 21) (Table 2.6) to the previously 
published mandelic acid derived ILs with the same ester alkyl chain length and 
headgroup (8–11)18 (Figure 2.20, Appendix B1). In all cases the previous class of ILs 
(8–11) had lower levels of inhibition for every bacterial strain that was screened against, 
with no high toxicity observed up to the maximum IL concentration limit (IC95 
> 2000 M).19,68 Again a lower level of inhibition is expected for the previous ILs (8–
 68   
11) due to the presence of the oxygen functionality on the aromatic ring, which 
increases IL hydrophilicity and in turn decreases IL toxicity. Despite a higher toxicity 
observed for the new ILs (16, 17, 20 and 21) the results herein do not represent a large 
increase in the level of inhibition. The greatest increase in inhibition was observed for 
IL 14 which inhibited S. aureus and S. epidermidis at 500 M after 24 h, which reduced 
to inhibition at 2000 M to S. aureus and 1000 M to S. epidermidis after 48 h. 
2.3.3 Antifungal Activity 
The in vitro antifungal activities of ILs 9–18 (Table 2.7) were evaluated against four 
ATCC strains: Candida albicans (CA1; ATCC 44859), Candida albicans (CA2; ATCC 
90028), Candida parapsilosis (CP; ATCC 22019), Candida krusei (CK1; ATCC 6258) 
and eight clinical isolates of fungi: five yeasts; Candida krusei (CK2; E28), Candida 
tropicalis (CT; 156), Candida glabrata (CG; 20/I), Candida lusitaniae (CL; 2446/I), 
Trichosporon asahii (TA; 1188) and three filamentous fungi; Aspergillus fumigatus 
(AF; 231), Absidia corymbifera (AC; 272), Trichophyton mentagrophytes (TM; 445). 
The CA1, CP and CK1 ATCC strains were also used as the quality control strains. All 
the isolates were maintained on Sabouraud dextrose agar prior to being tested. MICs 
were determined using a modified CLSI standard of the microdilution format of the 
M27-A3 and M38-A2 documents, for yeasts and filamentous fungi respectively.
69,70
 
MIC values were calculated after 72 and 120 h for TM, and for all other strains MIC 
values were calculated after 24 and 48 h. The MICs were defined as 50 % inhibition 
(IC50) of the control growth for yeasts or 80 % inhibition (IC80) of the control growth 
for filamentous fungi. The maximum test concentration of the IL was dependent on the 
IL aqueous solubility, with the highest IL concentration in the test being 2000 M. This 
work was carried out in collaboration with Dr Marcel Špulák from the Department of 
Organic and Inorganic Chemistry in the Faculty of Pharmacy at Charles University in 
Hradec Králové, Czech Republic.  
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Table 2.7 Antifungal screening results for ILs 16–25 (MIC, IC80 or IC50). 
Strain Time (h) 
IL MIC (µM)
a
 
16, 23 
24, 25 
17, 19, 
22 
18 20, 21 
CA1 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
CA2 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
CP 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
CK1 
24h >2000 >1000 500 >2000 
48h >2000 >1000 500 >2000 
CK2 
24h >2000 >1000 1000 >2000 
48h >2000 >1000 1000 >2000 
CT 
24h >2000 >1000 >2000 2000 
48h >2000 >1000 >2000 >2000 
CG 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
CL 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
TA 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
AF 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
AC 
24h >2000 >1000 >2000 >2000 
48h >2000 >1000 >2000 >2000 
TM 
72h >2000 >1000 >2000 >2000 
120h >2000 >1000 >2000 >2000 
a
IC50 values were assessed for AF, AC and TM and IC80 for all other strains. 
 
The 1-methylimidazolium methyl ester IL (16), the 3-(ethoxycarbonyl)pyridinium butyl 
ester IL (23) and the 1-methylimidazolium and pyridinium butyl amide ILs (24 and 25) 
did not have high toxicity up to the maximum IL concentration limit, with IC50/IC80 
values > 2000 M (Table 2.7). The pyridinium methyl and ethyl ester ILs (17 and 19) 
and the 3-methoxypyridinium butyl ester IL (22) did not have high toxicity up to the 
maximum IL concentration limit, with IC50/IC80 values > 1000 M. The 1-
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methylimidazolium ethyl ester IL (18) inhibited C. krusei (CK1) at 500 M after both 
24 and 48 h, and C. krusei (CK2) at 1000 M after both 24 and 48 h. Higher levels of 
fungal toxixity are usually observed as the length of the alkyl chain increases,
71
 so it is 
unexpected that the ethyl ester IL (18) presents here with the highest level of fungal 
toxicity. The only other ILs which showed fungal activity were the 1-
methylimidazolium and pyridinium butyl ester ILs (20 and 21) which inhibited C. 
tropicalis at 2000 M after 24 h. After 48 h ILs 20 and 21 no longer inhibited C. 
tropicalis up to the test concentration of 2000 M, suggesting that the fungal strain was 
able to overcome the initial observed inhibition at 2000 M after 24 h and recover. The 
overall findings are that none of the ILs demonstrated high toxicity towards the range of 
fungal strains that were screened against. 
 
It is again necessary to compare the IC80 or IC50 values of the 1-methylimidazolium and 
pyridinium methyl and butyl ester ILs (16, 17, 20 and 21) (Table 2.7) to the previously 
published mandelic acid derived ILs with the same ester alkyl chain length and 
headgroup (8–11)18 (Figure 2.20, Appendix B2). It was found that only IL 16 had the 
same low level of inhibition as the previous ILs (8–11), with no high toxicity up to the 
maximum IL concentration limit (IC50/IC80 > 2000 M).
19,68
 IL 17 had a lower 
maximum concentration limit (1000 M) and thus cannot be directly compared to the 
previous class of ILs. Of the previous ILs only IL 11 showed inhibition below the 
maximum IL concentration limit, with IC80 values of 2000 M against C. albicans 
(CA1) and 2000 M against C. tropicalis and C. lusitaniae after 24 h, which reduced to 
no toxicity up to the maximum IL concentration limit after 48 h (IC80 > 2000 M). ILs 
20 and 21 (which have the same butyl chain and pyridinium headgroup as IL 11) only 
showed inhibition against C. tropicalis at 2000 M after 24 h and > 2000 M, the 
maximum IL concentration limit, after 48 h. No high toxicity was observed for IL 20 
and 21 against all other fungal strains, up to the maximum IL concentration limit, with 
IC50/IC80 values > 2000 M. When comparing ILs 11 and 21 the data suggets that this is 
a unique case, where the oxidation of the aromatic ring actually results in a slight 
increase in toxicity, albeit it to only two fungal strains.   
 Biodegradation 2.4
The aerobic biodegradability of the ten mandelate ILs 16–25 (Table 2.8) was evaluated 
using the Closed Bottle Test (CBT) (OECD 301D).
72
 The validity of the test run was 
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confirmed by the biodegradation of the reference substance sodium acetate being 
> 60 % within 14 days, and the concentration of oxygen in the bottles not falling below 
0.5 mg L
−1
 at any time. This work was carried out in collaboration with Dr Klaus 
Kümmerer from the Institute of Sustainable and Environmental Chemistry at Leuphana 
University Lüneburg in Germany. 
 
Table 2.8 Percentage biodegradation for ILs 16–25 in the CBT after 28 days. 
IL Biodegradation (%) 
16 5 
17 8 
18 20 
19 16 
20 27 
21 21 
22 22 
23 31 
24 0 
25 1 
 
The results show that none of the ILs reached > 60 % biodegradation in 28 days and 
thus cannot be classified as readily biodegradable by the CBT (Table 2.8). The             
3-(ethoxycarbonyl)pyridinium butyl ester IL (23) had the highest level of 
biodegradation (31 % in 28 days) and the 1-methylimidazolium butyl amide IL (24) did 
not biodegrade under the test conditions (0 % in 28 days). The percentage 
biodegradation reached by each IL in the test can be rationalised as biodegradation of 
the ester/amide groups of the ILs. It is well known that ester groups show high levels of 
biodegradability and are often introduced into compounds to increase their levels of 
biodegradability.
26
 IL 23 contains the largest percentage of ester groups per molecule, 
with both an ethyl and butyl ester, thus it is not surprising that it shows the highest level 
of biodegradation in the CBT. The CBT results also show, as expected, that the level of 
biodegradation increased as the ester chain length increased. This trend is observed for 
the 1-methylimidazolium ester ILs 16, 18 and 20 (5, 20 and 27 % biodegradation in 28 
days for methyl, ethyl and butyl esters respectively) and the pyridinium ILs 17, 19 and 
20 (8, 16 and 21 % biodegradation in 28 days for methyl, ethyl and butyl esters 
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respectively). Amide moieties have been shown in the literature to have poor levels of 
biodegradation, thus the low levels of biodegradation observed for the                           
1-methylimidazolium butyl amide IL (24) and the pyridinium butyl amide IL (25) in the 
CBT (0 and 1 % biodegradation in 28 days respectively) are expected.
26
 When 
comparing the CBT results of the butyl ester ILs (20–23), the percentage biodegradation 
increased in the order pyridinium < 3-methoxypyridinium < 1-methylimidazolium <     
3-(ethoxycarbonyl)pyridinium (21, 22, 27 and 31 % biodegradation in 28 days for ILs 
21, 22, 20 and 23 respectively). 
 
A percentage of theoretical ester/amide biodegradation can be calculated for a 
compound by assuming that all the ester/amide carbons in the molecule are broken 
down during biodegradation. The calculated theoretical ester/amide biodegradation 
values can then be compared to the experimental biodegradation values. If the values 
are similar it is reasonable to conclude that biodegradation of the compound is occurring 
at the ester/amide. Significantly lower theoretical values than the experimental values 
would suggest that other parts of the molecule are also likely to be biodegrading. 
Theoretical values that are significantly higher than the experimental values would 
suggest the ester/amide bond is likely not biodegrading, or only partially biodegrading. 
The theoretical ester/amide biodegradation calculations for ILs 16–25 were performed 
and the values compared to the experimental results obtained in the CBT (Table 2.9).   
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Table 2.9 Calculation of theoretical ester/amide biodegradation for ILs 16–25 with a 
comparison to the experimental results obtained in the CBT after 28 days. 
IL 
Total 
carbon 
number 
Ester/amide 
carbon 
number 
Theoretical 
biodegradation 
(%) 
Experimental 
biodegradation 
(%) 
Prediction 
accuracy 
(%) 
16 13 1 8 5 +3 
17 14 1 7 8 −1 
18 14 2 14 20 −6 
19 15 2 13 16 −3 
20 16 4 25 27 −2 
21 17 4 24 21 +3 
22 18 4 22 22 +1 
23 20 6 30 31 −1 
24 16 4 25 0 +25 
25 17 4 24 1 +22 
 
The comparison of the theoretical ester/amide biodegradation values to the experimental 
values for the ILs 16–25 show a moderate to good prediction for the ester ILs 16–23, 
with the most accurate prediction made for the pyridinium methyl ester IL (17), the       
3-methoxypyridinium butyl ester IL (22) and the 3-(ethoxycarbonyl)pyridinium butyl 
ester IL (23). This analysis allows us to conclude that the biodegradation of the ester ILs 
is occurring only at the ester bonds. The theoretical ester/amide biodegradation 
calculation predicts a lower level of biodegradation (−6 %) than is observed 
experimentally for the 1-methylimidazolium ethyl ester IL (18), perhaps suggesting that 
an additional part of the molecule is biodegrading. However, the literature has shown 
that 1-methylimidazolium based ILs are often very poorly biodegradable.
73
 Thus when 
taking into account the confidence levels of the test, it can be postulated that the extra 
6 % biodegradation observed in the CBT over the prediction may likely not be 
significant enough to suggest that additional parts of the molecule (i.e. the                    
1-methylimidazolium ring) are breaking down.  
 
The calculated theoretical biodegradation values for the 1-methylimidazolium butyl 
amide IL (24) and the pyridinium butyl amide IL (25) are much higher than the 
biodegradation results obtained experimentally (+25 and +22 % for ILs 24 and 25 
respectively). The calculation is made assuming that biodegradation of the amide is 
occurring; however, from the experimental values it is clear that none of IL 24 
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biodegraded under the conditions of the CBT in the 28 day period. IL 25 gave a very 
low level of biodegradation (1 %), again most likely not be significant enough to 
suggest that the amide is biodegrading as the literature shows that amides have poor 
levels of biodegradation.
26
 Thus, the calculation overestimates the level of 
biodegradation expected for the amide ILs and it can be concluded that the amides did 
not biodegrade under the CBT conditions over 28 days. 
2.4.1 Proposed Biodegradation Metabolites 
A number of biodegradation metabolites are produced when a compound biodegrades.
74
 
The proposed biodegradation metabolites of ILs 16–25, formed by ester/amide 
breakdown, are the carboxylic acid derivatives of the parent ILs (38–41) (Figure 2.20, 
Table 2.10). Metabolites can be detected after biodegradation studies by carrying out 
HPLC-MS, MS/MS, and/or NMR analysis on the biodegradation products.
75,76
 An 
analysis of the toxicity of the metabolites is also always recommended, as they may be 
more toxic than the parent compounds.
77
 To analyse metabolite toxicity, synthesis of the 
individual metabolites needs to be carried out. With the same metabolites presenting for 
multiple ILs only a few metabolites would need to be synthesised to obtain 
toxicity/biodegradation data on the metabolites for multiple parent compounds.    
 
 
Figure 2.20 Proposed metabolites for ILs 16–25 (38–41).  
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Table 2.10 Proposed metabolites for ILs 16–25 (38–41). 
Parent IL Metabolite 
16 38 
17 39 
18 38 
19 39 
20 38 
21 39 
22 40 
23 41 
24 –
a
 
25 39 
a
No metabolite proposed; 0 % biodegradation in CBT. 
 
The 3-(ethoxycarbonyl)pyridinium butyl ester IL (23) contains two ester groups which 
may have different rates of biodegradation in the CBT, leading to the production of two 
additional metabolites (42 and 43) (Scheme 2.9). A comparison of the theoretical 
ester/amide biodegradation of IL 23 to the experimental biodegradation (30 and 31 % 
respectively) shows that they are very similar. This suggests that the biodegradation of 
IL 23 did not stop at either of the mono ester metabolites (42 and 43) during the 28 day 
period of the CBT. Both biodegradation pathways may have the same rapid rate leading 
to the predominant metabolite 41 (Scheme 2.9) at the end of the CBT. If one of the 
mono ester biodegradation pathways was faster, it would most likely be the primary 
pathway. The rate of biodegradation would however still be slow when compared to the 
rate of biodegradation of the remaining ester group. Otherwise, the mono ester 
metabolite would predominate and an experimental biodegradation of 10–30 % would 
likely be observed in the CBT. 
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Scheme 2.9 Proposed biodegradation pathway for IL 23. 
 Conclusion 2.5
A series of ten bromide ILs (16–25) derived from the renewable resource mandelic acid 
was synthesised with different structural moieties in a short and efficient synthesis in 
three stages: esterification/amidation of mandelic acid, halogenation of the α-position of 
the ester/amide and nucleophilic substitution reaction of the α-halo ester with an 
aromatic N-heterocycle. The ILs were produced in moderate to excellent yields (56–
99 %) as solids with melting points in the range 48–169 °C. The different structural 
moieties in the ILs (various alkyl chain lengths, ester/amide moieties and various N-
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heterocycle headgroups) allowed for the investigation of their effect on IL toxicity and 
biodegradation.    
 
The results show that the majority of the ILs presented with low toxicity towards the 
Gram-positive bacterial strain, and the four Gram-negative bacterial strains they were 
screened against at high IL concentrations. IL toxicity across all bacterial strains 
increased as the alkyl chain length increased in the order methyl ester < ethyl ester < 
butyl ester/amide. None of the ILs demonstrated high toxicity to the the three CCM 
strains and the five clinical isolates they were screened against at low IL concentrations, 
with moderate toxicity observed for the 1-methylimidazolium ethyl ester (18) against 
several of the bacterial strains. Also, none of the ILs demonstrated high toxicity to the 
four ATCC strains and eight clinical isolates of yeasts they were screened against. 
 
The biodegradation studies of the ILs in the CBT showed that the 3-
(ethoxycarbonyl)pyridinium butyl ester IL (23) had the highest level of biodegradation 
(31 % in 28 days), with the 1-methylimidazolium butyl amide IL (24) showing no 
biodegradation under the test conditions (0 % in 28 days). The amide ILs 24 and 25 
demonstrated zero to very poor levels of biodegradation in the CBT (0 and 1 % in 28 
days respectively). Biodegradation of the butyl ester ILs increased in the headgroup 
order pyridinium < 3-methoxypyridinium < 1-methylimidazolium < 3-
(ethoxycarbonyl)pyridinium. The biodegradation pathway proposed for the ILs is 
through ester alkyl chain biodegradation to a carboxylic acid derivative. This conclusion 
is based on previous results in the literature, and was reinforced by comparing the 
results of a predicted theoretical ester/amide biodegradation calculation to the results 
obtained in the CBT. 
 
The dielectric properties of a selection of these ILs have also been evaluated (see 
chapter 4, section 4.2) to investigate their polarity for their potential use as solvents both 
with and without microwave heating.  
 Future Work 2.6
It is proposed that a study involving the detection of the biodegradation metabolites by 
LCMS/MS, and an evaluation of their toxicity, should follow on from this work.  
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Further synthesis and evaluation for aqueous stability, antimicrobial activity and 
biodegradability of the monofluoro mandelic acid IL (37), and future synthesised 
candidates, is anticipated.  
 
It is also intended that these ILs will be used in relation to the overall theme of this 
work, which is targeted at the synthesis of low toxicity biodegradable ILs with 
applications in materials science.  
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3.0 Plasticisation of Poly(L-lactic acid) with 1-Methylimidazolium 
Ester ILs 
 Introduction 3.1
Poly(lactic acid) (PLA) is an aliphatic polyester consisting of lactic acid (2-
hydroxypropionic acid) subunits.
1
 Lactic acid is chiral and exists as the two optical 
isomers D-lactic (44) acid and L-lactic acid (45) (Figure 3.1). Synthesis of PLA from 
pure D-lactic acid (44) or L-lactic acid (45) produces poly(D-lactic acid) (PDLA) and 
poly(L-lactic acid) (PLLA) respectively. Synthesis of PLA from a mixture of the two 
enantiomers will result in poly(D,L-lactic acid) (PDLLA), where a different amount of 
each enantiomer will result in PLA with different material properties. This allows for 
the targeted synthesis of PLA with specific mechanical properties for a particular 
application.  
 
 
Figure 3.1 D-lactic acid (44) and L-lactic acid (45); the building blocks for poly(D-lactic 
acid) and poly(L-lactic acid) respectively. 
 
The majority of lactic acid is produced by carbohydrate fermentation, but it can also be 
obtained by chemical synthesis.
1
 High molecular weight PLA can be produced from 
lactic acid by azeotropic dehydrative condensation, direct condensation polymerisation 
and/or ring-opening polymerisation (ROP) of lactide.
2
 Commercially available PLA 
consists of copolymers of PLLA and PDLLA, and is mainly produced using the ring-
opening polymerisation of lactide monomers.
3
  
 
PLA is a biodegradable (e.g. ASTM D5201 and D5209)
4
 and compostable (e.g. 
ISO 14855)
5,6
 biobased thermoplastic obtained from renewable biomass sources such as 
starch and sugar.
2
 These properties have made PLA a very attractive alternative to 
petrochemical based polymers and also as a solution to the vast problem of excessive 
landfill when handled correctly. PLA is used heavily in the packaging industry for 
plastic bags and a variety of other food and drink containers.
2,7
 It is highly suitable for 
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this application due its low processing temperature, variable barrier properties, good 
printability and low toxicity.
1
 PLA is also biocompatible and has found use in the 
medical industry for the construction of biomedical devices.
8
 
3.1.1 Properties of PLA 
PLA possesses the required mechanical and barrier properties desirable for a number of 
applications to compete with existing petrochemical thermoplastics. The structural, 
thermal, barrier and mechanical properties of PLA are considerably affected by its 
optical purity. In general, PLA can be amorphous or crystalline depending on the 
content of isomers. PLA with > 90 % L-isomer PLA tends to be crystalline, whilst a 
lower optical purity PLA will be amorphous.
1
  
 
The thermal behaviour of polymers is widely characterised using differential scanning 
calorimetry (DSC). A typical DSC plot of PLLA is illustrated in Figure 3.2. As can be 
seen, PLLA has a glass transition temperature (Tg) of ca 60 °C, a cold crystallisation 
temperature (Tc) of ca 100 °C and a melting temperature (Tm) of ca 175 °C. Moreover, 
the DSC trace shows a small pre-melt crystallisation peak at ca 160 °C, which is typical 
to many types of polyester.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 DSC trace of PLLA showing the glass transition temperature (Tg), the 
crystallisation temperature (Tc) and the melting temperature (Tm). 
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The Tg and Tm of PLA decrease with decreasing L-isomer content.
1
 However, the Tg and 
Tm of PLA are high when compared with other thermoplastics such as polystyrene (PS), 
poly(ethylene terephthalate) (PET) and polypropylene (PP). The thermal history of the 
polymer is also known to affect the Tg of PLA.
1
   
 
PLLA is a slow crystallising polymer and its degree of crystallinity can be easily 
calculated from the DSC curve according to Equation 3.1.  
 
𝜒c =
Δ𝐻m − Δ𝐻c
∆𝐻m
0  ×  100 % 
 
Equation 3.1 The degree of crystallinity (𝜒c) of a polymer calculated from the DSC 
trace, where Δ𝐻m is the heat of fusion, Δ𝐻c is the enthalpy of cold-crystallisation and 
∆𝐻m
0  is the enthalpy of fusion for a 100 % crystalline polymer. ∆𝐻m
0  is 93.1 J g
−1
 for 
100 % crystalline PLLA.
1
    
 
When optically pure PLA is quenched from the melt phase the resultant polymer will be 
quite amorphous, with the degree of crystallinity increasing as the cooling rate 
decreases.
9
  
3.1.2 Mechanical Properties of Materials 
The mechanical behaviour of materials can be evaluated by measuring the resulting 
deformations on specimens of the test material from an applied load. A static or 
dynamic tension test can be carried out, where the rate of loading applied to the 
specimen is either slow or fast respectively. Rapid loading in a dynamic tension test 
affects the properties of the materials; therefore, the rate of loading must also be 
measured. For both tests the results depend on the dimensions of the test specimen, 
which must also be measured.
10
 
 
A material's mechanical properties can be defined by a variety of parameters, including: 
  
- Tensile strength: the maximum stress that a material can withstand under loading in 
a tensile test before failure occurs, also known as ultimate strength.
11
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- Elongation at break: a measure of how ductile a material is as determined by a 
tensile test.
12
 
 
- Young’s modulus: the rate of change of strain as a function of stress, also known as 
the modulus of elasticity in tension, and an indication of material stiffness.
13
 
 
Stress and strain in a test specimen can be calculated from the tensile test with a sample 
of known diameter and length. Axial stress (σ) is then calculated by dividing the axial 
load (P) by the cross sectional area of the sample (A) (Equation 3.2).
10
 
 
𝜎 =
𝑃
𝐴
 
 
Equation 3.2 Axial stress (σ) of test specimen, where P is the axial load and A is the 
cross sectional sample area.  
 
Axial strain (ɛ) is calculated by dividing the measured elongation (δ) between the gauge 
marks by the gauge length (L), where the gauge length is the length of the test section 
(Equation 3.3).
10
 When a sample is in tension the strain is called the tensile strain, 
which is an elongation or stretching of the material.  
 
ɛ =
𝛿
𝐿
 
 
Equation 3.3 Axial strain (ɛ) of test specimen, where δ is the measured elongation and 
L is the gauge length.  
 
Ductility of a material can be characterised by its elongation in area at the cross section 
where the fracture occurs. The percentage elongation at break is calculated by dividing 
the gauge length at fracture (L1) minus the original gauge length (L0), by the original 
gauge length (Equation 3.4).
10
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Percentage elongation =
𝐿1 −  𝐿0
𝐿0
 ×  100 
 
Equation 3.4 Percentage elongation at break, where 𝐿1 is the gauge length at fracture 
and 𝐿0 the original gauge length. 
 
Hooke’s law is valid if the stress varies linearly with strain, and Young’s modulus (E) 
can be calculated from the slope of the stress-strain curve or by dividing the stress (σ) 
by the strain (ɛ) (Equation 3.5).14  
 
𝐸 =
𝜎
ɛ
 
 
Equation 3.5 Young’s modulus (E) of test specimen, where σ is the axial stress and ɛ is 
the axial strain.  
 
After performing the tensile test on a sample a stress-strain diagram is obtained which 
gives important information on the mechanical properties and the behaviour of the 
material. Polymers often have non-linear stress strain behaviour.
14
 A typical stress strain 
diagram for various polymers is given in Figure 3.3, where curve 1 represents a linear 
elastic and brittle material (e.g. PS), curve 2 represents a semi-ductile material (e.g. 
PMMA), curve 3 represents a ductile material (e.g. PET) and curve 4 represents a 
typical elastomer (e.g. polyurethane).
15
   
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Typical stress-strain diagram for various polymer types.
15
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3.1.3 Modification of PLA 
Mechanically, unoriented PLA is quite brittle with poor elongation at break, but 
possesses good strength and stiffness.
1
 This is highlighted by comparing the mechanical 
properties of PLLA to PET, where PLLA is shown to have a tensile strength and 
Young’s modulus comparable to PET, but a much lower elongation at break (Table 
3.1). In order for PLA to be as versatile as possible, it is often necessary to modify the 
natural polymer through processing or the addition of specific additives. The additives 
are able to reduce the inherent brittleness of PLA by increasing the elongation at break. 
In this way, the crystallinity and processability of PLA can be modified, thus enabling it 
to be used in a much wider range of applications.  
 
Table 3.1 Comparison of the mechanical properties of the thermoplastics PLLA and 
PET.
16
  
Mechanical property PLLA PET 
Tensile strength (MPa) 59 57 
Elongation at break (%) 4–7 300 
Young’s modulus (GPa) 3.8 2.8–4.1 
 
Methods based on melt processing are the main conversion method currently utilised for 
PLA. This involves heating the polymer above its melting point and shaping to the 
desired form, and subsequently cooling to stabilise its dimensions. Some of these 
methods are extrusion, injection moulding, injection stretch blow moulding, casting, 
film blowing, thermoforming, foaming, fibre spinning and compounding.
1
 In order to 
optimise the conversion of PLA to moulded parts, films, foams and fibres, its unique 
material properties must be considered. It is also important to understand how these 
modifications affect the structural, thermal, physical, crystallisation and rheological 
properties of PLA. 
 
Physical modification of PLA is often carried out through blending or plasticisation. 
PLA has been blended with various polymers such as thermoplastic starch,
17
 poly(ɛ-
caprolactone)
18
 and PEG.
19
 In this way, the properties of the different polymers can be 
combined or new properties can arise due to the interaction of the materials. The 
addition of both biodegradable and non-biodegradable plasticisers to PLA is also 
employed to lower the Tg of the PLA and to increase its ductility and softness.
20
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Plasticisation of PLA has been carried out by the addition of a variety of chemicals such 
as citrate esters,
17,21,22,19
 oligomeric lactic acid
17
 and glycerol.
17
 The limitations of 
currently evaluated PLLA plasticisers include leaching of the plasticiser during use, 
inadequate thermal stability, a greater plasticising effect required (increased ductility 
and material performance), problems with biocompatibility, high cost, high percentage 
loading required and the need for biobased plasticisers.
23
 
3.1.4 ILs as Plasticisers  
ILs are effective plasticisers for polymeric materials because their chemical structures 
and molecular weights can easily be modified by structural changes to the IL cations 
and anions, directly affecting their ability to act as plasticisers. Currently the most 
heavily used plasticisers in industry are phthalates; however, they are now impacted by 
current REACH regulations
24
 due to concerns over their toxicity, as they were found to 
migrate and leach from the polymer matrix.
25-27
 As a result, the use of phthalates has 
been banned or restricted in several applications.
24,28
 Thus, low toxicity and 
biodegradable ILs are an even more attractive alternative to current plasticisers. 
 
Ammonium, imidazolium and phosphonium ILs have been used to plasticise 
poly(methyl methacrylate) (PMMA) and an increased flexibility and thermal stability of 
the material was demonstrated.
26
 Further use of imidazolium ILs to plasticise PMMA 
showed a reduction in the Tg to near zero, and an improvement in the thermal stability 
of PMMA.
29
 The use of ILs as plasticisers for biomedical grade polymers is deemed the 
most industrially relevant application, where the high cost of the IL is offset by the 
higher cost of the polymer. Phosphonium
30,31
 and pyridinium
31
 ILs have been 
successfully used to this effect with biomedical grade poly(vinyl chloride) (PVC). The 
antimicrobial activity of the ILs was also exploited to produce PVC films with 
antimicrobial and antibiofilm forming properties.
31
 Plasticisation of thermoplastic starch 
with [BMIM][Cl], as an alternative to glycerol, was able to increase the elongation at 
break by 300 %, coupled with a decrease in Young’s modulus.32 DES were also shown 
to be effective plasticisers for starch.
33
 The addition of ILs to polyether–polyamide 
block copolymer (Pebax®)
34
 and poly(vinylidene fluoride) (PVDF)
35
 has also been 
studied.  
 
There are several reports on the plasticisation of PLA with ILs.
36-39
 Chen et al. showed 
that plasticising PLA with 1-methyl-3-pentylimidazolium hexafluorophosphate 
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([MPI][PF6]) greatly improved PLA ductility, with elongation at break 25 times higher 
than neat PLA (62 % with 20 wt% IL).
36
 The thermal stability of the material was also 
maintained. Park and Xanthos studied the degradation of PLA by phosphonium ILs with 
decanoate and [BF4] anions and showed that the hydrolytic degradation of PLA was 
accelerated, with [BF4] ILs additionally increasing the thermal stability of the PLA.
37
 
Gui. et al. investigated the use of 1-acetoxyethyl-3-methylimidazolium tetrafluoroborate 
([AOEMIM][BF4]) as a plasticiser for PLLA and showed compatibility, with a gradual 
decrease of the Tg with increasing IL content.
39
 Plasticisation increased the impact 
strength and elongation at break (> 45 % and 200 % increase respectively at 4.8 wt% 
IL) of PLLA, with a slight decrease in tensile strength. However, the thermal stability of 
the plasticised PLLA was shown to decrease as the wt% of IL increased.  
3.1.5 Physical Ageing of PLA 
Rapid ageing of semi-crystalline PLLA has been observed to occur at ambient 
temperatures over the period of a few days.
40,41
 This is considered to be the cause of the 
brittleness of PLA, since ambient temperature is approximately 25 °C below the Tg.
1
 
Ageing is often been attributed to a reduction in free volume in the polymer,
42
 due to a 
rapid relaxation towards the equilibrium amorphous state.
1
 The rate of physical ageing 
has been shown to increase with increasing temperature; however, above the Tg physical 
ageing has been evaluated to no longer be occurring.
40
 The extent of ageing has also 
been determined to increase with decreasing PLA molecular weight, due to the 
increased number of chain terminals in the lower molecular weight PLA having greater 
motional freedom than the internal chain segments.
41
 Ageing below Tg is related 
entirely to the amorphous phase of the polymer, thus increasing the crystallinity of the 
polymer can reduce the ageing effect. The ageing of PLA is also affected by the 
temperature, pressure, cooling rate and cooling temperature when PLA is processed.
1
   
3.1.6 Selection of ILs for Plasticisation 
To increase the ductility of PLLA and overcome the effect of physical ageing the 
plasticisation of PLLA with ILs was proposed. The aim of this study was to utilise 
‘green’ ILs to overcome a number of the current PLLA plasticiser limitations by 
identifying plasticisers with increased thermal stability, a high plasticising effect and 
decreased leaching. This work was carried out as a proof of concept study where a 
number of prototype materials were synthesised. It is envisaged that this work will be 
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further progressed by utilising functionalised and task specific ILs as plasticisers, with 
the aim of creating plasticised materials targeted to specific applications. 
 
It was necessary that the chosen ILs fulfilled a number of specific criteria. These were:  
 
1. Liquid at room temperature – preferable to assist polymer chain mobility. 
2. Structural features present that promote low antimicrobial activity (e.g. ether) and 
increased biodegradability (e.g. ester) – desired to maintain biodegradability and 
material use in the medical and food packaging industries. 
3. Ideally > 300 g mol−1 – a minimum molar volume is necessary to fill the free 
volume of the polymer. 
4. Temperature resistant up to 200 °C – to prevent material decomposition when melt 
processing with PLLA. 
5. Low volatility – to prevent leaching from PLLA. 
6. Containing polar functionalities in cation or/and anion to interact with the polar 
hydroxyl groups of PLLA (e.g. ester carbonyl group) – prevent material ageing and 
IL leaching. 
 
A series of twelve target 1-methylimidazolium ester ILs (46–57) was selected for 
plasticisation with PLLA (Table 3.2). The ILs contained specific structural features that 
allowed for the investigation of their effect on the plasticisation of PLLA. These 
structural features included: 
 
- Four alkyl chain lengths: butyl, 2-ethoxy ethyl, 2-butoxy ethyl, 2-(2-butoxyethoxy) 
ethyl 
- Ester functional groups 
- Three anions: bromide, bistriflimide, octyl sulfate 
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Table 3.2 1-Methylimidazolium ester ILs (46–57) with various alkyl/ether chain lengths 
and different anions.  
 
R = 
X = 
Br NTf2 OctSO4 
 46 50 54 
 
47 51 55 
 
48 52 56 
 
49 
 
53 
 
57 
 
 
The antimicrobial activity of the 1-methylimidazolium ILs (46–57) has previously been 
reported, and low toxicity to a wide range of screened bacteria was demonstrated.
43
 The 
biodegradability of the octyl sulfate ILs were evaluated by the CO2 headspace test and 
showed that ILs 46–57 biodegraded 59–65 % during the 28 day test period, with ILs 56 
and 57 classified as readily biodegradable with 61 and 65 % biodegradation 
respectively.
43
    
 Synthesis of ILs for Plasticisation 3.2
The synthesis of the 1-methylimidazolium ester ILs consisted of three parts (Scheme 
3.1): 
 
1. Acylation of alcohol/glycol ether  
2. Nucleophilic substitution reaction of the alkylating reagent with 1-methylimidazole  
3. Anion metathesis with lithium bistriflimide or sodium octyl sulfate 
 
Full procedural detail for the preparation of the 1-methylimidazolium ester ILs is 
provided in the experimental section of this work (chapter 6, section 6.3).  
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Scheme 3.1 General synthesis route to 1-methylimidazolium ester ILs (46–57).  
3.2.1 Synthesis of Bromoester Alkylating Reagents 
The four bromoester alkylating reagents (58–60) (Figure 3.4) were synthesised by 
acylation of the appropriate alcohol/glycol ether, according to a modified version of the 
procedure reported in the literature.
43
  Bromoester alkylating reagent 61 (Figure 3.4) 
was available as a previously prepared sample, which was also synthesised according to 
a modified version of the literature procedure.
44
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Figure 3.4 Percentage yields for bromoester alkylating reagents (58–61), synthesised 
from bromoacetyl bromide. Percentage yield for 61 reported from previous synthesis.
44
  
 
The literature procedure to synthesise 58–61 employed TEA as a homogeneous base, 
with purification of the product carried out by vacuum distillation.
43
 However, the use 
of Na2CO3 as a heterogeneous base allowed simple filtration to be used to remove the 
base on reaction completion, and also negated the need for distillation to purify the 
product. Compound 61 was the only compound that required purification by column 
chromatography.
44
 The addition of bromoacetyl bromide at −78 °C was also no longer 
necessary. In a typical reaction, bromoacetyl bromide (1.2 eq.) was added dropwise to 
the appropriate alcohol/glycol ether dissolved in DCM at 0 °C, with Na2CO3 (1.5 eq.). 
After 12-24 h TLC confirmed reaction completion and 58–61 were obtained as 
colourless to yellow liquids in good to excellent yields (79–98 %) (Figure 3.1). Products 
58 and 61 were obtained as colourless liquids when using Na2CO3, but had previously 
been obtained as coloured products, even after distillation, when TEA was used.
45
 
Percentage yields also increased from 60–75 % when TEA was used to 79–98 % when 
using Na2CO3 (Table 3.3). These reactions are nucleophilic substitution reactions which 
are proposed to occur mainly via an addition-elimination mechanism.
46
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Table 3.3 Percentage yields for bromoester alkylating reagents (58–61). 
Compound Structure 
Yield (%) 
TEA
43
 Na2CO3 
58 
 
68 85 
59 
 
60 79 
60 
 
75 92 
61 
 
72 98
a
 
a
Percentage yield for 61 reported from the literature.
44
 
 
The 
1
H NMR of 58 in CDCl3 shows a characteristic singlet at 3.83 ppm for the H1 
protons (Figure 3.5). The CH2 signal is shifted downfield due to the presence of the 
bromine and carbonyl group, which are both electron withdrawing. A deshielding of the 
neighbouring CH2 protons occurs by negative induction (−I) through the sigma bonds, 
and through a negative mesomeric (−M) effect in the case of the ester group.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 
1
H NMR of alkylating reagent 58 in CDCl3.  
5
1
2 
43
CHCl3 
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3.2.2 Synthesis of 1-Methylimidazolium Ester ILs 
3.2.2.1 Synthesis of Bromide ILs 
The four 1-methylimidazolium ester bromide ILs (46–49) (Table 3.4) were synthesised 
from the alkylating reagents 58–61 according to a modified version of the literature 
procedure.
43
 The literature procedure states that the reactions were initiated at −15 °C 
and maintained for 3 h; however, this was deemed unnecessary for successful reaction 
completion. 1-Methylimidazole (1.02–1.1 eq.) was added dropwise to the bromoester 
alkylating reagent dissolved in diethyl ether. After 2 days of stirring under N2 reaction 
completion was confirmed by TLC, with the desired IL precipitating during the course 
of the reaction. The ILs were purified by trituration with diethyl ether to give a viscous 
liquid (46), a brown solid (47) and a white solid (48 and 49) in excellent yields (96–
99 %) (Table 3.4). The solid ILs had melting points significantly lower than 100 °C, in 
the range 36–70 °C (Table 3.3). The melting points increase as the length of the alkyl 
chain and number of ether oxygens in the chain increases. This increase has been 
attributed to inter-chain hydrophobic packing affects and bilayer-type structure 
formation.
47
  
 
Table 3.4 Percentage yields and melting points for 1-methylimidazolium ester bromide 
ILs (46–49). 
 
IL R = Yield (%) mp (°C) 
46  99 n/a
a
 
47 
 
98 36–38 
48 
 
98 40–42 
49 
 
96 68–70 
a
IL was liquid at rt. 
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The synthesis of ILs 46–49 is a nucleophilic substitution reaction, more specifically a 
Menschutkin reaction. Most often the reaction between 1-methylimidazole and an alkyl 
halide proceeds through a bimolecular SN2 process.
48
 However, the reaction mechanism 
can be influenced by the structure of the reactant and also the reaction conditions.
49
  
 
The 
1
H NMR spectra of IL 46 in CDCl3 shows a large downfield shift for the CH2 
singlet of the H5 protons, from 3.83 ppm for the corresponding peak in in the alkylating 
reagent (58) (Figure 3.6), to 5.42 ppm (Figure 3.5). This downfield shift is due to a 
greater electron withdrawing effect from the imidazolium ring in IL 46, by negative 
induction (−I), than from the bromine in compound 58.  
 
 
 
 
 
 
 
 
 
 
Figure 3.6 
1
H NMR of 1-methylimidazolium ester bromide IL 46 in CDCl3.  
3.2.2.2 Synthesis of Bistriflimide ILs 
The four 1-methylimidazolium ester bistriflimide (NTf2) ILs (50–53) (Table 3.5) were 
synthesised from the corresponding bromide ILs 46–58, according the literature 
procedure.
43
 This reaction is an anion metathesis reaction, where the product is 
insoluble in the reaction solvent. In a typical reaction, LiNTf2 (1.1 eq.) was added in one 
portion to the bromide IL dissolved in deionised water. The reaction was stirred for 2 
days at rt, with the desired IL precipitating during the course of the reaction. The IL was 
purified by trituration with deionised water to give either a light yellow liquid (50) or a 
colourless liquid (51–53) in excellent yields (83–94 %) (Table 3.5). None of the ILs 
were solid at rt, as is often the case for NTf2 ILs, as the anion is known to give RTILs 
with lower melting points and lower viscosities than the corresponding halide ILs.
47
 The 
4 
5 
8 7 
2/3
9
6 
1 
CHCl3 
H2O 
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low viscosity of the NTf2 ILs can be attributed to the increase in asymmetry of the anion 
compared to the halide anions.
47
 The low melting points of NTf2 ILs are most often 
attributed to the ability of the NTf2 anion to delocalise its negative charge, weakening 
its ability to hydrogen bond with the cation.
47,50
  
 
Table 3.5 Percentage yields and melting points for 1-methylimidazolium ester NTf2 ILs 
(50–53). 
 
IL R = Yield (%) 
50  89 
51 
 
83 
52 
 
94 
53 
 
89 
 
The 
1
H NMR of IL 50 in CDCl3 shows a characteristic upfield shift of the CH singlet 
for the H4 proton, from 10.04 ppm in the corresponding bromide IL (46) (Figure 3.6), to 
8.74 ppm (Figure 3.7). This is caused by a slight shielding of the proton by the NTf2 
anion, due to it having a much more delocalised negative charge than the bromide 
anion.
44
 In the 
13
C NMR spectra of 50 in CDCl3, the presence of the NTf2 anion is 
confirmed by the appearance of a quartet at 119.79 ppm with 
1
JC-F = 320.9 Hz (Figure 
3.8).
51
 This quartet is formed by each of the CF3 carbons (C11) coupling to the three 
neighbouring fluorine atoms through one bond coupling. The 
19
F NMR of IL 65 also 
gives a singlet at -79.22 ppm, which is a characteristic fluorine NMR chemical shift for 
CF3 containing compounds.
51
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Figure 3.7 
1
H NMR of 1-methylimidazolium ester bistriflimide IL 50 in CDCl3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 
13
C NMR of 1-methylimidazolium ester bistriflimide IL 50, showing the 
quartet formed by C-F coupling of the CF3 groups in the NTf2 anion in CDCl3.  
 
11 
2/3 
 
CHCl3 
4 
2/3 
8 7 
9
6 
1
5 
H2O 
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3.2.2.3 Synthesis of Octyl Sulfate ILs 
The four 1-methylimidazolium ester octyl sulfate (OctSO4) ILs (54–57) (Table 3.6) 
were synthesised from the corresponding bromide ILs 46–49, according to a modified 
version of the literature procedure.
43
 The literature states that the reaction was 
maintained at 60 °C for 2 h; however, heating was deemed unnecessary for reaction 
completion. This reaction is an anion metathesis reaction, where the product is insoluble 
in the reaction solvent. In a typical reaction, NaOctSO4 (1.05 eq.) was added in one 
portion to the bromide IL dissolved in deionised water. The reaction was stirred 
overnight and after work-up the desired IL was isolated as either a colourless grease 
(54), a light yellow grease (55), a colourless liquid (56) or a light yellow gel (57) in 
good to excellent yields (75–99 %) (Table 3.6). The ILs were very hygroscopic and 
required extensive drying under high vacuum for 2 days at 50 °C. 
 
Table 3.6 Percentage yields and melting points for 1-methylimidazolium ester OctSO4 
ILs (54–57). 
 
IL R = Yield (%) 
54  92 
55 
 
84 
56 
 
75 
57 
 
99 
 
The 
1
H NMR of IL 54 in CDCl3 shows the acidic proton on the 1-methylimidazolium 
ring (H4) as a singlet at 9.37 ppm (Figure 3.9). This indicates that the octyl sulfate anion 
is shielding compared to the bromide anion, but not as shielding as the NTf2 anion, with 
chemical shifts of 10.04 ppm and 8.74 ppm for the corresponding H4 proton in the 
bromide and NTf2 ILs respectively.  
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Figure 3.9 
1
H NMR of 1-methylimidazolium ester octyl sulfate IL 54 in CDCl3.  
 Thermogravimetric Analysis of ILs 3.3
The ILs needed to be stable in the melt extruder up to the temperature that the PLLA 
and IL were processed at during mixing. PLLA has a melting temperature of 176.3 °C 
(identified by DSC); therefore, to reach the molten state of PLLA and facilitate 
homogeneous mixing with the IL, the temperature of the extruder was maintained at 
200 °C. Thus, evaluation of each IL decomposition temperature was necessary. With 
this information, the ILs suitable for plasticisation with PLLA could be identified. The 
thermal decomposition data for each IL was used as an indication of the thermal 
stability of the IL when mixed with PLLA in the extruder, as the decomposition of the 
IL would likely be affected on mixing with PLLA.  
 
The thermal stabilities of the 1-methylimidazolium ester ILs (46–57) were analysed by 
thermogravimetric analysis (TGA). The TGA curve for IL 53, characteristic for ILs 46–
57, displays how the decomposition start temperature (Tstart) and onset temperature 
(Tonset) of the ILs were detected (Figure 3.10). The TGA graphs for ILs 46–57 are 
provided in Appendix C. 
4 
5 
8, 
12–16 
7, 11 
17 
6 
2/3 
1, 10 
9
CHCl3 TMS 
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Tonset 
Tstart 
  
Figure 3.10 TGA curve for IL 53 showing how the start (Tstart) and onset (Tonset) 
decomposition temperatures were detected. 
 
The TGA curve for IL 53 (Figure 3.10) shows two prominent areas of decomposition. 
The first decomposition (Tonset = 290 °C) is proposed breakdown of the ester moiety and 
the second decomposition (Tonset = 390 °C) is proposed breakdown of the 1-methyl 
imidazolium ring.
39,52
 The decomposition of the 1-methylimidazolium ring for all other 
1-methylimidazolium ILs cannot be detected as clearly as seen in IL 53. This is most 
likely due to decomposition of other areas of the IL (e.g. ether breakdown) masking the 
sharp transition that is expected for the 1-methylimidazolium breakdown. As the lowest 
temperature of IL decomposition will determine its use in the extruder at 200 °C, the 
Tonset and Tstart decomposition temperatures for the first transition (most likely ester 
breakdown) were used to evaluate the thermal stability of the 1-methylimidazolium ILs 
(46–57) (Table 3.7).    
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Table 3.7 TGA data for ILs 46–57, where Tstart is the start temperature of decomposition 
and Tonset is the onset temperature of decomposition. 
IL Anion Tstart (°C) Tonset (°C) 
46 
Br 
161 207 
47 157 213 
48 162 208 
49 155 207 
50 
NTf2 
284 332 
51 273 329 
52 279 327 
53 253 289 
54 
OctSO4 
 
159 278 
55 157 199 
56 182 217 
57 159 276 
 
When comparing the Tstart and Tonset of ILs 46–57 (Table 3.6) it is observed that the 
anion has a large impact on the decomposition temperatures of the ILs. IL thermal 
stability increased in the order Br < OctSO4 < NTf2. An average Tonset of 209, 242 and 
319 °C was observed for the Br, OctSO4 and NTf2 ILs respectively. This was expected 
as the literature shows that NTf2 ILs have higher decomposition temperatures than 
bromide ILs, with the reduced thermal stability of the halide ILs attributed to a high 
nucleophilicity and basic character.
53
 The decomposition of the octyl sulfate IL 
[BMIM][OctSO4] at 341 °C
54
 is also between that of [BMIM][NTf2] and [BMIM][Br], 
which have decomposition temperatures of 409 and 273 °C respectively.
53
 The 
decomposition temperatures of ILs 46–57 are lower than would be expected for the 
equivalent alkyl ILs (no ester group), as the thermal stability of ILs has been shown to 
decrease with the addition of ester groups
39
 and ether groups
55
 (e.g. Tonset = 207 and 
273 °C for IL 46 and [BMIM][Br] respectively). 
 
The Tonset of the bromide ILs (46–49) at 201–213 °C (Table 3.6) was only a few degrees 
higher than the 200 °C temperature required to process PLLA and IL in the extruder. 
The Tstart between 155–162 °C for ILs 46–49 was also much lower than the processing 
temperature. For this reason, the bromide ILs were deemed unsuitable for processing in 
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the extruder at 200 °C; therefore, the plasticisation of PLLA with ILs 46–49 was not 
carried out. However, not being able to use the bromide ILs 47–48 as plasticisers was 
acceptable as they were solid at rt, which is not an ideal quality for a plasticiser. ILs 46–
49 were also key intermediates in the synthesis of ILs 50–53, thus their thermal stability 
was assessed alongside ILs 50–53 to see if they could also be investigated as 
plasticisers. 
 
The Tonset of the NTf2 ILs (50–53) at 289–332 °C (Table 3.6) was much higher than the 
200 °C temperature required to process PLLA and IL in the extruder. The Tstart between 
253–284 °C for ILs 50–53 was also much higher than the processing temperature. Thus, 
all the NTf2 ILs had a suitable thermal stability for melt processing with PLLA. 
 
The Tonset of the OctSO4 ILs (54–57), at 199–278 °C (Table 3.6), was between the 
200 °C temperature required to process the PLLA and IL in the extruder. The Tstart of 
ILs 54–57, 157–182 °C, was also lower than the processing temperature. However, the 
thermal stability of the IL would likely be affected by mixing with PLLA and also 
needed to be considered. The ILs (54–57) would also only be in the extruder at 200 °C 
for 7 minutes during the melt processing with PLLA. Consequently, it was decided to 
investigate ILs 54–57 as plasticisers for PLLA, taking into account the thermal 
decomposition temperatures of the ILs. The TGA curve of the OctSO4 IL 57 (Appendix 
C, Figure C12) shows a large initial decomposition, with a Tstart of 79 °C and a Tonset of 
107 °C. As a result, the IL was not plasticised with PLLA due to its observed very low 
initial decomposition temperature. However, on subsequent analysis of the TGA curve 
it was deduced that this decomposition was highly likely to be due to the loss of water, 
despite the OctSO4 ILs being extensively dried before TGA due to their hygroscopic 
nature. The initial IL decomposition, due to the ester breakdown, was subsequently 
calculated with a Tstart and Tonset of 159 and 276 °C respectively, only 1°C different to 
the OctSO4 IL 54 (Table 3.6).  
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  Plasticisation of PLLA with ILs 3.4
PLLA (> 99 % L-isomer) was used for this work as it was desired to work with semi-
crystalline PLA for the plasticisation. It is also known that lactic acid from biological 
sources consists mostly of L-lactic acid, thus a greater amount of PLLA can be derived 
from renewable resources.
1
 This work was carried out in collaboration with the Polymer 
Technology Group in the Department of Materials at ETH Zürich, Switzerland. 
3.4.1 PLLA and PLLA/IL Film Formation 
PLLA was plasticised with each IL (50–56) at 10, 20 and 30 wt% IL. Mixing was 
performed in a co-rotating twin-screw extruder (Figure 3.11) at 200 °C for 7 minutes. 
Films of approximately 0.5 mm in thickness were produced using a compression 
moulding technique. Firstly, the extrudate was compressed at 200 °C (above the PLLA 
melting point) in a hot press, followed by quenching to room temperature in a cold 
press. Neat PLLA films (i.e. without any IL) were produced for baseline measurements. 
Full procedural detail for the preparation of the PLLA/IL films is provided in the 
experimental section of this work (chapter 6, section 6.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Laboratory scale co-rotating twin-screw extruder used for mixing of PLLA 
and ILs 50–56.  
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A key to the structure of each IL (50–56) and the resultant PLLA/IL films (PLLA/IL50–
56) formed after plasticisation is provided in Table 3.8.  
 
Table 3.8 Key to the structures of the 1-methylimidazolium ester ILs (50–56) used for 
the synthesis of the corresponding PLLA/IL films (PLLA/IL50–56). 
 
IL R = X = Film  
50  NTf2 PLLA/IL50 
51 
 
NTf2 PLLA/IL51 
52 
 
NTf2 PLLA/IL52 
53 
 
NTf2 PLLA/IL53 
54  OctSO4 PLLA/IL54 
55 
 
OctSO4 PLLA/IL55 
56 
 
OctSO4 PLLA/IL56 
 
The visual characteristics of the resultant PLLA/IL films are displayed in Table 3.9. 
PLLA plasticised with the NTf2 ILs (50–53) at 10, 20 and 30 wt% formed homogenous 
transparent to mostly transparent films (Table 3.9). Transparency of plasticised films is 
usually a good indication of compatibility and total miscibility of the plasticiser with the 
polymer.
30
 Thus, the NTf2 ILs appeared to be compatible with the PLLA. However, 
PLLA plasticised with the OctSO4 ILs (54–56) formed hazy films at 10 wt% IL, with 
opaque films formed at 20 and 30 wt% IL, which also had a greasy texture. It was also 
difficult to obtain a film without bubbles for PLLA plasticised with the OctSO4 ILs (54–
56). All these visual signs are an indicator of possible incompatibility of the OctSO4 ILs 
with PLLA. The greasy texture of PLLA/IL55–56 with 20 and 30 wt% IL may be an 
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indication of leaching of the IL from the film. The PLLA/IL films containing 30 wt% 
NTf2 or OctSO4 IL were very flexible, which was in stark contrast to the PLLA/IL films 
containing 10 wt% NTf2 ILs (50–53) or OctSO4 ILs (54–56), which appeared to be very 
brittle. PLLA/IL films with 20 wt% IL appeared moderately flexible and not brittle.  
 
Table 3.9 Visual appearance of PLLA/IL films with 10, 20 and 30 wt% IL.  
Anion IL  
IL content (wt%) 
10 20 30 
NTf2 
50 Transparent Transparent Transparent 
51 Transparent Mostly Transparent Mostly Transparent 
52 Transparent Transparent Transparent 
53 Transparent Transparent Transparent 
OctSO4 
54 Hazy film Opaque  Opaque 
55 Hazy film Opaque greasy film Opaque greasy film 
56 Hazy film Opaque greasy film Hazy, greasy film 
3.4.2 Mechanical Properties  
The mechanical properties of neat PLLA and PLLA/IL films containing 10, 20 and 
30 wt% of ILs 50–56 were analysed. The elongation at break, Young’s modulus and 
tensile strength were obtained from the stress-strain curves of the measured films. A 
uniaxial tension test at constant rate of strain was carried out on the PLLA and PLLA/IL 
films, which had been cut into dumbbell-shaped specimens with a gauge length of 12 
mm (Figure 3.12). For each sample a minimum of three specimens were tested, with the 
mean average of the values reported herein. Full procedural detail for the tensile testing 
of neat PLLA and PLLA/IL films is given in the experimental section of this work 
(chapter 6, section 6.1.9).  
 
 
 
 
Figure 3.12 Dumbbell-shaped specimen used for tensile testing of the PLLA/IL films, 
with a gauge length of 12.7 mm. 
 
Gauge length 
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The initial tensile testing of the PLLA and PLLA/IL50–56 films was carried out on the 
same day as the melt extrusion and film formation were undertaken (day 0). The tensile 
testing results for the neat PLLA film, without any IL (0 wt% IL), on day 0 show that a 
relatively ductile material (> 300 % elongation at break), with a high Young’s modulus 
(1514.30 MPa) and high tensile strength (55.62 MPa) were obtained (Table 3.10). 
However, the mechanical properties of PLLA films are greatly affected by physical 
ageing, which causes embrittlement of the films.
40
 Ageing was confirmed by evaluation 
of the mechanical properties of the neat PLLA film four days after initial film formation 
(day 4), which showed a vast reduction in the elongation at break from 373.53 % on day 
0 to 8.93 % on day 4 (Table 3.10). The Young’s modulus and tensile strength of the 
neat PLLA increased slightly during the 4 day ageing period, indicating an increase in 
both the stiffness and strength. 
 
Table 3.10 Effect of physical aging on the mechanical properties of neat PLLA films. 
Day 
Elongation at 
break (%) 
Young’s 
modulus (MPa) 
Tensile 
strength (MPa) 
0 373.53 1514.30 55.6 
4 8.93 1630.57 62.8 
 
The tensile testing results for the PLLA/IL50–56 with 10 wt% IL showed a significant 
change in the elongation at break for the testing of subsequent samples (Table 3.11). All 
the initial samples tested (sample 1) had a high to moderate elongation at break (157–
470 and 103–236 % for NTf2 and OctSO4 ILs respectively). However, the elongation at 
break drastically reduced in all subsequent samples for each PLLA/IL film, with only 
the PLLA/IL53 film with 10 wt% IL giving an elongation at break higher than that of 
the 4 day aged PLLA (Table 3.10 and 3.11). The PLLA/IL50–53 and PLLA/IL54–56 
with 10 wt% IL all had an elongation at break less than 7 %, which was less than for 4 
day aged PLLA (8.93 %). The ILs 50–54 are initially acting as plasticisers with 10 wt% 
IL (Sample 1) as the elongation at break is higher than neat PLLA. However, overall 
ILs 50–54 can be said to be acting as antiplasticisers as they caused the PLLA to age 
and become brittle much faster than the neat PLLA film.
30
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Table 3.11 Elongation at break for PLLA/IL50–56 plasticised with 10 wt% NTf2 and 
OctSO4 ILs on day 0, for four consecutively tested samples.  
Anion IL  
Elongation at break (%) 
Sample 1 Sample 2 Sample 3 Sample 4 
NTf2 
50 470.31 6.89 6.38 6.63 
51 372.74 27.67 15.35 6.86 
52 156.82 5.78 6.62 6.00 
53 414.34 159.03 22.79 22.8 
OctSO4 
54 102.66 25.32 19.13 4.13 
55 236.13 28.75 18.19 7.83 
56 219.29 14.82 10.82 5.01 
 
The comparison of the stress-strain curves for neat PLLA, aged for four days, and 
PLLA plasticised with 10 wt% IL 50, last of four samples tested, is illustrated in Figure 
3.13.   
 
 
Figure 3.13 Stress-strain curves of neat PLLA (4 days aged) and PLLA/IL50 with 
10 wt% IL (last of four samples tested). 
 
The tensile testing results for PLLA/IL50–53 with 20 and 30 wt% NTf2 ILs show a vast 
increase in the elongation at break, compared to neat PLLA, on addition of the ILs 50–
53 (Table 3.12). The elongation at break also increased as the wt% of plasticiser in the 
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film is increased. The IL plasticiser increased the mobility of the PLLA chains, to a 
greater extent at higher wt% of IL, and the PLLA/IL films had much greater ductility as 
a result. The elongation of break was on average 56 times higher with 20 wt% IL 50–
53, and more than 80 times higher with 30 wt% IL 50–53. The highest increase in the 
elongation at break was observed for PLLA/IL50 with 30 wt% IL, with an elongation at 
break almost 90 times higher than neat PLLA. The greatest increase with 20 wt% IL 
was observed for PLLA/IL53, with an elongation at break 66 times higher than neat 
PLLA. These results show a much greater increase in the elongation at break than is 
observed in the literature for plasticising PLA with ILs, where 20 wt% [MPI][PF6] gave 
a 25 times increase in the elongation at break.
36
 As previously discussed (Table 3.11) 
the PLLA/IL50–53 films with 10 wt% ILs showed poor elongation at break. 
 
Table 3.12 Tensile testing results for neat PLLA, aged for 4 days, and PLLA/IL50–53 
with 10, 20 and 30 wt% NTf2 IL. 
Sample 
IL content 
(wt%) 
Elongation at 
break (%)
a
 
Young’s 
Modulus 
(MPa) 
Tensile 
strength 
(MPa) 
PLLA 0 8.93 1630.57 62.82 
PLLA/IL50 
10 6.63 1531.05 50.29 
20 510.82 1091.23 29.86 
30 798.43 241.31 25.68 
PLLA/IL51 
10 6.86 1331.12 49.65 
20 502.39 1102.68 31.67 
30 702.28 53.68 17.88 
PLLA/IL52 
10 6.00 1551.35 51.56 
20 403.07 860.97 22.74 
30 714.77 252.44 25.65 
PLLA/IL53 
10 22.8 1510.32 47.80 
20 589.99 902.47 26.14 
30 727.19 175.07 17.46 
a
For 10 wt% ILs the values are given for the last of 4 samples tested. 
 
The Young’s modulus of PLLA/IL50–53 with 20 and 30 wt% NTf2 IL decreased as the 
wt% of IL increased (Table 3.12). This result corresponds with the literature data for 
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PLLA plasticised with ILs.
36
 The Young’s modulus was on average 1481, 989 and 
181 MPa for 10, 20 and 30 wt% IL respectively. The greatest decrease in the Young’s 
modulus was observed for PLLA/IL51 with 30 wt% IL, which decreased from 
1630.57 MPa in neat PLLA to 53.68 MPa. This shows that the stiffness of the PLLA 
significantly reduced on plasticisation with the PLLA, which corresponds to the 
increased elongation at break observed for this material. For PLLA/IL50 with 30 wt%, 
the material with the highest elongation at break, the Young’s modulus was reduced 
from 1630.57 MPa in neat PLLA to 241.31 MPa. For PLLA/IL53 with 20 wt%, the 
material with the highest elongation at break with 20 wt% IL, the Young’s modulus was 
decreased from 1630.57 MPa to 902.47 MPa. The Young’s modulus decreased in 
PLLA/IL50–53 with 10 wt% IL despite the decrease in the elongation at break 
compared to neat PLLA.    
 
The tensile strength of PLLA/IL50–53 with 10, 20 and 30 wt% NTf2 IL decreased as 
the wt% of IL increased (Table 3.12). This result corresponds with the literature data for 
PLLA plasticised with ILs.
36,39
 The tensile strength was on average 50, 28 and 22 MPa 
for 10, 20 and 30 wt% IL respectively. The greatest decrease in the tensile strength was 
observed for PLLA/IL53 with 30 wt% IL, which decreased from 62.82 MPa in neat 
PLLA to 17.46 MPa. For PLLA/IL50 with 30 wt%, the material with the highest 
elongation at break, the tensile strength was reduced from 62.82 MPa in neat PLLA to 
25.68 MPa. For PLLA/IL53 with 20 wt%, the material with the highest elongation at 
break with 20 wt% IL, the tensile strength was decreased from 62.82 MPa to 
26.14 MPa.  
 
These results show that the NTf2 ILs 50–53 at 20 and 30 wt% were able to successfully 
plasticise PLLA and prevent embrittlement, with a large increase in the elongation 
compared to neat PLLA. Due to the decrease in the tensile strength with increasing wt% 
of IL, PLLA plasticisation with 20 wt% IL 50–53 gave the most promising results. The 
PLLA/IL51 with 20 wt% IL gave a high elongation at break (502.39 %), with a 
moderate decrease in the Young’s modulus and tensile strength of 1102.68 and 
31.67 MPa respectively. In all cases the mechanical properties of PLLA plasticised with 
20 wt% IL 50–53 were superior to the literature, which reported that the addition of 
20 wt% [MPI][PF6] to PLA gave an elongation of break of 61.6 % with a tensile 
strength of only 20.6 MPa.
36
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The difference in the stress-strain curves of PLLA/IL50 with 20 and 30 wt% IL is 
illustrated in Figure 3.14. Noticeably, PLLA/IL50 with 20 wt% IL yields at higher 
stress and shows strain softening followed by strain hardening. On the other hand, 
PLLA/IL50 with 30 wt% shows characteristic stress-strain behaviour of a rubber like 
material.  
 
 
Figure 3.14 Stress-strain curves for PLLA/IL50 with 20 and 30 wt% IL.  
 
The tensile testing results for PLLA/IL54–56 with 10, 20 and 30 wt% OctSO4 ILs show 
that there was an increase in the elongation at break for PLLA/IL54 and PLLA/IL55 on 
increasing the wt% of the IL from 10 to 20 % (Table 3.13). The tensile properties of 
PLLA/IL56 with 20 and 30 wt% IL could not be measured as the films were too brittle 
to allow an intact sample to be cut for testing. This result demonstrates the 
incompatibility of the OctSO4 ILs 54–56 with the PLLA, as it has been previously 
shown that the introduction of an incompatible component into the PLLA matrix can 
cause a dramatic loss of the PLLA mechanical properties.
17
 For PLLA/IL54 the 
elongation at break decreased from 18.41 % to 3.21 % with 30 wt% IL. For PLLA/IL55 
with 30 wt% IL the elongation at break increased to 76.34 %, the highest elongation 
measured for the OctSO4 ILs (54–56). However, this elongation at break is only 8.5 
times higher than the elongation at break measured for neat PLLA, with the 
corresponding NTf2 IL (PLLA/IL51 at 30 wt% IL) giving a much higher elongation of 
break at 702.28 % (Table 3.12). The tensile strength is also lower than was measured 
for the most promising result for PLLA plasticised with an NTf2 IL (PLLA/IL51 with 
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20 wt% IL). The Young’s modulus and tensile strength decreased as the wt% of 
plasticiser increased for the PLLA/IL54–55 films, with the exception of PLLA/IL51 
with 30 wt% IL where the Young’s modulus increased between 20 and 30 wt% IL. 
 
Table 3.13 Tensile testing results for 4 day aged PLLA and PLLA/IL50–53 with 10, 20 
and 30 wt% OctSO4 IL. 
Sample 
IL content 
(wt%) 
Elongation at 
break (%)
a
 
Young’s 
Modulus 
(MPa) 
Tensile 
strength 
(MPa) 
PLLA 0 8.93 1630.57 62.82 
PLLA/IL54 
10 4.13 1349.59 40.78 
20 18.41 1243.42 33.22 
30 3.21 1283.37 29.96 
PLLA/IL55 
10 7.83 1394.18 37.47 
20 10.40 1231.17 24.28 
30 76.34 1217.59 26.28 
PLLA/IL56
b
 
10 5.01 1485.91 46.42 
20 – – – 
30 – – – 
a
For 10 wt% ILs the values are given for the last of 4 samples tested. 
b
Samples PLLA/IL56 with 20 and 30 wt% IL were too brittle to be tested. 
3.4.3 Physical Ageing Study 
To understand how the properties of the PLLA/IL films change over time, a physical 
ageing study was carried out on PLLA/IL50–53 with 20 and 30 wt% NTf2 IL. These 
PLLA/IL films showed a successful plasticising effect on PLLA during testing on day 
0. The PLLA/IL50–53 with 20 and 30 wt% IL were stored in polyethylene sample bags 
at ambient conditions and mechanical properties were measured on day 1, 10 and 100. 
All the ageing study results for PLLA/IL50–53 with 20 and 30 wt% IL are presented as 
graphs in Appendix D. 
 
Ageing was observed in all PLLA/IL50–53 films. Moreover, it occurred faster in films 
with a higher wt% of IL. In particular, the elongation at break of PLLA/IL50–53 
reduced faster and to a greater extent with 30 wt% IL than with 20 wt% IL (Table 3.14). 
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During the physical aging the ability of the PLLA/IL film to dissipate energy through 
molecular motion decreases,
40
 and the films become increasingly brittle and the 
elongation at break is reduced as a result. The smallest reduction in the elongation at 
break is observed for PLLA/IL51 with 20 wt% IL, where there was a loss of only 144 % 
in the elongation at break, to 358.74 %, after 100 days of aging (Table 3.14). None of 
the PLLA/IL50–53 films showed an elongation at break lower than aged neat PLLA 
(8.93%), with PLLA/IL51 with 30 wt% the closest at 33.92 % elongation at break after 
100 days. In almost all cases the rate of ageing significantly decreased as the time from 
initial sample preparation (day 0) increased. This trend has also been observed in the 
literature.
40
 PLLA/IL51 with 20 wt% IL was an exception to this, where ageing did not 
seem to be occurring between day 1 and day 10.  
 
Table 3.14 Effect of physical aging on the elongation at break of PLLA/IL51–53 with 
20 and 30 wt% NTf2 IL. 
Sample 
IL content 
(wt%) 
Elongation at break (%) 
Day 0 Day 1 Day 10 Day 100 
PLLA/IL50 
20 510.82 480.92 419.48 349.33 
30 798.43 679.70 622.46 152.08 
PLLA/IL51 
20 502.39 437.11 506.23 358.74 
30 702.28 650.78 58.74 33.92 
PLLA/IL52 
20 403.07 385.1 295.28 130.55 
30 714.77 677.55 462.57 120.92 
PLLA/IL53 
20 589.99 523.28 467.61 228.01 
30 727.19 648.68 400.48 151.40 
 
Physical ageing of PLLA has been attributed to a molecular rearrangement of the 
polymer chains that drive the thermodynamic variables (e.g. enthalpy) closer to 
equilibrium values.
41
 This is due to the polymer forming a non-equilibrium glassy state 
when it is quenched from the melt. Thus, it is unsurprising that PLLA/IL52 at both 20 
and 30 wt% IL have similar elongations at break after 100 days of ageing (131 and 
121 % respectively) (Table 3.14). This could indicate that an equilibrium state is indeed 
being reached after 100 days of ageing, with PLLA having a certain free volume that 
can be occupied by the IL. 
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In general, the Young’s modulus of PLLA/IL50–53 with 20 wt% IL decreased as the 
films aged over the 100 day period of the test (Table 3.15). Exceptions were noted for 
PLLA/IL51 with 20 wt% IL (day 0 to day 10) and PLLA/IL52 with 20 wt% (day 10 to 
day 100), where an increase in the Young’s modulus was observed. There was in 
general an increase in the Young’s modulus from day 0 to day 100 for PLLA/IL50–53 
with 30 wt% IL, with exceptions noted for PLLA/IL50 with 30 wt% IL (day 0 to day 
10) and PLLA/IL52 with 20 wt% (day 0 to day 10). The change in Young’s modulus 
during ageing supports the idea that the films were ageing to an equilibrium state. At 
day 100 the Young’s modulus for the PLLA/IL films with the same IL had similar 
values at 20 and 30 wt% IL, especially PLLA/IL51 which had a Young’s modulus of 
457 and 478 MPa for 20 and 30 wt% IL respectively. This conclusion is highlighted 
when viewing the graphs of the ageing results for the tensile modulus of PLLA/IL50–53 
with 20 and 30 wt% IL, which are provided in Appendix D, Figures D5–D8. 
 
Table 3.15 Effect of physical aging on the Young’s modulus of PLLA/IL51–53 with 20 
and 30 wt% NTf2 IL. 
Sample 
IL content 
(wt%) 
Young’s modulus (MPa) 
Day 0 Day 1 Day 10 Day 100 
PLLA/IL50 
20 1091.23 1071.72 1023.73 527.43 
30 241.31 225.33 255.88 390.13 
PLLA/IL51 
20 1102.68 1184.27 860.14 456.80 
30 53.68 193.05 337.47 478.25 
PLLA/IL52 
20 860.97 742.78 465.43 645.44 
30 252.44 242.59 293.64 444.36 
PLLA/IL53 
20 902.47 832.12 755.24 598.64 
30 175.07 231.78 452.77 548.26 
 
For the majority of the PLLA/IL50–53 with 20 and 30 wt% IL the tensile strength 
initially increased during the ageing of the sample, and then decreased again to reach a 
lower tensile strength on day 100 than measured on day 1 (Table 3.16). PLLA/IL52 
with 20 wt% IL is an exception to this trend where the tensile strength initially 
decreased from day 0 to day 10, and subsequently increased from day 10 to day 100. In 
all cases it appears that the tensile strength of the PLLA/IL50–53 films are ageing to an 
equilibrium state, with similar values in tensile strength observed for PLLA/IL50–53 
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with the same wt% of IL on day 100. The PLLA/IL50–53 films had a tensile strength of 
ca 21 and ca 14 MPa for 20 and 30 wt% IL respectively on day 100. The smallest aging 
effects were observed for PLLA/IL50–53 with 20 wt% IL, with a reduction of 1.26 MPa 
in tensile strength observed over the 100 days for PLLA/IL52 with 20 wt% IL. 
PLLA/IL51–53 with 20 wt% IL all had a higher tensile strength after 100 days of 
ageing than was measured in the literature for the least brittle sample of non-aged PLLA 
plasticised with 20 wt% [MPI][PF6], which had a tensile strength of 20.6 MPa. 
 
Table 3.16 Effect of physical aging on the tensile strength of PLLA/IL51–53 with 20 
and 30 wt% NTf2 IL.  
Sample 
IL content 
(wt%) 
Tensile strength (MPa) 
Day 0 Day 1 Day 10 Day 100 
PLLA/IL50 
20 29.86 31.83 34.34 20.58 
30 25.68 27.04 28.21 12.50 
PLLA/IL51 
20 31.67 35.86 26.66 21.67 
30 17.88 25.38 21.18 14.95 
PLLA/IL52 
20 22.74 21.07 16.82 21.48 
30 25.65 29.74 24.74 13.45 
PLLA/IL53 
20 26.14 26.33 29.04 21.29 
30 17.46 28.43 23.76 16.32 
3.4.4 Differential Scanning Calorimetry Analysis of PLLA/IL Films 
Differential scanning calorimetry (DSC) was carried out on neat PLLA and the 
PLLA/IL50–53 films with 10, 20 and 30 wt% IL, to estimate the efficiency of 
plasticisation by analysing the Tg, Tc, Tm and degree of crystallinity of the PLLA/IL 
films (Table 3.17). The DSC traces for neat PLLA and PLLA/IL50–53 with 10, 20 and 
30 wt% IL are provided in Appendix E. 
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Table 3.17 Effect of plasticisation with 10, 20 and 30 wt% NTf2 IL 50–53 on the 
thermal properties and degree of crystallinity of PLLA.  
Sample 
IL content 
(wt%) 
Tg (°C) Tc (°C) Tm (°C) 
Crystallinity 
(%) 
PLLA 0 60.2 94.0 176.3 21.1 
PLLA/IL50 
10 47.8 84.7 173.5 24.3 
20 36.5 75.8 171.9 25.1 
30 14.5 63.8 168.9 27.0 
PLLA/IL51 
10 44.5 81.7 174.0 25.2 
20 34.9 72.2 171.7 25.7 
30 –* 73.1 168.7 38.6 
PLLA/IL52 
10 47.7 83.6 173.7 22.8 
20 35.9 73.0 171.2 25.7 
30 –* 73.5 168.6 35.67 
PLLA/IL53 
10 43.6 80.9 170.2 24.4 
20 33.0 69.3 172.6 26.9 
30 –* 73.3 170.2 34.6 
*Exact Tg value unable to be determined by DSC software. 
 
The results show that for all the PLLA/IL50–53 samples there is a significant 
depression of the Tg compared to that of neat PLLA, indicating that all the ILs have a 
substantial plasticising effect on PLLA (Table 3.17). Tg was shown to decrease with 
increasing plasticiser content (ca 15 and ca 25 °C depression of Tg for 10 and 20 wt% IL 
respectively). The greatest drop in the Tg (45 °C) is observed for PLLA/IL50 where a Tg 
of 14.5 °C was measured. In the case of PLLA/IL51–53 with 30 wt% IL, rather broad 
glass transitions were detected at a temperature range of 0–40°C. Unfortunately, the 
software could not extract a single Tg value from the DSC curves; however, they are 
believed to give a comparable Tg depression to PLLA/IL50 with 30 wt% IL (below 
room temperature) as they all have similar DSC traces (Appendix E). Furthermore, no 
additional Tg was detected when analysing PLLA/IL52 with 30 wt% IL with cryogenic 
DSC (−50 °C to 200 °C), confirming there was no phase separation between the PLA 
and the IL. The decrease in the Tg on the addition of ILs has been attributed to 
weakening of the interactions of PLLA chains, caused by the IL acting as a diluent of 
the PLLA chains and increasing chain mobility.
39
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There is a significant increase in the crystallinity of the PLLA/IL50–53 films as the 
percentage of plasticiser increases (Table 3.17). The greatest increase in the 
crystallinity, 38.6 %, is observed for PLLA/IL51 with 30 wt% IL, which is about 18 % 
higher than the crystallinity of neat PLLA. The increase in the crystallinity is due to the 
plasticiser promoting the crystallinity of the material due to enhanced PLLA chain 
mobility.
17
  
 
There is a significant decrease in the Tc of the PLLA/IL50–53 as the wt% of plasticiser 
increases from neat PLLA to 10 and 20 wt% IL (Table 3.17). This is caused by the 
greater ease of PLLA crystallising at lower temperatures at higher plasticiser content, 
due to an increase in the chain mobility of the PLLA.
17
 The Tc appears to decrease 
linearly with increasing IL content, with a shift of ca 10 °C. The same ca 10 °C decrease 
in Tc is also observed for PLLA/IL50 when the wt% of plasticiser increases from 
20 wt% IL to 30 wt% IL. However, for PLLA/IL51–53 there is a slight increase in the 
Tc of ca 2 % observed when the wt% of plasticiser increases from 20 wt% IL to 30 wt% 
IL.    
 
There is a very slight decrease in the Tm as the plasticiser content increases, with only a 
deviation from this trend seen for PLLA/IL53 with 30% IL (Table 3.17). This may 
indicate that the IL predominantly affects the amorphous phase without changing the 
crystal structure of the PLLA. 
3.4.5 Thermal Stability of PLLA/IL Films 
TGA of neat PLLA and PLLA/IL52 with 30 wt% IL was carried out to assess the effect 
of the IL on the thermal stability of PLLA (Figure 3.15). (TGA curves are also provided 
in Appendix C for PLLA and PLLA/IL52, in Figure C13 and C14 respectively.) 
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Figure 3.15 TGA curves of neat PLLA and PLLA/IL52 with 30 wt% IL. 
 
When comparing the Tstart and Tonset of degradation for PLLA to PLLA/IL52 with 
30 wt% IL (Table 3.18), it can be seen that the addition of the IL has a minimal effect 
on the thermal stability of the PLLA. For the PLLA/IL52 with 30 wt% IL the Tstart 
decreased by 28 °C and the Tonset decreased by 12 °C, compared to neat PLLA. The 
decrease of Tonset by 12 °C is less than the decrease measured by Gui et al. (24 °C) for 
PLLA plasticised with 0.99 wt% [AOEMIM][BF4].
39
 Furthermore, PLLA plasticised 
with 8.3 wt% [AOEMIM][BF4], the maximum IL content studied by Gui et al., showed 
a decrease in Tonset of 52 °C compared to neat PLLA. Thus, PLLA/IL53 shows a higher 
thermal stability at much higher levels of plasticisation (30 wt% IL); illustrating the 
minimal impact that plasticisation with 30 wt% IL 52 has on the thermal stability of 
PLLA. 
 
Table 3.18 TGA data for PLLA and PLLA/IL52 with 30 wt% IL. 
Sample IL content (wt%) Tstart (°C) Tonset (°C) 
PLLA – 315 355 
IL 52 – 279 327 
PLLA/IL52 30 287 343 
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 Conclusions 3.5
In this proof of concept study a successful number of IL plasticised PLLA prototype 
materials were synthesised. It can be concluded that the NTf2 ILs 50–53 
have a significant plasticising effect on PLLA at 20 and 30 wt%, with the elongation at 
break increased by > 400 and > 700 % with 20 and 30 wt% IL respectively. The most 
promising result was observed for PLLA plasticised with 20 wt% IL 51 which had an 
elongation at break of more than 500 %, a Young’s modulus of 1103 MPa and a tensile 
strength of 32 MPa. A significant depression of the Tg for PLLA/IL50–53 was 
observed, on average 15, 20 and 45 °C at 10, 20 and 30 wt% IL respectively. However, 
10 wt% NTf2 ILs 50–53 appeared to have an antiplasticising effect on PLLA, with a 
decrease in the elongation at break observed compared to neat PLLA. 
 
The OctSO4 ILs 54–56 appeared to be incompatible with PLLA, initially from the 
appearance of the PLLA/IL54–56 films, and subsequently from the tensile testing 
results where an antiplasticising effect on PLLA was observed for PLLA/IL54 with 20 
and 30 wt% IL, PLLA/IL55 with 10 wt% IL and PLLA/IL56 with 10, 20 and 30 wt% 
IL. Any plasticising effects observed with the OctSO4 ILs 54–56 were minimal 
compared to those observed for the NTf2 ILs.  
 
The ageing results show that the plasticisation of PLLA with NTf2 ILs 50–53 can in all 
cases significantly reduce the ageing rate of PLLA, with several ILs showing a very 
minimal ageing effect over 100 days, especially PLLA/IL50 and PLLA/IL51 with 
20 wt% IL. During ageing the Young’s modulus appeared to be ageing to an 
equilibrium state for each IL (50–53), and the tensile strength appeared to be ageing to 
an equilibrium state for each wt% of IL (50–53).   
 
The thermal stability of PLLA/IL52 with 30 wt% IL show that IL 52 had very little 
effect on the thermal stability of PLLA, with only a 12 °C decrease in Tonset observed 
for PLLA/IL52 with 30 wt% IL compared to neat PLLA. This is a very promising result 
that shows that the NTf2 ILs 50, 51 and 53 at 20 and 30 wt% also have the potential to 
minimally effect the thermal stability of PLLA.      
 
Overall, plasticisation of PLLA with 1-methylimidazolium NTf2 ILs (50–53) 
successfully overcame several of the limitations of currently reported PLLA plasticisers 
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by utilising plasticisers with high thermal stabilities, preventing plasticiser leaching, 
demonstrating high plasticiser compatibility and increasing the ductility of PLLA to a 
greater extent than the previously published work.
39
 
 Future Work 3.6
The morphology of the PLLA/IL films could be studied using microscopy, more 
specifically field emission scanning electron microscopy (FESEM). With this technique 
a comparison of the morphology of the neat PLLA film to that of the plasticised PLLA 
films could be carried out. Also, by comparing FESEM micrographs of PLLA 
plasticised with OctOSO4 ILs and with NTf2 ILs, the effect of IL miscibility on film 
morphology could be examined. Any phase separation in the PLLA/IL films containing 
OctOSO4 ILs could be identified. Any defects due to the plasticisation would also be 
detected. By comparing aged and non-aged PLLA/IL films, changes in the morphology 
of the films during ageing could be studied.  
 
Literature data shows that the plasticisation of PLA with ILs can increase the hydrolytic 
degradation of PLA.
37
 Thus, it would be very interesting to investigate to what extent 
the ILs studied herein affect the biodegradation of PLLA. 
 
From this work it is clear that the level of plasticisation is greatly dependent on the 
anion of the IL. It would be of great interest to investigate the use of the dicyanamide 
(DCA) anion, with the same series of cations employed herein, as ILs for plasticisation 
of PLLA. Literature data shows that these ILs would be liquid at room temperature,
43
 
with the potential to have low viscosity
56
 and a thermal stability above 200 °C.
57,58
 They 
have also been shown to have low antimicrobial activity.
43
 If the 1-methylimidazolium 
DCA ILs have suitable thermal properties to allow for plasticisation with PLLA, it is 
hoped that they would give promising results as plasticisers, as they would be an 
attractive alternative to the NTf2 ILs as they do not contain any fluorine. In addition, 
when comparing the cost of the starting materials used to synthesise the ILs, sodium 
dicyanamide is cheaper than lithium bistriflimide, which will result in a cheaper 
synthesis for the DCA ILs making them more attractive to industry.  
 
It is envisaged that this work will be further progressed by utilising functionalised and 
task specific ILs as plasticisers, with the aim of creating plasticised materials targeted to 
specific applications. 
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4.0 The Dielectric Properties of ILs 
 Introduction 4.1
Microwaves are electromagnetic waves that consist of an electric field and a magnetic 
field which oscillate perpendicularly to each other at a frequency between 300 MHz to 
300 GHz.
1
 Molecules can be heated by the electric field of microwaves through both 
dipole rotation and ionic conduction, thus only polar materials are heated based on their 
dielectric constant.
1
 Understanding solvent polarity is very important in determining the 
potential use of a solvent in a given application. A measure of solvent polarity is given 
by its dielectric constant (relative permittivity), where a high dielectric constant 
indicates a high susceptibility to heating by microwaves.
1
 Solvent behaviour is also 
often modelled using dielectric constants as many approaches to do so use dielectric 
continuum models.
2
 
 
Microwaves have been extensively applied in synthetic chemistry and have been shown 
to shorten reaction times, prevent side product formation, increase percentage yields and 
simplify multi-step reactions.
3
 ILs are very susceptible to heating by microwaves due to 
their ionic nature (through ionic conduction), which has led to their simultaneous use 
with microwaves in areas such as polymer synthesis,
4
 organic synthesis,
3,5
 catalysis,
5
 
extractions
6-8
 and dissolution.
9
 Properties of a low vapour pressure and high thermal 
stability have also made ILs highly attractive for use in microwave chemistry.
5
 ILs with 
high dielectric properties have also been investigated for use in energy storage 
applications, such as replacements for current electrolytes in lithium-ion batteries, as 
ILs can offer the potential to increase the thermal and electrochemical stability of the 
devices.
10-12
 
 
When a dielectric material is placed in an external electric field dielectric polarisation 
occurs, resulting in a separation of positive and negative charges and dipole formation.
13
 
The three mechanisms which describe dielectric polarisation include:  
 
1) Electronic polarisation – displacement of electrons relative to the nucleus.14 
2) Atomic polarisation – displacement of atomic position in a molecule or lattice (ionic 
polarisation) relative to each other.
13
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3) Orientational polarisation – orientation of the dipole of polar molecules with the 
electric field, resulting in a net polarisation in the direction of the applied field.
13
 This is 
also known as dipolar polarisation.  
 
The mechanisms of polarisation are depicted in Figure 4.1. 
 
 
Figure 4.1 Mechanisms of polarisation in an applied electric field (E); a) electronic; b) 
atomic; c) ionic; d) orientational (dipolar). 
 
The absolute complex permittivity (𝜀) of a material describes its interaction with an 
electromagnetic field
15
 and is usually expressed in terms of the relative complex 
permittivity (𝜀𝑟) and the permittivity of free space (𝜀0) (8.854 × 10
−12 
F m
−1
) (Equation 
4.1).
16
 
𝜀 =  𝜀𝑟𝜀0 
 
Equation 4.1 Absolute permittivity (𝜀) of a material, where 𝜀𝑟 is the relative 
permittivity and 𝜀0 is the permittivity of free space (8.854 × 10
−12 
F m
−1
).
16
  
 
Thus, the relative permittivity of a material can be obtained using equation 4.2.  
 
𝜀𝑟 =  
𝜀
𝜀0
 
 
Equation 4.2 Relative permittivity (𝜀𝑟) of a material expressed as a ratio of absolute 
complex permittivity (𝜀) to the permittivity of free space (𝜀0) (8.854 × 10
−12 
F m
−1
).  
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 Relative permittivity (𝜀𝑟) varies with both temperature and frequency
17
 and contains 
both real and imaginary parts (Equation 4.3).
16
 The real part of permittivity (𝜀′), also 
called the dielectric constant, is a measure of how much energy from an external field is 
stored in a material.
17
 The imaginary part of permittivity (𝜀′′) is the dielectric loss factor 
and is a measure of how dissipative a material is in the presence of an external electric 
field
17
 and also represents the ability of a material to convert stored electromagnetic 
energy to heat.
18
 
 
𝜀𝑟 =  𝜀
′ − 𝑗𝜀′′ 
 
Equation 4.3 Relative permittivity (𝜀𝑟) of a material expressed in terms of the dielectric 
constant (𝜀′) and the dielectric loss factor (𝜀′′), where 𝑗 is an imaginary unit.16 
 
Permanent polarisation occurs in the presence of a static electric field. However, in an 
alternating electric field the polarisation oscillates with the electric field.
14
 The modes of 
polarisation contributing to the overall dielectric constant of the material depend on the 
frequency of the applied field.
14
 When a dielectric material is placed in an alternating 
electric field a relaxation is observed, which can be described as a ‘lag’ observed in the 
system which is trying to reach an equilibrium state.
13
 Dielectric relaxation is described 
as the exponential decay with time of the dielectric polarisation on the removal of the 
external electric field.
13
 Dielectric relaxation consists of dipole relaxation and ionic 
relaxation and is most usually observed between 10
2–1010 Hz, as depicted in the 
dielectric resonance spectra given in Figure 4.2.
13
 Atomic and electronic transitions are 
much faster than dielectric relaxation mechanisms and usually occur at frequencies 
greater than 10
12
 Hz (Figure 4.2). 
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Figure 4.2 Frequency response of dielectric mechanisms as shown by the dielectric 
resonance spectra for the real (𝜀′) and imaginary (𝜀′′) parts of permittivity, where 
dielectric relaxation occurs up to 10
10
 Hz.
13
 Figure adapted by author from M. Huang, 
PhD Thesis, Ruhr University Bochum, 2011. 
 
A measure of the relative “lossiness” of a material is given by the dielectric loss tangent 
(tan 𝛿) and is the ratio of the energy lost to the energy stored.17 It also quantifies the 
extent to which a material absorbs microwave energy.
18
 The loss tangent is calculated 
by dividing the dielectric loss factor (𝜀′′) by the dielectric constant (𝜀′) (Equation 4.4).16 
 
tan 𝛿 =  
𝜀′′
𝜀′
 
 
Equation 4.4 Dielectric loss tangent (tan 𝛿), where 𝜀′ is the dielectric constant and 𝜀′′ is 
the dielectric loss factor of the material.
16
  
 
The loss tangent (tan 𝛿) can be described schematically as depicted in Figure 4.3. 
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Figure 4.3 Schematic representation of the loss tangent (tan 𝛿). 
4.1.1 Dielectric Measurement Techniques 
To make an informed decision about the technique that should be selected for 
measuring the dielectric properties of a material, a number of factors need to be 
considered, which include:
17
 
 
- Frequency of interest 
- Cost of technique 
- Expected dielectric constant 
- Required measurement accuracy 
- Ease of sample preparation and measurement 
- Required measurement speed 
- Material properties 
- Material form  
- Available sample size 
- Destructive or non-destructive technique 
- Contacting or non-contacting technique  
- Temperature  
 
A variety of techniques exist for measuring the dielectric properties of materials, which 
include the coaxial probe, free space, resonant cavity, transmission line and parallel 
plate methods.
15
 A technique can be either resonant or non-resonant, where resonant 
techniques take measurements at a single frequency or at discrete frequency points.
15
 
Due to the high electrical conductance of ILs, their dielectric properties cannot be 
measured using traditional capacitance methods,
19
 so the coaxial probe and cavity 
perturbation techniques are often used. For materials with high dielectric constants the 
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coaxial probe is the preferred technique, which can be used for semi-solids and liquids 
with simple sample preparation and high accuracy for high loss materials.
15
 However, 
this technique requires a large amount of sample material.
15
 The cavity perturbation 
technique (also known as resonant cavity) is suitable for both solid and liquid samples, 
and is able to give high accuracy for low permittivity materials with only small sample 
sizes required.
15
 
4.1.1.1 The Cavity Perturbation Technique 
The most accurate methods currently used to measure the dielectric permittivity of 
materials are the resonant measurement methods which are usually limited to the 
microwave frequency range (300 MHz and 300 GHz).
20
 A common resonant method 
used for measuring microwave permittivity of materials is the cavity perturbation 
technique, which consists of a resonant cavity connected to a vector network analyser 
(VNA). (Figure 4.4) 
 
Figure 4.4 Schematic of the cavity perturbation apparatus.
18
 Reprinted with permission 
from A. D. Smith, E. H. Lester, K. J. Thurecht, S. W. Kingman, J. El Harfi, G. 
Dimitrakis, J. P. Robinson and D. J. Irvine, Ind. Eng. Chem. Res., 2010, 49, 3011. 
Copyright 2010 American Chemical Society.  
 
A sample is introduced into the centre of the empty resonant cavity where the electric 
field has the maximum value, to allow for maximum interaction with the sample. This 
causes the resonant frequency of the cavity (𝑓C) to decrease to that of the resonant 
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frequency of the cavity containing the sample (𝑓S). The shift in the resonant frequency is 
related to the dielectric constant (𝜀′) of the specimen, and results in a decrease in the 
quality factor (𝑄), due to dielectric loss (𝜀′′). The VNA detects the frequency shift and 
resultant quality factor (𝑄) (using Equation 4.5 and 4.6) and calculates the dielectric 
constant (𝜀′) and dielectric loss factor (𝜀′′) using Equations 4.7 and 4.8.21  
 
𝑄C =
𝑓C
∆𝑓C
 
 
Equation 4.5 Quality factor of the empty cavity (𝑄C), where 𝑓C is the resonant 
frequency of the empty cavity and ∆𝑓C is the bandwidth at half power of the empty 
cavity.
21
 
 
𝑄S =
𝑓S
∆𝑓S
  
 
Equation 4.6 Quality factor of the cavity containing the sample (𝑄S), where 𝑓S is the 
resonant frequency of the cavity containing the sample and ∆𝑓S is the bandwidth at half 
power of the cavity containing the sample.
21
 
 
𝜀′ =  
(𝑉C(𝑓C − 𝑓S)
2𝑉S𝑓S
 
 
Equation 4.7 Dielectric constant (𝜀′), where 𝑉𝐶 is the volume of the empty cavity, 𝑉𝑆 is 
the volume of the sample, 𝑓𝐶  is the resonant frequency of the empty cavity and 𝑓𝑆 is the 
resonant frequency of the cavity containing the sample.
21
 
 
𝜀′′ =
𝑉C
4𝑉S
 (
1
𝑄S
−
1
𝑄C
) 
 
Equation 4.8 Dielectric loss factor (𝜀′′), where 𝑉C is the volume of the empty cavity, 𝑉S 
is the volume of the sample, 𝑄S is the quality factor of the cavity containing the sample 
and 𝑄C is the quality factor of the empty cavity.
21
 
 
A furnace is situated above the cavity (Figure 4.1) and allows high temperature 
measurements to be carried out. During a high temperature experiment, the sample 
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resides in the furnace and is moved into the cavity using a step-motor for the 
measurement to be taken. Minimal time is spent outside the furnace and in the cavity 
during the measurement, thus the heat loss is considered negligible. 
4.1.2 Static Dielectric Constants of ILs  
Static dielectric constants (𝜀) (zero frequency) of ILs can been determined by zero 
frequency extrapolation of the frequency dependent dielectric constants.
2,19,22-24
 Huang 
et al. studied the dielectric properties of 42 ILs using a coaxial method and showed the 
ILs were tuneable over a wide range by variation of the cation and anion.
19
 Low 
dielectric constants were observed for aprotic ILs with high symmetry (𝜀 = 10–16), with 
an increase observed when oxoanions were employed. Protic ILs exhibited higher 
dielectric constants than aprotic ILs (𝜀 = 20–30 for monoalkylammonim ILs). Hydroxyl 
functionalised alkylammonium ILs had the highest dielectric constants, with 2-
hydroxyethyl ammonium lactate, prepared from DL-lactic acid, (Figure 4.5) giving the 
highest dielectric constant of 𝜀 = 85.6.19 
 
 
Figure 4.5 2-Hydroxyethyl ammonium lactate with static dielectric constant 𝜀 = 85.6, 
as determined using the coaxial probe method.
19
      
 
A material’s dielectric constant changes with both temperature and frequency and is 
most often seen to decrease as frequency increases, which in turn increases the dielectric 
loss factor.
15
 As the temperature of a material increases, the dielectric constant also 
increases for low permittivity materials, but this relation has also been seen to inverse in 
high permittivity materials.
15
 Due to the complex way in which dielectric properties of 
components change over a range of frequencies and temperatures, it is necessary to 
study these changes to understand how materials will respond under a wide range of 
conditions. The temperature, physical state and chemical composition of components in 
a reaction will also change as it progresses, thus it is necessary to understand how these 
changes affect the dielectric properties of the components. This information will enable 
microwaves to be successfully employed to enhance reaction rates, improve solvation 
and enhance the extraction of a variety of components.    
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4.1.3 Selection of ILs for Dielectric Property Measurements 
Seven mandelic acid ILs 18–20 and 22–25 (Figure 4.6) and three 1-methylimidazolium 
ILs 49, 50 and 51 (Figure 4.7) were chosen to investigate the dielectric properties of ILs 
using the cavity perturbation technique. The different structural features and different 
states (solid and liquid) of the ILs allowed for an investigation into how the structures 
and physical states of the ILs relate to their dielectric properties. It is desired that by 
analysing the dielectric properties at high temperatures and different frequencies, 
information can be gathered on how both these factors affect the dielectric properties of 
the ILs.  
 
 
Figure 4.6 Mandelic acid ILs 18–20 and 22–25 selected to investigate the dielectric 
properties of ILs using the cavity perturbation technique.  
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Figure 4.7 1-Methylimidazolium ILs 49–51 selected to investigate the dielectric 
properties of ILs using the cavity perturbation technique. 
 Results and Discussion 4.2
Dielectric properties of the mandelic acid ILs 18–20 and 22–25 (Figure 4.6) and 1-
methylimidazolium ester ILs 49–51 (Figure 4.7) were measured using a cavity 
perturbation technique. 
 
Full experimental details of this technique are provided in chapter 6, section 6.1.11. 
Two frequencies, 910 and 2470 MHz, were used to measure the dielectric properties, as 
these frequencies are similar to those used for microwave heating in industry.
25
 The 
study herein does not discuss the static dielectric constants of the ILs, only the 
frequency dependent dielectric constants, hence the results are not directly comparable 
to previously published results on the static dielectric constants of ILs.
19
 Frequency 
dependent dielectric constants of the ILs were measured over a wide temperature range, 
and provide a direct insight into the use of the ILs in microwave reactions carried out at 
the measured temperatures and frequencies, as the dielectric properties are known to 
change with frequency and temperature.
17
 This work was undertaken in collaboration 
with Dr Derek Irvine from the Department of Chemical and Environmental Engineering 
at The University of Nottingham, UK. 
4.2.1 Mandelic Acid ILs 
Room temperature dielectric properties of the mandelic acid ILs 18–20 and 22–25 were 
initially measured at 910 and 2470 MHz. The results show that the dielectric constants 
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(𝜀′) of the ILs fall between 1.48–2.26 and 1.49–2.30 for 910 and 2470 MHZ 
respectively (Table 4.1 and 4.2). The 𝜀′ of the ILs are very similar at both frequencies, 
with a very slight increase in 𝜀′ observed at 2470 MHz (maximum 0.1 MHz increase 
measured between 910 and 2470 MHz observed for IL 18).   
 
Table 4.1 Dielectric properties of mandelic acid ILs 18–20 and 22–25 measured at 
room temperature and 910 MHz, where 𝜀′ is the dielectric constant, 𝜀′′ is the dielectric 
loss and tan 𝛿 is the loss tangent.  
IL 𝜺′ 𝜺′′ 𝐭𝐚𝐧 𝜹 
18 1.70 0.00 0.00 
19 1.91 0.00 0.00 
20 2.25 0.00 0.00 
22 2.24 0.00 0.00 
23 2.26 0.00 0.00 
24 2.08 0.00 0.00 
25 1.48 0.00 0.00 
 
ILs 20, 22 and 23, which contain a butyl ester chain, had the highest 𝜀′ with very similar 
values of 2.25, 2.24 and 2.26 at 910 MHz measured respectively (Table 4.1). As the 
ester alkyl chain length increased in the 1-methylimidazolium ILs from ethyl (18) to 
butyl (20) the 𝜀′ increased from 1.70 to 2.25 at 910 MHz respectively. This increase in 
𝜀′ with increasing alkyl chain length for imidazolium ILs with a common anion has 
previously been observed in the literature.
19
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Table 4.2 Dielectric properties of mandelic acid ILs 18–20 and 22–25 measured at 
room temperature and 2470 MHz, where 𝜀′ is the dielectric constant, 𝜀′′ is the dielectric 
loss and tan 𝛿 is the loss tangent. 
IL 𝜺′ 𝜺′′ tan 𝜹 
18 1.80 0.00 0.00 
19 1.96 0.00 0.00 
20 2.28 0.00 0.00 
22 2.26 0.00 0.00 
23 2.30 0.00 0.00 
24 2.11 0.00 0.00 
25 1.49 0.00 0.00 
 
The dielectric loss (𝜀′′) and loss tangent (tan 𝛿) of the mandelic acid ILs 18–20 and 22–
25 at both 910 and 2470 MHz are all zero (Table 4.1 and 4.2). ILs 18–20 and 22–25 are 
solid at room temperature. When subjected to an alternating electric field the dipoles of 
the IL will attempt to align with the field, causing intra- and intermolecular motion.
18
 
This molecular motion is restricted in a solid, where strong intermolecular forces 
prevent the dipoles from significantly aligning with the very fast alternating electric 
field at microwave frequencies. Orientational motion of dipoles causes internal friction 
in materials and results in dielectric energy losses.
26
 Thus, due to the restriction of 
molecular motion in solids, zero tan 𝛿 and 𝜀′′ are measured for ILs 18–20 and 22–25.  
4.2.2 1-Methylimidazolium Ester ILs 
The dielectric properties of the 1-methylimidazolium ester ILs 49–51 were initially 
measured at room temperature at 910 and 2470 MHz. The results show that the 𝜀′ of the 
ILs fall between 3.15–5.79 and 3.13–3.57 for 910 and 2470 MHZ respectively (Table 
4.3 and 4.4). Very similar 𝜀′ of IL 49 were measured at both frequencies, with 3.15 and 
3.13 at 910 and 2470 MHz respectively. However, there was a lower 𝜀′ observed at a 
higher frequency for ILs 50 and 51, which is an observation that has also been described 
in the literature for RTILs.
19
 The highest 𝜀′ of 5.79 is observed for IL 50 at 910 MHz, 
with a higher 𝜀′ observed for the NTf2 ILs 50 and 51 compared to the bromide IL 49. 
NTf2 ILs are known to have lower viscosities than halide ILs,
27
 thus the decrease in IL 
viscosity and subsequent reduction in intermolecular interactions would result in an 
increased interaction of the ILs electronic structure with the applied electric field
25
 and 
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decreased relaxation times,
13
 which may be the reason for the increase in dielectric 
constant observed. However, ILs 50 and 51 have a different cation than IL 49, so these 
ILs cannot be directly compared because the decrease in 𝜀′ may be due to the decrease 
in cation size, which has shown to lead to a decrease in IL 𝜀′.13 In the NTf2 ILs as the 
ester alkyl chain is changed from a butyl (50) to a polyether chain (51) there is a 
decrease in 𝜀′ at 910 MHz but an increase at 2470 MHz, demonstrating the complex 
nature of the dielectric properties of materials at different frequencies.   
 
Table 4.3 Dielectric properties of 1-methylimidazolium ester ILs 49–51 measured at 
room temperature and 910 MHz, where 𝜀′ is the dielectric constant, 𝜀′′ is the dielectric 
loss and tan 𝛿 is the loss tangent. 
IL 𝜺′ 𝜺′′ tan 𝜹 
49 3.15 0.31 0.10 
50 5.79 1.72 0.30 
51 5.76 1.47 0.26 
 
Table 4.4 Dielectric properties of 1-methylimidazolium ester ILs 49–51 measured at 
room temperature and 2470 MHz, where 𝜀′ is the dielectric constant, 𝜀′′ is the dielectric 
loss and tan 𝛿 is the loss tangent. 
IL 𝜺′ 𝜺′′ tan 𝜹 
49 3.13 0.23 0.07 
50 5.42 1.23 0.22 
51 5.57 1.15 0.21 
 
The 𝜀′′ of the 1-methylimidazolium ILs 49–51 are 0.31–1.72 and 0.23–1.23 at 910 and 
2470 MHz respectively (Table 4.1 and 4.2). Non-zero tan 𝛿 for 49–51 ILs at 910 and 
2470 MHz tells us that the ILs are permeable to the microwaves and they are able to 
absorb the microwaves to an appreciable degree, with tan 𝛿 of 0.10–0.30 and 0.07–0.21 
at 910 and 2470 MHz respectively. At room temperature ILs 49–51 are liquid, thus 
there are less restrictions on its molecular motions than in a solid IL (e.g. mandelic acid 
ILs 18–20 and 22–25) so the dipoles are able to align with the alternating electric field, 
causing molecular rotation
18
 and non-zero tan 𝛿 values are measured as a result. 
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4.2.3 High Temperature Experiments 
The dielectric properties of the mandelic acid ILs 20 and 23 and the 1-
methylimidazolium IL 50 (Figure 4.8) were studied between 20 and 120 °C at 910 and 
2470 MHz to investigate how the dielectric properties of the IL vary with temperature at 
the two different frequencies. Measurements were taken every 5 °C. The exact values 
for 𝜀′, 𝜀′′ and tan 𝛿 for each high temperature experiment are given in Appendix F.  
 
 
Figure 4.8 Mandelic acid ILs 20 and 23 and 1-methylimidazolium IL 50 utilised in the 
high temperature studies on the dielectric properties of ILs. 
4.2.3.1 Mandelic Acid ILs 
It can be seen that as the temperature increases from 20 to 120 °C the 𝜀′ of IL 20 
increases (Figure 4.9). The dielectric constant is also observed to be higher for the lower 
frequency of 910 MHz, with a maximum value of 4.15 at 115 °C recorded. This 
increase in 𝜀′ is caused by a decrease in the amount/strength of the intermolecular 
interactions of the IL as the temperature increases.
25
 This causes an increase in the 
interaction of the ILs electronic structure with the electric field, as restrictions on the IL 
molecular motion are reduced, resulting in the increase observed in the 𝜀′. There is a 
sharp increase in the dielectric constant observed between 80 °C and 85 °C, where the 
dielectric constant increases from 3.12 to 3.67. This observation was initially deduced to 
be most likely due to a change in the state of the IL when passing through its melting 
point transition, which would significantly reduce the restrictions on the IL molecular 
 139   
motion. However, the melting point of IL 20 was measured to be 99–101 °C and was 
thus unable to confirm this hypothesis. A sudden break in the constant increase in 𝜀′ 
with increasing temperature has previously been observed in the literature for ILs and 
was attributed to be caused by a sudden change in IL structure or the physicochemical 
interactions between the ions.
12
 There is a slight decrease in 𝜀′ for IL 20 between 115 
and 120 °C at 910 and 2470 MHz. This is potentially due to a change in the relaxation 
characteristics of the IL as the temperature increases, as respective relaxation times are 
temperature dependent.
25
  
  
 
Figure 4.9 Variation in 𝜀′ of IL 20 at 910 and 2470 MHz over the temperature range 
20–120 °C using the cavity perturbation technique.  
 
The 𝜀′′ of IL 20 remains constant until 80 °C where it increases at both 910 and 
2470 MHz (Figure 4.10). This increase was once again postulated to be due to sudden 
change in IL structure or the physicochemical interactions between the ions,
12
 resulting 
in an increased capacity of the IL to turn stored energy to heat. The highest 𝜀′′ measured 
is 0.75 at 120 °C and 910 MHz. 
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Figure 4.10  Variation in 𝜀′′ of IL 20 at 910 and 2470 MHz over the temperature range 
20–120 °C using the cavity perturbation technique.  
 
The tan 𝛿 of IL 20 remains constant until 80 °C where it increases at both 910 and 
2470 MHz (Figure 4.11). This increase was once again postulated to be due to sudden 
change in IL structure or the physicochemical interactions between the ions.
12
 The 
highest tan 𝛿 measured is 0.18 at 120 °C and 910 MHz. 
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Figure 4.11 Variation in tan 𝛿 of IL 20 at 910 and 2470 MHz over the temperature 
range 20–120 °C using the cavity perturbation technique.  
 
The high temperature dielectric measurements for IL 23 were undertaken between 
20 °C and 105 °C. It can be seen that as the temperature increases from 20 to 105 °C the 
𝜀′ of IL 20 decreases, more significantly at 910 MHz (Figure 4.12). This is the opposite 
behaviour to that which was observed for IL 20, where 𝜀′ was seen to increase with 
increasing temperature. However, 𝜀′ has been shown to decrease with temperature in 
solvents with high dielectric constants (e.g. water, acetonitrile, ethanol etc.).
28
 There 
was an increase in the 𝜀′ observed at 90 °C, which decreased rapidly at 95 °C and 
increased again at 100 °C at 910 and 2470 MHz. This was postulated to be due to a 
breakdown of the IL during the measurements. However, with the melting point of IL 
20 being above this temperature at 112–113 °C this was deemed unlikely. Sudden 
changes in the IL structure or the physicochemical interactions between the ions under 
microwave irradiation at this temperature may again be the reason for this observation.
12
 
Further analysis to obtain thermal degradation data on IL 23 (TGA) would help to aid 
an understanding of this result.      
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Figure 4.12 Variation in 𝜀′ of IL 23 at 910 and 2470 MHz over the temperature range 
20–105 °C using the cavity perturbation technique. 
 
The 𝜀′′ of IL 23 remains constant and zero until 80 °C where it increases at both 910 
and 2470 MHz (Figure 4.13). This is the same change at the same temperature as was 
observed for IL 20, and is once again postulated to be due to sudden change in IL 
structure or the physicochemical interactions between the ions,
12
 resulting in an 
increased capacity of the IL to turn stored energy to heat. The 𝜀′′ are lower than were 
measured for IL 20 with the highest 𝜀′′ measured being 0.37 at 100 °C and 910 MHz. 
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Figure 4.13 Variation in 𝜀′′ of IL 23 at 910 and 2470 MHz over the temperature range 
20–105 °C using the cavity perturbation technique.  
 
The tan 𝛿 of IL 23 remains constant until 80 °C where it increases at both 910 and 
2470 MHz (Figure 4.14). This increase was once again postulated to be due to sudden 
change in IL structure or the physicochemical interactions between the ions.
12
 There is a 
slight decrease in tan 𝛿 at 105°C. This may be due to a decrease in the resistance to 
molecular movement, caused by a reduction in the IL viscosity as the temperature 
increases, meaning less energy is dissipated as heat.
18
 The highest tan 𝛿 measured is 
0.26 at 100 °C and ji910 MHz. 
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Figure 4.14 Variation in tan 𝛿 of IL 23 at 910 and 2470 MHz over the temperature 
range 20–105 °C using the cavity perturbation technique.  
 
It is interesting to note that the sudden changes in IL dielectric properties are observed 
at 80 °C for both mandelic acid ILs 20 and 33. One suggestion is that a specific 
structural change that is taking place at 80 °C for both the ILs that is specifically related 
to the change in the dielectric properties. A more detailed study would be required to 
investigate this observation further.   
4.2.3.2 1-Methylimidazolium Ester ILs 
For the 1-methylimidazolium IL 50 the 𝜀′ increases as the temperature increases from 
20 to 120 ° for both 910 and 2740 MHz (Figure 4.15). A maximum 𝜀′ of 15.64 and 
11.55 at 120 °C are recorded at 910 and 2470 MHz respectively. This increase is caused 
by a decrease in the amount/strength of the intermolecular interactions of the IL at 
higher temperatures.
25
 This causes an increase in the interaction of the ILs electronic 
structure with the electric field, causing the increase observed in the 𝜀′. 
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Figure 4.15 Variation in 𝜀′ of IL 50 at 910 and 2470 MHz over the temperature range 
20–120 °C using the cavity perturbation technique.  
 
For IL 50 at both 910 and 2740 MHz the 𝜀′′ increases initially as the temperature 
increases (Figure 4.16). This increase is consistent at 2470 MHz and continues to reach 
a maximum 𝜀′′ of 6.51 at 120 °C. However, at 910 MHz there is a decrease in 𝜀′′ at 
90 °C which continues to decrease until 120°C. This is postulated to be caused by a 
decrease in the viscosity/density of the IL as the temperature increases above 85 °C at 
910 MHz, which causes a decrease in the intermolecular interactions of the IL.
25
 
Consequently, less energy is dissipated as heat and the 𝜀′′ decreases as a result.18    
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Figure 4.16 Variation in 𝜺′′ of IL 50 at 910 and 2470 MHz over the temperature range 
20–120 °C using the cavity perturbation technique.  
There were differing observations for the tan 𝛿 of IL 50 at 910 and 2470 MHz (Figure 
4.17). Initially, at both frequencies the tan 𝛿 increases; however, it appears to reach a 
plateau at 80 °C at 2470 MHz with an approximate tan 𝛿 of 0.58. This is not observed at 
910 MHz where tan 𝛿 reaches a maximum of 0.61 at 45 °C and continues to decrease 
after this point to 0.32 at 120 °C. This decrease is likely due to a decrease in the 
resistance to molecular movement caused by a reduction in the IL viscosity as the 
temperature increases, meaning less energy is dissipated as heat.
18
 The decomposition 
of IL 50 is much higher than the temperature of the observed decrease in tan 𝛿 (Tstart = 
284 °C) thus it is not likely that the decrease observed is due to mass loss caused by IL 
breakdown.   
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Figure 4.17 Variation in tan 𝛿 of IL 50 at 910 and 2470 MHz over the temperature 
range 20–120 °C using the cavity perturbation technique.  
 Conclusion 4.3
The highest 𝜀′ for the mandelic acid ILs 18–20 and 22–25 at room temperature were 
recorded for IL 23 with dielectric constants of 2.26 and 2.30 at 910 and 2470 MHz 
respectively. The 𝜀′ of the ILs were very similar at both frequencies and increased as the 
length of the ester alkyl chain increased from ethyl to butyl. All the mandelic acid ILs 
had zero 𝜀′′ and tan 𝛿 at room temperature as all the ILs are in a solid state and have 
restricted molecular motion.. At higher temperatures the mandelic acid ILs 20 and 23 
are able to absorb microwave energy and 𝜀′′ and tan 𝛿 increases as a result. A maximum 
tan 𝛿 was measured for IL 20 of 0.18 at 910 MHz.  
 
The 1-methylimidazolium ester ILs 49–51 have very promising dielectric properties 
with high dielectric properties observed at room temperature, with a maximum 𝜀′′ 
observed for IL 50 of 5.79 at 910 MHz and for IL 51 of 5.57 at 2470 MHz. The 1-
methylimidazolium ester ILs 49–51 are liquid at room temperature and thus are able to 
absorb microwave energy to an appreciable degree at room temperature, with non-zero 
𝜀′′ and tan 𝛿 measured as a result. During the high temperature experiment of IL 50 𝜀′ 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 20 40 60 80 100 120 140
Lo
ss
 T
an
ge
n
t,
 t
an
 δ
  
Temperature (°C) 
910 MHz
2470 MHz
 148   
increased as the temperature increased to reach a maximum of 15.64 at 120 °C and 
910 MHz. The maximum tan 𝛿 of 0.61 for IL 50 was reached at 45 °C at 910 MHz. 
 
Despite this work not reporting on the static dielectric constants of the ILs, and thus not 
being directly comparable to previous studies,
19
 the results obtained herein provide a 
clear insight into the complex relationship between the dielectric properties of the ILs 
and both frequency and temperature. Necessary preliminary data has been collected to 
enable further informed studies on dielectric properties of ILs to be carried out using the 
cavity perturbation technique. A greater understanding of how IL structures influence 
their dielectric properties can thus be obtained, facilitating the targeted design of high 
polarity ILs for applications in extractions, dissolution and synthetic chemistry both 
with and without microwave irradiation.  
 Future Work 4.4
It would be of great interest to further investigate the dielectric properties of the 
mandelic acid ILs 18–20 and 22–25. To try and exploit the maximum dielectric 
potential of the ILs, it is proposed that examples of mandelic acid ILs with DCA and 
NTf2 anions should be investigated. DCA and NTf2 examples of the mandelic acid ILs 
(63–66) would likely have lower melting points, with the potential to be liquid at room 
temperature, as it is widely known that DCA and NTf2 ILs often have lower melting 
points than the corresponding halide ILs.
29
 The reduction in IL melting point would 
ideally give a much larger window for the dielectric properties of the ILs to be 
measured, thus enabling higher dielectric properties at lower temperatures to be 
recorded. This would increase the potential of the mandelic acid ILs to be used as 
reaction solvents both with and without microwaves. Reactions with the ILs could be 
carried out at lower temperatures to achieve the same dielectric constant, making them 
applicable to a wider range of reactions (e.g. temperature sensitive reactions).      
 
Before further dielectric measurements are carried out, it would beneficial to investigate 
into the thermal decomposition temperatures of the mandelic acid ILs 18–20 and 22–25. 
With this information the high temperature experiments could be carried out to the 
maximum possible temperature. This would enable the highest amount of dielectric data 
for the processing range of the ILs to be obtained. It would be highly undesirable for the 
IL to break down during the temperature ramp and whilst in the cavity as the ILs 
pyrolysis products may contaminate the cavity.   
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5.0 Conclusion and Future Work 
 Conclusion 5.1
A series of ten bromide ILs (16–25) derived from mandelic acid was synthesised with 
different structural moieties (various alkyl chain lengths, ester/amide moieties and 
various N-heterocycle headgroups) to facilitate an investigation into their effect on IL 
toxicity and biodegradation. The results showed that the majority of the ILs have low 
toxicity towards the Gram-positive bacterial strain and four Gram-negative bacterial 
strains screened at high IL concentrations. IL toxicity was shown to the increase with 
increasing alkyl chain length, with methyl ester < ethyl ester < butyl ester/amide. None 
of the ILs demonstrated high toxicity to the the three CCM strains and the five clinical 
isolates screened at low IL concentrations. Moderate toxicity was observed for the 1-
methylimidazolium ethyl ester IL (18) against several bacterial strains screened. Also, 
none of the ILs demonstrated high toxicity to the four ATCC strains and eight clinical 
isolates of yeasts screened. 
 
Biodegradation studies of the mandelic acid ILs (16–25) in the CBT showed that the 3-
(ethoxycarbonyl)pyridinium butyl ester IL (23) had the highest level of biodegradation, 
with the 1-methylimidazolium butyl amide IL (24) showing no biodegradation under the 
test conditions. The amide ILs 24 and 25 showed none to very poor levels of 
biodegradation in the CBT. The butyl ester ILs had an increased biodegradation in the 
headgroup order pyridinium < 3-methoxypyridinium < 1-methylimidazolium < 3-
(ethoxycarbonyl)pyridinium. Biodegradation of the ILs was proposed to proceed 
through ester alkyl chain biodegradation to a carboxylic acid derivative. This conclusion 
is based on previous results found in the literature, and was reinforced by carrying out a 
comparison of a predicted theoretical ester/amide biodegradation calculation to the 
results obtained in the CBT.  
 
Plasticisation of PLLA with 1-methylimidazolium ester ILs with NTf2 (50–53) and 
OctSO4 (54–56) anions was undertaken to increase the ductility of PLLA and overcome 
the effect of physical ageing. The results showed that NTf2 ILs 50–53 have a significant 
plasticising effect on PLLA at 20 and 30 wt%, with the elongation at break increased by 
two orders of magnitude. PLLA plasticised with 20 wt% IL 51 gave the most promising 
results with an elongation at break of more than 500 %, a Young’s modulus of 1103 
MPa and a tensile strength of 32 MPa. A significant depression of the Tg for 
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PLLA/IL50–53 was observed. However, plasticisation of PLLA with 10 wt% NTf2 ILs 
50–53 appeared to have an antiplasticising effect, with a decrease in the elongation at 
break observed compared to neat PLLA. The OctSO4 ILs 54–56 appeared to be 
incompatible with PLLA, where an antiplasticising effect was observed for PLLA/IL54 
with 20 and 30 wt% IL, PLLA/IL55 with 10 wt% IL and PLLA/IL56 with 10, 20 and 
30 wt% IL. Any plasticising effects observed with the OctSO4 ILs 54–56 were minimal 
compared to those observed for the NTf2 ILs. 
 
Plasticisation of PLLA with NTf2 ILs 50–53 was shown in all cases to significantly 
reduce the ageing rate of PLLA, with several ILs showing a very minimal ageing effect 
over 100 days, especially PLLA/IL50 and PLLA/IL51 with 20 wt% IL. During ageing 
the Young’s modulus appeared to be ageing to an equilibrium state for each IL (50–53), 
and the tensile strength appeared to be ageing to an equilibrium state for each wt% of IL 
(50–53). The thermal stability of PLLA/IL52 with 30 wt% IL showed that IL 52 had 
very little effect on the thermal stability of PLLA.  
 
Dielectric properties of the mandelic acid ILs 18–20 and 22–25 and 1-
methylimidazolium ester ILs 49–51 were measured using a cavity perturbation 
technique at 910 and 2470 MHz. At room temperature the mandelic acid ILs 18–20 and 
22–25 are all in a solid state and have restricted molecular motion and consequently 
have zero 𝜀′′ and tan 𝛿 values. Mandelic acid IL 23 gave the highest 𝜀′ values at room 
temperature, of 2.26 and 2.30 at 910 and 2470 MHz respectively. Very similar 𝜀′ at both 
frequencies were recorded for ILs 18–20 and 22–25, which increased as the length of 
the ester alkyl chain increased from ethyl to butyl. During the high temperature 
experiments the mandelic acid ILs 20 and 23 were able to absorb microwave energy and 
thus had non-zero 𝜀′′ and tan 𝛿. A maximum tan 𝛿 was measured for IL 20 of 0.18 at 
910 MHz.  
 
The dielectric properties of the 1-methylimidazolium ester ILs 49–51 at room 
temperature were very promising, with a maximum 𝜀′′ observed for IL 50 of 5.79 at 
910 MHz and for IL 51 of 5.57 at 2470 MHz. At room temperature the ILs were able to 
absorb microwave energy to an appreciable degree due to being in a liquid state. During 
the high temperature experiment of IL 50 𝜀′ increased as the temperature increased to 
reach a maximum of 15.64 at 120 °C and 910 MHz. The maximum tan 𝛿 of 0.61 for IL 
50 was reached at 45 °C at 910 MHz. 
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A clear insight into the complex relationship between the dielectric properties of the ILs 
and both frequency and temperature have been gained through this work. Preliminary 
data on the dielectric properties of the mandelic acid ILs 18–20 and 22–25 and 1-
methylimidazolium ester ILs 49–51 was collected and will allow further informed 
studies on dielectric properties of ILs to be carried out using the cavity perturbation 
technique.  
 
In conclusion, a series of ten bromide ILs (16–25) derived from mandelic acid was 
synthesised and demonstrated low toxicity to the bacterial strains screened, with all ILs 
showing no high toxicity to the fungal strains screened. This work succesfully satisfied 
the 7
th
 principle of green cheimstry (use of renewable feedstocks) by utilising mandelic 
acid for the synthesis of the ILs (16–25). The 4th principle of green chemistry (designing 
safer chemicals) was also succesfully fufilled as all the ILs (16–25) presented with low 
bacterial toxicity and no high fungal toxicity to all the strains screened against. 
Biodegradation of the ILs in the CBT was concluded to proceed through ester alkyl 
chain biodegradation to a carboxylic acid derivative, and has highlighted the relevance 
of considering biodegradation breakdown products (metabolites) in future studies. 
Despite designing the synthesis of the ILs with the aim of achieving high 
biodegradation, and thus satisfying the 10
th
 principle of green chemistry, none of the ILs 
reached the threshold of  > 60 % biodegradation in 28 days in the CBT and thus cannot 
be classed as readily biodegradable. Plasticisation of PLLA with 1-methylimidazolium 
NTf2 ILs (50–53) showed a significant plasticising effect on PLLA and in all cases 
significantly reduced the ageing rate compared to pure PLLA. Investigation into the 
dielectric properties of the mandelic acid ILs 18–20 and 22–25 and 1-
methylimidazolium ester ILs 49–51 demonstrated the complex relationship between 
dielectric properties and both frequency and temperature, paving the way for future in-
depth studies in this area.  
 Future Work 5.2
Further work on the mandelic acid bromide ILs (16–25) will involve a study targeted at 
the detection of the biodegradation metabolites by LCMS/MS, and an evaluation of 
their toxicity. Structural modification of the ILs could be undertaken with the aim of 
increasing the biodegradability of the ILs to fully satisfy the 10
th 
principle of green 
chemistry (designing for degradation). Further synthesis and evaluation for aqueous 
stability, antimicrobial activity and biodegradation of the monofluoro mandelic acid IL 
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(37), and future synthesised candidates, is also anticipated. It is proposed that the 
mandelic acid ILs (16–25) will be used in relation to the overarching theme of this 
work, which is towards synthesis of low toxicity biodegradable ILs with applications in 
materials science.   
 
To further investigate the plasticising effect of the 1-methylimidazolium ester ILs (50–
56) on PLLA, the morphology of the PLLA/IL films could be studied using field 
emission scanning electron microscopy (FESEM). With this technique, a comparison of 
the morphology of the neat PLLA film to the plasticised PLLA films could be carried 
out. Also by comparing FESEM micrographs of PLLA plasticised with OctOSO4 ILs to 
PLLA plasticised with NTf2 ILs the effect of IL miscibility on film morphology could 
be examined. Any phase separation in the PLLA/IL films containing OctOSO4 ILs 
could be identified, and any defects caused by the plasticisation would also be detected. 
By comparing aged and non-aged PLLA/IL films, changes in the morphology of the 
films during ageing could be studied. Literature data shows that the plasticisation of 
PLA with ILs can increase the hydrolytic degradation of PLA.
1
 Thus, it would be very 
interesting to investigate to what extent the ILs studied herein affect the biodegradation 
of PLLA. 
 
It is clear from the work carried out on the plasticisation of PLLA with ILs (50–56) that 
the level of plasticisation is greatly dependent on the IL anion. Thus, investigation into 
the use of the dicyanamide (DCA) anion with the same series of cations employed 
herein, as ILs for plasticisation of PLLA, is proposed. Literature data shows that these 
ILs would be liquid at room temperature
2
 with the potential to have low viscosity
3
 and a 
thermal stability above 200 °C.
4,5
 They also demonstrated low antimicrobial activity.
2
 If 
the proposed 1-methylimidazolium DCA ILs have suitable thermal stability to 
withstand the PLLA plasticisation process, it is hoped that they would give promising 
results as plasticisers as they would be an attractive alternative to the NTf2 ILs as they 
do not contain any fluorine. Also, when comparing the cost of the starting materials 
used to synthesise the ILs, sodium dicyanamide is cheaper than lithium bistriflimide, 
which will result in a cheaper synthesis for the DCA ILs making them more attractive to 
industry.  
 
It would be of great interest to further investigate the dielectric properties of the 
mandelic acid ILs 18–20 and 22–25. With the aim of exploiting the maximum dielectric 
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potential of the ILs, it is proposed that examples of mandelic acid ILs with DCA and 
NTf2 anions should be investigated. Four mandelic acid ILs have been suggested for 
this purpose (Figure 5.1). 
 
 
Figure 5.1 Suggested mandelic acid ILs (63–66) with DCA and OctSO4 anions for 
further investigation into the dielectric properties of ILs. 
 
DCA and NTf2 examples of the mandelic acid ILs 63–66 would be likely to have lower 
melting points, with the potential to be liquid at room temperature, as it is widely known 
that DCA and NTf2 ILs often have lower melting points than the corresponding halide 
ILs.
5
 The reduction in IL melting point would ideally give a much larger window for the 
dielectric properties of the ILs to be measured, thus enabling higher dielectric properties 
at lower temperatures to be recorded. This would increase the potential of the mandelic 
acid ILs to be used as reaction solvents both with and without microwaves. The desired 
dielectric constants could be reached at lower temperatures, making them applicable to 
a wider range of reactions (e.g. temperature sensitive reactions). Using these ILs would 
also satisfy the 6
th
 principle of green chemistry (design for energy efficiency) as 
reactions could be undertaken at lower temperatures. Mandelic acid ILs that are liquid at 
RT would also be of interest to investigate for the plasticisation of PLLA (see chapter 
2). 
 
Before further dielectric measurements are undertaken, an investigation into the thermal 
decomposition temperatures of the mandelic acid ILs 18–20 and 22–25 would be 
beneficial. The high temperature experiments could then be carried out to the maximum 
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possible temperature. This would enable the highest amount of dielectric data for the 
processing range of the ILs to be obtained. It would be highly undesirable for the IL to 
break down during the temperature ramp and whilst in the cavity, as the ILs pyrolysis 
products may contaminate the cavity.   
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6.0 Experimental 
 Introduction 6.1
6.1.1 Chemicals 
The majority of chemicals were purchased from Sigma Aldrich, with the exception of 
lithium bis(trifluromethanesulfonyl) imide (LiNTf2) which was purchased from 
Solvionic and sodium octyl sulfate (NaOctSO4) which was purchased from Alfa Aesar. 
Pyridine (99.8 %), bromoacetyl bromide (≥ 98 %), thionyl chloride (≥ 99 %) and 
thionyl bromide (97 %) were used without further purification. 1-methylimidazole 
(99 %) was distilled before use. Methanol and ethanol were pre-dried with magnesium 
sulphate and subsequently 3 Å molecular sieves. n-Butanol was dried over molecular 
sieves and used without further purification. THF was dried over sodium/benzophenone 
ketyl and was distilled before use. DCM was dried over calcium hydride, and distilled 
before use. Sodium carbonate (Na2CO3) and magnesium sulphate heptahydrate 
(MgSO4.7H2O) were obtained from Riedel de Haën and Fluka respectively. Riedel de 
Haën silica gel was used for flash and thin layer chromatography. Commercial grade 
PLLA 1010 (> 99% L-isomer) was supplied by Synbra Technology in pellet form. 
Weight-average molecular weight and polydispersity were 127400 g mol
−1
 and 1.83 
respectively, as determined by GPC using polystyrene standards. The glass transition, 
crystallisation and melting temperature were 58, 100 and 175 °C respectively, as 
measured by DSC. Compound 61 was available within the group from stock. 
6.1.2 NMR Analysis 
All the NMR analysis was undertaken using a Bruker AC 400 MHz spectrometer 
operating at 400 MHz for 
1
H NMR and 101 MHz for 
13
C NMR, in deuterated 
chloroform (99.8 % D) or DMSO-d6 (99.8 % D). Chemical shifts are reported in parts 
per million (ppm) relative to the internal standard (TMS) and coupling constants (J) are 
reported in Hertz (Hz). When stating peak multiplicity the following abbreviations are 
used; s – singlet, bs – broad singlet, d – doublet, t – triplet, q – quartet, dd – doublet of 
doublets, dt – doublet of triplets, dq – doublet of quartets, tt – triplet of triplets, tq – 
triplet of quartets, ddd – doublet of doublet of doublets, ddt – doublet of doublet of 
triplets, dtd – doublet of triplet of doublets and m – multiplet. NMR assignment was 
assisted by 2D NMR spectroscopy (
1
H–1H COSY, 1H–13C HMQC and 1H–13C HMBC). 
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6.1.3 IR Analysis 
All IR analysis was carried out on a Perkin Elmer 100 FT-IR spectrum GX spectrometer 
with a Thermo Scientific iD5 Diamond ATR attachment.  
6.1.4 Melting Points 
All melting points (uncorrected) were obtained using a Stuart SMP40 Melting Point 
Apparatus and the values are expressed in degrees Celsius (°C). 
6.1.5 Mass Spectrometry 
High resolution mass spectrometry (HRMS) was obtained in the ABCRF Mass 
Spectrometry Laboratory in University College Cork (UCC) using a Waters Micromass 
LCT Premier mass spectrometer (KD 160). The analysis was performed in ESI+ mode 
with an external reference standard of leucine enkephalin. A sulfadimethoxine 
concentration test was performed to ensure peak accuracy in the ion count range 1 × e
3 
to 1 × e
6
. 
6.1.6 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) was obtained in ETH Zurich using a Mettler Toledo 
TGA/SDTA 851e instrument (Mettler Toledo, Switzerland). TGA thermograms were 
recorded under N2 at a heating rate of 10 K min
−1
, with an average sample weight of ca 
10 mg. Alumina pans were used for all TGA carried out.  
6.1.7 Melt Extrusion 
Melt extrusion was carried out in ETH Zurich using a co-rotating twin-screw extruder 
(Eindhoven University of Technology, Netherlands) under N2 at 200 °C and 100 rpm 
for approximately 10 min. Films with a thickness of 0.5 ± 0.05 mm were prepared by 
melt-compressing the compounded PLLA/IL blends of various ratios at 200 °C, under 
ca 5 kN force in a hot-press (Rondol Technology), followed by quenching to room 
temperature in a cold press (Rondol Technology). To ensure consistency in the film 
thickness, a rectangular steel spacer was used. 
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6.1.8 Film Casting 
Films were made in ETH Zurich using a hot press (Rondol Technology) and a cold 
press. (Rondol Technology). 
6.1.9 Tensile Testing 
Mechanical characteristics were investigated using an Instron 5864 Mechanical Testing 
Equipment. The measurements were performed using the compression moulded films 
cut into dumbbell-shaped specimens with a gauge length of 12.7 mm, at an extension 
rate of 5 mm min
−1
 or 0.007 s
−1
. Samples were initially tested on the same day as melt 
extrusion and film formation (day 0). Samples were stored in polyethylene bags at rt 
between the ageing tests, which were carried out on day 4 for the PLLA films and on 
day 1, 10 and 100 for the PLLA/IL films. For each sample a minimum of three 
specimens were tested with the mean average of the values reported herein. 
6.1.10  Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) measurements were carried out in ETH Zurich 
using a DSC822e instrument (Mettler Toledo, Switzerland). DSC calorigrams were 
recorded under N2 purge at standard heating and cooling rates of 10 K min
−1
, with a 
sample weight of 5–10 mg. Aluminium pans were used for all DSC carried out. 
6.1.11  Cavity Perturbation Apparatus1,2  
Dielectric property measurements were carried out in The University of Nottingham 
using an in house built cavity perturbation apparatus. The system consists of a 
cylindrical copper cavity (diameter 570 mm and height 50 mm) connected to a Hewlett 
Packard 8753B vector network analyser (VNA). Samples of approximately 15 mm were 
encased in a quartz tube of approximately 3 mm internal diameter (diameter to length 
ratio of 0.2–0.3) and introduced into the centre of the resonant cavity, resonating in 
TM0n0 mode. The frequency shift and change in quality factor were measured by the 
VNA at a resonant frequency of 910 MHz and 2470 MHz. Perturbation theory was 
subsequently used to determine the dielectric properties of the sample. A linear stage 
driven by a step motor and a furnace enabled high temperature measurements to be 
carried out. The temperature of the furnace was increased by 1 °C per minute, with 
measurements recorded every 5 °C. The sample resided in the furnace above the cavity 
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until the test temperature was reached. The sample was maintained at the test 
temperature for 10 min to allow the sample to equilibrate, after which the step-motor 
rapidly moved the sample into the cavity for testing. During the measurement the 
sample spent ca 3 s outside the furnace in the cavity, thus the heat loss was considered 
negligible. The high temperature experiments were carried out between 20–120 °C. For 
rt measurements the results recorded herein are an average of a minimum of four 
measurements.  
 Experimental Preparations for Mandelate ILs  6.2
6.2.1 Mandelate Esters 
General Procedure A: Preparation of Mandelate Ester (26–28) 
 
Methyl 2-hydroxy-2-phenylacetate (26)
3
 
A flask was charged with mandelic acid (10.10 g, 66.38 mmol) 
and methanol (50 mL), under N2. Whilst stirring and cooling in an 
ice bath (0 °C), thionyl chloride (2.40 mL, 33.1 mmol) was added 
dropwise and the reaction was stirred for 4 h at rt. TLC confirmed 
reaction completion. N2 was bubbled through the reaction for 1 h. The solvent was 
removed, deionised water (25 mL) was added and the product extracted with ethyl 
acetate (3 × 25 mL). The combined organic extracts were washed with saturated 
aqueous sodium bicarbonate (20 mL), dried over MgSO4, filtered and the solvent 
removed. The organic phase was dried under reduced pressure to give the title 
compound (26) as a white waxy solid (10.20 g, 61.38 mmol), 92 % yield. 
Chemical formula: C9H10O3; Molecular weight: 166.18 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.45–7.30 (m, 5H), 5.18 (d, J = 5.1 Hz, 1H), 3.77 (s, 
3H), 3.44 (d, J = 5.1 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 174.28, 138.34, 128.77, 
128.67, 126.73, 73.01, 53.22. 
1
H and 
13
C NMR data are in agreement with the literature.
3
 
 
Ethyl 2-hydroxy-2-phenylacetate (27)
4
  
The title compound (27) was synthesised from mandelic acid 
(10.03 g, 65.92 mmol), ethanol (50 mL) and thionyl chloride 
(2.40 mL, 33.1 mmol) according to the general procedure A to 
give a colourless liquid (10.90 g, 60.49 mmol), 92 % yield. 
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Chemical formula: C10H12O3; Molecular weight: 180.20 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.46–7.29 (m, 5H), 5.16 (d, J = 5.8 Hz, 1H), 4.27 (dq,    
J = 10.8, 7.1 Hz, 1H), 4.17 (dq, J = 10.8, 7.1 Hz, 1H), 3.51 (d, J = 5.8 Hz, 1H), 1.23 (t,    
J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 173.79, 138.52, 128.67, 128.50, 
126.63, 72.98, 62.36, 14.14. 
1
H and 
13
C NMR data are in agreement with the literature.
4
  
 
Butyl 2-hydroxy-2-phenylacetate (28)
5
 
The title compound (28) was synthesised from mandelic 
acid (50.01 g, 328.7 mmol), n-butanol (250 mL) and 
thionyl chloride (12.0 mL, 165 mmol) according to the 
general procedure A to give a yellow liquid (66.68 g, 
320.2 mmol), 97 % yield. 
Chemical formula: C12H16O3; Molecular weight: 208.26 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.46–7.39 (m, 2H), 7.39–7.28 (m, 3H), 5.16 (d, J = 5.8 
Hz, 1H), 4.22–4.09 (m, 2H), 3.59 (bs, 1H), 1.61–1.50 (m, 2H), 1.30–1.19 (m, 2H), 0.85 
(t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 173.88, 138.55, 128.61, 128.46, 
126.58, 72.94, 66.12, 30.48, 18.94, 13.65. 
1
H and 
13
C NMR data are in agreement with the literature.
5
 
6.2.2 Mandelate Amide 
Preparation of Mandelate Amide (29) 
 
N-Butyl-2-hydroxy-2-phenylacetamide (29)
6
 
Coupling Procedure 
A flask was charged with mandelic acid (2.08 g, 
13.7 mmol) and DCM (20 mL), under N2. Whilst stirring 
and cooling in an ice bath (0 °C), HOSu (1.74 g, 
15.1 mmol) and EDC (2.34 g, 15.1 mmol) were added 
simultaneously. The reaction was stirred at 0 °C for 30 min. n-Butylamine (1.35 mL, 
13.7 mmol) was added and the reaction was stirred for a further 15 min at 0 °C, and 
subsequently for 2 days at rt. TLC confirmed reaction completion. The organic phase 
was washed with deionised water (2 × 15 mL) and saturated aqueous ammonium 
chloride (20 mL). Next, the organic phase was dried over MgSO4, filtered and the 
solvent removed. The crude product was purified by column chromatography (SiO2, 
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EtOAc:hexane, 60:40) and dried under reduced pressure to give the title compound (29) 
as a white crystalline solid (1.29 g, 6.22 mmol), 45 % yield. 
 
Acetyl Chloride Procedure 
A flask was charged with mandelic acid (50.19 g, 329.9 mmol) and methanol (300 mL), 
under N2. Whilst stirring and cooling in an ice bath (0 °C), acetyl chloride (24.0 mL, 
336 mmol) was added dropwise and the reaction was stirred overnight at rt. TLC 
confirmed reaction completion. The solvent was removed and methanol (150 mL) was 
added. Whilst stirring and cooling in an ice bath (0 °C), n-butylamine (130 mL, 
1.32 mol) was added dropwise and the reaction was left in the fridge (< 5 °C) overnight. 
TLC confirmed reaction completion. The solvent was removed, DCM (250 mL) was 
added, and the organic phase was washed with water (3 × 100 mL) and saturated 
aqueous ammonium chloride (100 mL). The organic phase was dried over MgSO4, 
filtered and the solvent removed. The product was dried under reduced pressure to give 
the title compound (29) as a white crystalline solid (61.05 g, 294.5 mmol), 89 % yield. 
Chemical formula: C12H17NO2; Molecular weight: 207.27 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.41–7.29 (m, 5H), 6.12 (bs, 1H), 4.98 (s, 1H), 3.77 (bs, 
1H), 3.31–3.17 (m, 2H), 1.48–1.38 (m, 2H), 1.33–1.21 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 172.09, 139.66, 129.05, 128.82, 127.01, 74.25, 39.54, 
31.63, 20.06, 13.83. 
1
H and 
13
C NMR data are in agreement with the literature.
6
 
6.2.3 Mandelate Alkylating Reagents 
General Procedure B: Preparation of Mandelate Alkylating Reagent (30–33) 
 
Methyl 2-bromo-2-phenylacetate (30)
7
 
A flask was charged with methyl 2-hydroxy-2-phenylacetate (26) 
(18.08 g, 108.8 mmol) and dry DCM (100 mL), under N2. Whilst 
stirring, triethylamine (22.8 mL, 163 mmol) was added. The 
reaction was cooled in an ice bath (0 °C), thionyl bromide 
(10.0 mL, 129 mmol) was added dropwise and the reaction was stirred overnight at rt. 
TLC confirmed reaction completion and N2 was bubbled through the reaction for 1 h. 
The organic phase was washed with deionised water (3 × 50 mL) and the combined 
aqueous phase was subsequently washed with DCM (20 mL). The combined organic 
phase was dried over MgSO4, filtered and the solvent removed. The crude product was 
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purified by column chromatography (SiO2, hexane to EtOAc:hexane, 20:80): and dried 
under reduced pressure to give the title compound (30) as a yellow liquid (16.68 g, 
72.82 mmol), 67 % yield. 
Chemical formula: C9H9BrO2; Molecular weight: 229.07 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.58–7.50 (m, 2H), 7.41–7.31 (m, 3H), 5.37 (s, 1H), 3.79 
(s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 168.94, 135.85, 129.46, 128.99, 128.78, 53.55, 
46.67. 
1
H and 
13
C NMR data are in agreement with the literature.
7
 
 
Ethyl 2-bromo-2-phenylacetate (31)
8
 
The title compound (31) was synthesised from ethyl 2-
hydroxy-2-phenylacetate (27) (15.00 g, 83.24 mmol), dry DCM 
(100 mL), triethylamine (17.5 mL, 125 mmol) and thionyl 
bromide (7.7 mL, 99 mmol), according to the general 
procedure B. The crude product was purified by column chromatography (SiO2, 
EtOAc:hexane, 20:80) to give a yellow liquid (11.32 g, 46.57 mmol), 56 % yield. 
Chemical formula: C10H11BrO2; Molecular weight: 243.10 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.59–7.52 (m, 2H), 7.41–7.31 (m, 3H), 5.35 (s, 1H), 
4.32–4.16 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 168.42, 
135.98, 129.38, 128.94, 128.78, 62.66, 46.99, 14.07. 
1
H and 
13
C NMR data are in agreement with the literature.
8
 
 
Butyl 2-bromo-2-phenylacetate (32) 
The title compound (32) was synthesised from butyl 2-
hydroxy-2-phenylacetate (28) (30.07 g, 144.4 mmol), 
dry DCM (250 mL), triethylamine (30.0 mL, 215 mmol) 
and thionyl bromide (13.5 mL, 174 mmol), according to 
the general procedure B. The organic phase was washed with deionised water 
(3 × 150 mL), and the crude product was purified by column chromatography (SiO2, 
EtOAc:hexane, 40:60) to give a yellow liquid (19.85 g, 73.21 mmol), 51 % yield. 
Chemical formula: C12H15BrO2; Molecular weight: 271.15 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.59–7.51 (m, 2H), 7.41–7.31 (m, 3H), 5.35 (s, 1H), 
4.25–4.12 (m, 2H), 1.68–1.58 (m, 2H), 1.44–1.27 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 168.46, 135.98, 129.33, 128.88, 128.75, 66.43, 47.03, 30.47, 
19.06, 13.74. 
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IR (neat) 2960, 2874, 1744, 1455, 1251, 1138, 693 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M+H]
+
 C12H16
79
BrO2
+
, requires 271.0328 found 
271.0329. 
 
2-Bromo-N-butyl-2-phenylacetamide (33) 
The title compound (33) was synthesised from n-butyl-
2-hydroxy-2-phenylacetamide (29) (20.05 g, 
96.73 mmol), dry DCM (110 mL), triethylamine 
(20.0 mL, 143 mmol) and thionyl bromide (9.0 mL, 
0.12 mol), according to the general procedure B. The crude product was purified by 
column chromatography (SiO2, EtOAc:hexane, 20:80) to give a light yellow crystalline 
solid (13.64 g, 50.49 mmol), 52 % yield. 
Chemical formula: C12H16BrNO; Molecular weight:
 
270.17 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.47–7.40 (m, 2H), 7.40–7.28 (m, 3H), 6.67 (bs, 1H), 
5.43 (s, 1H), 3.32 (dt, J = 6.8, 6.8 Hz, 2H), 1.60–1.50 (m, 2H), 1.43–1.31 (m, 2H), 0.94 
(t, J = 7.3 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.95, 137.74, 129.21, 129.11, 
128.40, 52.02, 40.35, 31.49, 20.17, 13.88. 
IR (neat) 3295, 2931, 1657, 1545, 1231, 1168, 692 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M+H]
+
 C12H17
79
BrNO
+
, requires 270.0488 found 
270.0485. 
6.2.4 Mandelate Bromide ILs 
General Procedure C: Preparation of Mandelate Bromide ILs (16–25) 
 
3-(2-Methoxy-2-oxo-1-phenylethyl)-1-methyl-1H-imidazol-3-ium bromide (16) 
A flask was charged with methyl 2-bromo-2-phenylacetate (30) 
(5.04 g, 22.0 mmol) and diethyl ether (20 mL), under N2. Whilst 
stirring 1-methylimidazole (1.72 mL, 21.6 mmol) was added and 
the reaction was stirred overnight at rt. TLC confirmed reaction 
completion. Diethyl ether was decanted and the product was 
washed with diethyl ether (5 × 25 mL). The volatiles were removed via rotary 
evaporation and the product was dried under reduced pressure to give the title 
compound (16) as a white solid (6.37 g, 20.5 mmol), 95 % yield. 
Chemical formula: C13H15BrN2O2; Molecular weight: 311.18 g mol
−1
; mp: 61−63 °C 
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1
H NMR (400 MHz, CDCl3) δ 10.67 (bs, 1H), 7.62–7.55 (m, 2H), 7.48–7.41 (m, 4H), 
7.41 (s, 1H), 7.34 (dd, J = 1.9, 1.9 Hz, 1H), 4.04 (s, 3H), 3.82 (s, 3H). 
13
C NMR 
(101 MHz, CDCl3) δ 168.24, 138.13, 132.13, 130.61, 129.96, 128.80, 122.57, 121.91, 
64.04, 53.92, 36.96. 
IR (neat) 3042, 2954, 1744, 1552, 1437, 1278, 1216, 1160, 986, 733 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C13H15N2O2
+
, requires 231.1128, found 
231.1125. 
 
1-(2-Methoxy-2-oxo-1-phenylethyl)pyridin-1-ium bromide (17) 
The title compound (17) was synthesised from methyl 2-bromo-2-
phenylacetate (30) (5.02 g, 21.9 mmol), diethyl ether (5 mL) and 
pyridine (1.73 mL, 21.5 mmol), according to the general procedure 
C to give a white solid (5.66 g, 18.4 mmol), 86 % yield. 
Chemical formula: C14H14BrNO2;  
Molecular weight: 308.18 g mol
−1
; mp: 140−142 °C 
1
H NMR (400 MHz, CDCl3) δ 9.63–9.56 (m, 2H), 8.56 (tt, J = 7.8, 1.4 Hz, 1H), 8.51 (s, 
1H), 8.11–8.03 (m, 2H), 7.77–7.68 (m, 2H), 7.54–7.42 (m, 3H), 3.87 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 167.98, 146.51, 145.30, 131.27, 131.13, 130.23, 129.88, 127.92, 
73.25, 54.35. 
IR (neat) 3021, 2959, 1743, 1628, 1482, 1279, 1218, 1159, 993, 748 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C14H14NO2
+
, requires 228.1019 found 
228.1022. 
 
3-(2-Ethoxy-2-oxo-1-phenylethyl)-1-methyl-1H-imidazol-3-ium bromide (18) 
The title compound (18) was synthesised from ethyl 2-bromo-2-
phenylacetate (31) (5.01 g, 20.6 mmol), diethyl ether (20 mL) 
and 1-methylimidazole (1.61 mL, 20.2 mmol), according to the 
general procedure C. The reaction was stirred for 2 days to give 
a white solid (6.15 g, 18.9 mmol), 94 % yield. 
Chemical formula: C14H17BrN2O2; Molecular weight: 325.21 g mol
−1
; mp: 101−102 °C 
1
H NMR (400 MHz, CDCl3) δ 10.87 (bs, 1H), 7.63–7.56 (m, 2H), 7.48–7.42 (m, 3H), 
7.40 (dd, J = 1.8, 1.8 Hz, 1H), 7.30 (s, 1H), 7.18 (dd, J = 1.8, 1.8 Hz, 1H), 4.308 (q,       
J = 7.1 Hz, 1H), 4.305 (q, J = 7.1 Hz, 1H), 4.03 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H). 
13
C 
NMR (101 MHz, CDCl3) δ 167.61, 137.87, 132.27, 130.49, 129.88, 128.71, 122.82, 
121.90, 64.11, 63.44, 36.94, 14.04. 
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IR (neat) 3070, 3016, 1746, 1576, 1280, 1209, 1170, 1010, 735 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C14H17N2O2
+
, requires 245.1285, found 
245.1277. 
 
1-(2-Ethoxy-2-oxo-1-phenylethyl)pyridin-1-ium bromide (19)
9
 
A flask was charged with ethyl 2-bromo-2-phenylacetate (31) 
(5.00 g, 20.6 mmol) under N2. With no stirring, pyridine 
(1.62 mL, 20.1 mmol) was added and the reaction was left for 2 
days at rt. TLC confirmed reaction completion. The product was 
washed with diethyl ether (5 × 25 mL). The volatiles were 
removed via rotary evaporation, and the product was dried under reduced pressure to 
give the title compound (19) as a white solid (6.35 g, 19.7 mmol), 98 % yield. 
Chemical formula: C15H16BrNO2; Molecular weight: 322.20 g mol
−1
;
 
mp: 161−162 °C 
1
H NMR (400 MHz, CDCl3) δ 9.61–9.56 (m, 2H), 8.53 (tt, J = 7.8, 1.3 Hz, 1H), 8.41 (s, 
1H), 8.08–8.01 (m, 2H), 7.79–7.70 (m, 2H), 7.53–7.44 (m, 3H), 4.43–4.35 (m, 1H), 
4.35–4.28 (m, 1H), 1.30 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 167.52, 
146.30, 145.38, 131.24, 131.24, 130.21, 129.92, 127.77, 73.41, 64.11, 14.08. 
IR (neat) 3029, 2949, 1747, 1629, 1486, 1216, 1160, 1012, 706 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C15H16NO2
+
, requires 242.1176, found 
242.1170. 
1
H and 
13
C NMR data are in agreement with the literature.
9
 
 
3-(2-Butoxy-2-oxo-1-phenylethyl)-1-methyl-1H-imidazol-3-ium bromide (20)  
The title compound (20) was synthesised from butyl 
2-bromo-2-phenylacetate (32) (7.04 g, 26.0 mmol), 
diethyl ether (20 mL) and 1-methylimidazole 
(2.03 mL, 25.5 mmol), according to the general 
procedure C. The reaction was stirred for 5 days to 
give a white solid (7.55 g, 21.4 mmol), 84 % yield. 
Chemical formula: C16H21BrN2O2; Molecular weight: 353.26 g mol
−1
; mp: 99−101 °C 
1
H NMR (400 MHz, CDCl3) δ 10.52 (bs, 1H), 7.59–7.51 (m, 2H), 7.49 (dd, J = 1.9, 
1.9 Hz, 1H), 7.45 (dd, J = 1.9, 1.9 Hz, 1H), 7.43–7.35 (m, 3H), 7.23 (s, 1H), 4.23 (dt, 
J = 10.7, 6.8 Hz, 1H), 4.16 (dt, J = 10.7, 6.7 Hz, 1H), 4.03 (s, 3H), 1.64–1.48 (m, 2H), 
1.21 (tq, J = 7.4, 7.4 Hz, 2H), 0.81 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 
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167.64, 137.68, 132.28, 130.44, 129.80, 128.65, 122.99, 121.87, 67.12, 64.10, 36.93, 
30.23, 18.87, 13.58. 
IR (neat) 3060, 2958, 1742, 1549, 1280, 1210, 1192, 1158, 794, 729 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C16H21N2O2
+
, requires 273.1598, found 
273.1601. 
 
1-(2-Butoxy-2-oxo-1-phenylethyl)pyridin-1-ium bromide (21) 
The title compound (21) was synthesised from butyl 2-
bromo-2-phenylacetate (32) (7.03 g, 25.9 mmol), diethyl 
ether (7 mL) and pyridine (2.04 mL, 25.3 mmol), 
according to the general procedure C. The reaction was 
stirred for 5 days to give a brown solid (4.94 g, 
14.1 mmol), 56 % yield. 
Chemical formula: C17H20BrNO2; Molecular weight: 350.26 g mol
−1
; mp: 48−50 °C 
1
H NMR (400 MHz, CDCl3) δ 9.59–9.53 (m, 2H), 8.54 (tt, J = 7.7, 1.4 Hz, 1H), 8.37 (s, 
1H), 8.09–8.01 (m, 2H), 7.78–7.69 (m, 2H), 7.53–7.43 (m, 3H), 4.34 (dt, J = 10.7, 
6.7 Hz, 1H), 4.23 (dt, J = 10.7, 6.7 Hz, 1H), 1.71–1.53 (m, 2H), 1.28 (tq, J = 7.5, 
7.4 Hz, 2H), 0.85 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 167.42, 146.60, 
145.19, 131.20, 131.17, 130.11, 129.84, 127.93, 73.46, 67.76, 30.22, 18.91, 13.59. 
IR (neat) 3036, 2958, 2871, 1739, 1628, 1480, 1279, 1212, 1159, 748 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C17H20NO2
+
, requires 270.1489, found 
270.1482. 
 
1-(2-Butoxy-2-oxo-1-phenylethyl)-3-methoxypyridin-1-ium bromide (22) 
The title compound (22) was synthesised from butyl 2-
bromo-2-phenylacetate (32) (5.00 g, 18.4 mmol), diethyl 
ether (25 mL) and 3-methoxypyridine (1.77 mL, 
17.6 mmol), according to the general procedure C. The 
reaction was stirred for 5 days to give a white solid 
(4.95 g, 13.0 mmol), 74 % yield. 
Chemical formula: C18H22BrNO3; Molecular weight: 380.28 g mol
−1
; mp: 127−128 °C 
1
H NMR (400 MHz, CDCl3) δ 9.81 (dd, J = 2.6, 1.3 Hz, 1H), 8.63 (ddd, J = 6.0, 1.3, 
1.1 Hz, 1H), 8.38 (s, 1H), 7.99 (ddd, J = 8.8, 2.6, 1.1 Hz, 1H), 7.87 (dd, J = 8.8, 6.0 Hz, 
1H), 7.74–7.68 (m, 2H), 7.50–7.41 (m, 3H), 4.32 (dt, J = 10.7, 6.8 Hz, 1H), 4.20 (dt, J = 
10.7, 6.8 Hz, 1H), 4.16 (s, 3H), 1.61 (ddt, J = 13.8, 11.6, 6.8 Hz, 2H), 1.26 (tq, J = 7.5, 
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7.4 Hz, 2H), 0.83 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 167.46, 158.50, 
136.80, 132.63, 132.62, 131.42, 131.06, 129.99, 129.86, 127.69, 73.44, 67.66, 58.80, 
30.21, 18.91, 13.60. 
IR (neat) 3034, 2956, 1741, 1624, 1519, 1294, 1284, 1209, 1153, 744 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C18H22NO3
+
, requires 300.1594, found 
300.1592. 
 
1-(2-Butoxy-2-oxo-1-phenylethyl)-3-(ethoxycarbonyl)pyridin-1-ium bromide (23)  
The title compound (23) was synthesised from butyl 2-
bromo-2-phenylacetate (32) (5.03 g, 18.2 mmol), diethyl 
ether (5 mL) and ethyl nicotinate (2.49 mL, 18.2 mmol), 
according to the general procedure C. The reaction was 
stirred for 5 days give a light pink solid (4.80 g, 
11.4 mmol), 63 % yield. 
Chemical formula: C20H24BrNO4; Molecular weight: 422.32 g mol
−1
; mp: 112−113 °C 
1
H NMR (400 MHz, CDCl3) δ 10.41 (ddd, J = 6.3, 1.4, 1.4 Hz, 1H), 9.43 (bs, 1H), 8.96 
(ddd, J = 8.0, 1.4, 1.4 Hz, 1H), 8.59 (s, 1H), 8.23 (dd, J = 8.0, 6.3 Hz, 1H), 7.85–7.76 
(m, 2H), 7.56–7.48 (m, 3H), 4.47 (q, J = 7.1 Hz, 2H), 4.36 (dt, J = 10.7, 6.8 Hz, 1H), 
4.25 (dt, J = 10.7, 6.8 Hz, 1H), 1.64 (ddt, J = 13.8, 12.0, 6.8 Hz, 2H), 1.42 (t,                 
J = 7.1 Hz, 3H), 1.28 (tq, J = 7.4, 7.4 Hz, 2H), 0.87 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 
MHz, CDCl3) δ 167.58, 160.84, 149.43, 146.07, 145.23, 131.50, 130.65, 130.51, 
130.29, 130.11, 128.05, 73.91, 68.05, 63.81, 30.26, 18.96, 14.23, 13.64. 
IR (neat) 3045, 2961, 1737, 1721, 1635, 1456, 1297, 1280, 1177, 706 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C20H24NO4
+
, requires 342.1700, found 
342.1692. 
 
3-(2-(Butylamino)-2-oxo-1-phenylethyl)-1-methyl-1H-imidazol-3-ium bromide (24) 
The title compound (24) was synthesised from 2-bromo-
N-butyl-2-phenylacetamide (33) (5.00 g, 18.5 mmol), 
diethyl ether (20 mL) and 1-methylimidazole (1.40 mL, 
17.6 mmol), according to the general procedure C. The 
reaction was stirred for 2 days to give a white solid 
(6.12 g, 17.4 mmol), 99 % yield. 
Chemical formula: C16H22BrN3O; Molecular weight: 352.28 g mol
−1
; mp: 143−145 °C 
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1
H NMR (400 MHz, CDCl3) δ 9.76 (bs, 1H), 8.29 (t, J = 5.3 Hz, 1H), 7.79 (s, 1H), 7.75 
(dd, J = 1.8, 1.8 Hz, 1H), 7.67–7.60 (m, 2H), 7.42–7.34 (m, 3H), 7.19 (dd, J = 1.9, 
1.9 Hz, 1H), 3.98 (s, 3H), 3.34–3.25 (m, 1H), 3.25–3.16 (m, 1H), 1.53 (dtd, J = 8.8, 7.4, 
5.8 Hz, 2H), 1.38–1.23 (m, 2H), 0.86 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ 166.17, 136.32, 133.49, 129.96, 129.48, 128.44, 123.00, 122.30, 63.89, 39.94, 36.91, 
31.09, 20.25, 13.79. 
IR (neat) 3158, 3022, 2929, 1675, 1554, 1227, 1164, 742 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C16H22N3O
+
, requires 272.1757, found 
272.1757. 
 
1-(2-(Butylamino)-2-oxo-1-phenylethyl)pyridin-1-ium bromide (25) 
The title compound (25) was synthesised from 2-bromo-
N-butyl-2-phenylacetamide (33) (5.00 g, 18.5 mmol), 
diethyl ether (5 mL) and pyridine (1.42 mL, 17.6 mmol), 
according to the general procedure C. The reaction was 
stirred for 2 days to give a white solid (5.26 g, 
15.1 mmol), 86 % yield. 
Chemical formula: C17H21BrN2O; Molecular weight: 349.27 g mol
−1
; mp: 167−169 °C 
1
H NMR (400 MHz, CDCl3) δ 9.60–9.53 (m, 2H), 8.72 (bs, 1H), 8.68 (s, 1H), 8.43 (tt,  
J = 7.8, 1.4 Hz, 1H), 8.01–7.92 (m, 2H), 7.69–7.62 (m, 2H), 7.51–7.41 (m, 3H), 3.43–
3.31 (m, 1H), 3.31–3.21 (m, 1H), 1.65–1.52 (m, 2H), 1.35 (tq, J = 7.4, 7.3 Hz, 2H), 0.89 
(t, J = 7.3 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 164.93, 145.47, 144.92, 132.40, 
130.82, 129.94, 129.39, 127.63, 72.58, 40.25, 31.05, 20.29, 13.80. 
IR (neat) 3126, 3014, 2958, 1674, 1626, 1553, 1481, 1226, 1157, 708 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M–Br–]+ C17H21N2O
+
, requires 269.1648, found 
269.1644. 
6.2.4.3 Monofluoro Mandate Bromide IL 
Preparation of α-Fluoroester of Mandelic Acid (35) 
 
Ethyl 2-fluoro-2-phenylacetate (35)
9
 
A flask was charged with ethyl 2-hydroxy-2-phenylacetate 
(27) (1.08 g, 5.99 mmol) and dry DCM (15 mL), under N2. 
Whilst stirring and cooling in an ice bath (0 °C), DAST 
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(1.42 mL, 10.7 mmol) was added dropwise and the reaction was stirred for 1 day at rt. 
TLC confirmed reaction completion. The reaction was quenched by the slow dropwise 
addition of saturated aqueous sodium bicarbonate (15 mL), and the product was 
subsequently extracted with DCM (2 × 15 mL). The combined organic extracts were 
washed with 0.5 N HCl solution (2 × 15 mL) and dried over MgSO4. After filtering, the 
solvent was removed. The crude product was purified by column chromatography 
(SiO2, EtOAc:hexane, 10:90) and dried under reduced pressure to give the title 
compound (35) as a yellow oil (0.703 g, 3.86 mmol), 64 % yield. 
Chemical formula: C10H11FO2; Molecular weight: 182.19 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.52–7.43 (m, 2H), 7.43–7.35 (m, 3H), 5.78 (d,            
JH-F = 47.8 Hz, 1H), 4.34–4.14 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, 
CDCl3) δ 168.66 (d, 
2
JC-F = 27.4 Hz), 134.36 (d, 
2
JC-F = 20.4 Hz), 129.68 (d,               
5
JC-F = 2.3 Hz), 128.86, 126.74 (d, 
3
JC-F = 6.0 Hz), 89.45 (d, 
1
JC-F = 185.3 Hz), 61.94, 
14.13. 
19
F NMR (376 MHz, CDCl3) δ −179.77 (d, 
2
JH-F = 47.9 Hz). 
1
H, 
13
C and 
19
F NMR data are in agreement with the literature.
10
 
 
Preparation of α-Bromo-α-fluoroester of Mandelic Acid (36) 
 
Ethyl 2-bromo-2-fluoro-2-phenylacetate (36) 
A flask was charged with ethyl 2-fluoro-2-phenylacetate (35) 
(0.500 g, 2.74 mmol) and dry CCl4 (10 mL). NBS (0.488 g, 
2.74 mmol) was added in one portion and the reaction was 
refluxed whilst under illumination from a 300 W mercury 
lamp. After 1 h the reaction turned orange and subsequently yellow after 19 h. TLC 
confirmed reaction completion. After filtering the solvent was removed. The crude 
product was purified by column chromatography (SiO2, EtOAc:hexane, 5:95) and dried 
under reduced pressure, to give the title compound (36) as a colourless viscous liquid 
(0.608 g, 2.33 mmol), 85 % yield. 
Chemical formula: C10H10BrFO2; Molecular weight: 261.09 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 7.77–7.67 (m, 2H), 7.47–7.37 (m, 3H), 4.40–4.27 (m, 
2H), 1.33 (t, J = 7.1 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 165.71 (d, 
2
JC-F = 
28.5 Hz), 136.89 (d, 
2
JC-F = 21.6 Hz), 130.37 (d, 
5
JC-F = 1.2 Hz), 128.51 (d, 
4
JC-F = 
1.3 Hz), 126.12 (d, 
3
JC-F = 7.9 Hz), 96.77 (d, 
1
JC-F = 264.0 Hz), 63.73, 13.91. 
19
F NMR 
(376 MHz, CDCl3) δ −114.41 (d, 
4
JF-H = 8.2 Hz). 
IR (neat) 2985, 1752, 1450, 1252, 1221, 1094, 1069, 1018, 859, 738, 691 cm
−1
. 
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HRMS (ESI
+
, m/z) Calculated for [M+H]
+
 C10H11
79
BrFO2
+
, requires 260.9921, found 
260.9938. 
 
Preparation of Monofluoro Mandelate Bromide IL (37)  
 
3-(1-Fluoro-2-methoxy-2-oxo-1-phenylethyl)-1-methyl-1H-imidazol-3-ium bromide 
(37) 
A flask was charged with ethyl 2-bromo-2-fluoro-2-phenylacetate 
(36) (0.251 g, 0.961 mmol) under N2. Whilst stirring 1-
methylimidazole (77 µL, 0.96 mmol) was added and the reaction 
was stirred for 2 days at rt. TLC confirmed reaction completion. 
The product was washed with diethyl ether (5 × 5 mL). The 
volatiles were removed via rotary evaporation and the crude 
product was purified by column chromatography (SiO2, DCM to MeOH:DCM, 1:9), 
where transesterification to the methyl ester occurred. The product was dried under 
reduced pressure to give the title compound (37) as an off-white solid (53 mg, 
0.16 mmol), 17 % yield. 
Chemical formula: C13H14BrFN2O2; Molecular weight: 329.17 g mol
−1
; mp: 
174−175 °C 
1
H NMR (400 MHz, DMSO-d6) δ 9.44 (bs, 1H), 7.72 (dd, J = 1.9, 1.9 Hz, 1H), 7.64 
(dd, J = 1.9, 1.9 Hz, 1H), 7.52–7.41 (m, 5H), 3.87 (s, 3H), 3.35 (s, 3H). 13C NMR 
(151 MHz, DMSO-d6) δ 162.12 (d, 
2
JC-F = 22.1 Hz), 137.24, 136.36 (d, 
2
JC-F = 25.7 Hz), 
129.58, 128.38, 125.83 (
3
JC-F, J = 6.8 Hz), 123.46, 121.15, 100.23 (d, 
1
JC-F = 223.2 Hz), 
40.06, 35.97. 
19
F NMR (376 MHz, DMSO-d6) δ −115.39. 
IR (neat) 3072, 3036, 1665, 1578, 1537, 1350, 1272, 1233, 1162, 1052, 1043, 749 cm
−1
. 
HRMS (ESI
+
, m/z) Calculated for [M-Br
-
]
+
 C13H14FN2O2
+
, requires 249.1034, found 
249.1048. 
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 Experimental Preparations for 1-Methylimidazolium Ester ILs 6.3
6.3.1 Alkylating Regents 
General Procedure D: Preparation of α-Bromoesters (58–60) 
 
Butyl 2-bromoacetate (58)
11
 
A flask was charged with n-butanol (6.02 g, 81.2 mmol), 
Na2CO3 (12.91 g, 121.8 mmol) and dry DCM (30 mL), 
under N2. Whilst stirring and cooling in an ice bath (0 °C) 
bromoacetyl bromide (8.5 mL, 98 mmol) was added dropwise and the reaction was 
stirred overnight at rt. TLC confirmed reaction completion. The Na2CO3 was removed 
by vacuum filtration and the organic phase was washed with saturated aqueous sodium 
bicarbonate (2 × 20 mL) and deionised water (2 × 25 mL). The organic phase was dried 
over MgSO4, filtered and the solvent removed via rotary evaporation. The product was 
dried under reduced pressure to give the title compound (58) as a colourless liquid 
(13.5 g, 69.2 mmol), 85 % yield. 
Chemical formula: C6H11BrO2; Molecular weight: 195.06 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 4.17 (t, J = 6.6 Hz, 2H), 3.83 (s, 2H), 1.70–1.58 (m, 2H), 
1.46–1.32 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 167.47, 
66.30, 30.54, 26.12, 19.12, 13.79. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
2-Ethoxyethyl 2-bromoacetate (59) 
The title compound (59) was synthesised from 2-
ethoxyethanol (8.02 g, 89.0 mmol), Na2CO3 (14.15 g, 
133.5 mmol), dry DCM (50 mL) and bromoacetyl 
bromide (9.3 mL, 0.11 mol), according to the general procedure D to give a yellow 
liquid (14.8 g, 70.1 mmol), 79 % yield. 
Chemical formula: C6H11BrO3; Molecular weight: 211.06 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 4.36–4.29 (m, 2H), 3.88 (s, 2H), 3.70–3.62 (m, 2H), 3.54 
(q, J = 7.0 Hz, 2H), 1.22 (t, J = 7.0 Hz, 3H).
 13
C NMR (101 MHz, CDCl3) δ 167.45, 
68.08, 66.87, 65.60, 26.03, 15.23. 
1
H and 
13
C NMR data are in agreement with the literature.
11
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2-Butoxyethyl 2-bromoacetate (60)
11
 
The title compound (60) was synthesised from 2-
butoxyethanol (10.02 g, 84.79 mmol), Na2CO3 
(13.48 g, 127.2 mmol), dry DCM (50 mL) and 
bromoacetyl bromide (8.9 mL, 0.10 mol), according to the general procedure D to give 
a yellow liquid (18.7 g, 78.2 mmol), 92 % yield. 
Chemical formula: C8H15BrO3; Molecular weight: 239.11 g mol
−1
 
1
H NMR (400 MHz, CDCl3) δ 4.36–4.28 (m, 2H), 3.88 (s, 2H), 3.69–3.61 (m, 2H), 3.47 
(t, J = 6.7 Hz, 2H), 1.61–1.51 (m, 2H), 1.43–1.31 (m, 2H), 0.92 (t, J = 7.4 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 167.44, 71.38, 68.28, 65.58, 31.75, 26.02, 19.37, 14.05. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
6.3.2 Bromide ILs 
General Procedure E: Preparation of Bromide ILs (46–49) 
 
3-(2-Butoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium bromide (46)
11
 
A flask was charged with butyl 2-bromoacetate (58) 
(13.00 g, 66.65 mmol) and diethyl ether (30 mL), 
under N2. Whilst stirring 1-methylimidazole 
(4.85 mL, 60.8 mmol) was added dropwise and the 
reaction was stirred for 2 days at rt. TLC confirmed reaction completion. Diethyl ether 
was decanted and the product was washed with diethyl ether (5 × 25 mL). Residual 
volatiles were removed via rotary evaporation and the product was dried under reduced 
pressure to give the title compound (46) as a colourless viscous liquid (16.73 g, 
60.36 mmol), 99 % yield. 
Chemical formula: C10H17BrN2O2; Molecular weight: 277.16 g mol
−1
;
 
Tdec: 161 °C
 
1
H NMR (400 MHz, CDCl3) δ 10.04 (bs, 1H), 7.66 (dd, J = 1.8, 1.8 Hz, 1H), 7.58 (dd,  
J = 1.8, 1.8 Hz, 1H), 5.42 (s, 2H), 4.13 (t, J = 6.8 Hz, 2H), 4.04 (s, 3H), 1.64 – 1.51 (m, 
2H), 1.37 – 1.25 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 
166.22, 138.62, 123.84, 122.98, 66.91, 50.38, 37.00, 30.42, 19.06, 13.75. 
1
H and 
13
C NMR data are in agreement with the literature.
11
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3-[2-(2-Ethoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium bromide (47)
11
 
The title compound (47) was synthesised from 2-
ethoxyethyl 2-bromoacetate (59) (10.51 g, 
49.80 mmol), diethyl ether (20 mL) and 1-
methylimidazole (3.65 mL, 45.8 mmol), 
according to the general procedure E to give a brown solid (13.19 g, 44.99 mmol), 98 % 
yield. 
Chemical formula: C10H17BrN2O3; Molecular weight: 293.16 g mol
−1
; mp: 36−38 °C; 
Tdec: 157 °C 
1
H NMR (400 MHz, CDCl3) δ 10.16 (bs, 1H), 7.61 (dd, J = 1.8, 1.8 Hz, 1H), 7.48 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.51 (s, 2H), 4.37–4.30 (m, 2H), 4.07 (s, 3H), 3.69–3.61 (m, 2H), 
3.52 (q, J = 7.0 Hz, 2H), 1.19 (t, J = 7.0 Hz, 3H).
 13
C NMR (101 MHz, CDCl3) δ 
166.26, 138.99, 123.74, 122.78, 67.83, 66.87, 66.00, 50.42, 37.03, 15.23. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-[2-(2-Butoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium bromide (48)
11
 
The title compound (48) was synthesised 
from 2-butoxyethyl 2-bromoacetate (60) 
(12.98 g, 54.28 mmol), diethyl ether 
(30 mL) and 1-methylimidazole (3.95 mL, 
49.5 mmol), according to the general procedure E to give a white solid (15.62 g, 
48.63 mmol), 98 % yield. 
Chemical formula: C12H21BrN2O3; Molecular weight: 321.22 g mol
−1
;
 
mp: 40−42 °C; 
Tdec: 162 °C 
1
H NMR (400 MHz, CDCl3) δ 10.11 (bs, 1H), 7.63 (dd, J = 1.8, 1.8 Hz, 1H), 7.55 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.47 (s, 2H), 4.33–4.27 (m, 2H), 4.06 (s, 3H), 3.64–3.58 (m, 2H), 
3.42 (t, J = 6.7 Hz, 2H), 1.55–1.45 (m, 2H), 1.37–1.25 (m, 2H), 0.87 (t, J = 7.3 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 166.29, 138.49, 123.84, 123.08, 71.30, 68.01, 65.85, 
50.37, 37.02, 31.64, 19.29, 14.01. 
1
H and 
13
C NMR data are in agreement with the literature.
11
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3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium bromide 
(49) 
The title compound (49)            
was synthesised from 2-(2-
butoxyethoxy)ethyl2-bromoacetate 
(61) (19.01 g, 67.14 mmol), diethyl ether (35 mL) and 1-methylimidazole (5.24 mL, 
65.8 mmol) according to the general procedure E to give a white solid (23.13 g, 
63.32 mmol), 96 % yield. 
Chemical Formula: C14H25BrN2O4 Molecular Weight: 365.27 g mol
−1
 mp: 68−70 °C 
Tdec: 155 °C 
1
H NMR (400 MHz, CDCl3) δ 10.12 (bs, 1H), 7.65 (dd, J = 1.8, 1.8 Hz, 1H), 7.48 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.50 (s, 2H), 4.38–4.30 (m, 2H), 4.06 (s, 3H), 3.75–3.68 (m, 2H), 
3.65–3.59 (m, 2H), 3.59–3.53 (m, 2H), 3.42 (t, J = 6.8 Hz, 2H), 1.58–1.46 (m, 2H), 
1.39–1.25 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 166.29, 
138.50, 124.00, 122.98, 71.29, 70.69, 70.03, 68.62, 65.74, 50.33, 36.99, 31.71, 19.33, 
14.03. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
6.3.3 Bistriflimide ILs 
General Procedure F: Preparation of Bistriflimide ILs (50–53) 
 
3-(2-Butoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (50)
11
 
A flask was charged with 3-(2-             
butoxy-2-oxoethyl) -1-methyl-1H-imidazol-
3-ium bromide (46) (49.68 g, 179.2 mmol) 
and deionised water (100 mL). Whilst stirring 
LiNTf2 (56.56 g, 197.0 mmol) was added in 
one portion and the reaction was stirred for 2 days at rt. The water was decanted and the 
product was washed with deionised water (5 × 50 mL). The volatiles were removed via 
rotary evaporation and the product was dried under reduced pressure to give the title 
compound (50) as a light yellow liquid (76.28 g, 159.8 mmol), 89 % yield. 
Chemical formula: C12H17F6N3O6S2; Molecular weight: 477.39 g mol
−1
;
 
Tdec: 284 °C 
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1
H NMR (400 MHz, CDCl3) δ 8.74 (bs, 1H), 7.38 (dd, J = 1.8, 1.8 Hz, 1H), 7.33 (dd, 
J = 1.8, 1.8 Hz, 1H), 4.98 (s, 2H), 4.19 (t, J = 6.7 Hz, 2H), 3.92 (s, 3H), 1.68–1.57 (m, 
2H), 1.42–1.30 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 165.89, 137.53, 123.98, 123.38, 119.79 (q, 
1
JC-F = 
320.9 Hz), 66.95, 49.94, 36.53, 30.30, 18.94, 13.61. 
19
F NMR (376 MHz, CDCl3) δ −79.22. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-[2-(2-Ethoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (51)
11
 
The title compound (51) was synthesised 
from 3-[2-(2-ethoxyethoxy)-2-oxoethyl]-1-
methyl-1H-imidazol-3-ium bromide (47) 
(5.87 g, 20.0 mmol), deionised water (20 mL) 
and LiNTf2 (6.32 g, 22.0 mmol) ), according 
to the general procedure F. Trituration was carried out with deionised water (5 × 10 mL) 
to give a colourless liquid (8.19 g, 16.6 mmol), 83 % yield. 
Chemical formula: C12H17F6N3O7S2; Molecular weight: 493.39 g mol
−1 
Tdec: 273 °C 
1
H NMR (400 MHz, CDCl3) δ 8.81 (bs, 1H), 7.36 (dd, J = 1.8, 1.8 Hz, 1H), 7.31 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.04 (s, 2H), 4.39–4.33 (m, 2H), 3.95 (s, 3H), 3.70–3.61 (m, 2H), 
3.53 (q, J = 7.0 Hz, 2H), 1.20 (t, J = 7.0 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 
165.88, 137.78, 123.90, 123.34, 119.81 (q, 
1
JC-F = 320.9 Hz), 67.74, 66.80, 66.09, 
50.05, 36.69, 15.13. 
19
F NMR (376 MHz, CDCl3) δ −79.08. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-[2-(2-Butoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium  
bis(trifluoromethylsulfonyl)imide (52)
11
 
The title compound (52) was synthesised 
from 3-[2-(2-butoxyethoxy)-2-oxoethyl]-1-
methyl-1H-imidazol-3-ium bromide (48) 
(6.52 g, 20.3 mmol), deionised water 
(20 mL) and LiNTf2 (6.41 g, 22.3 mmol), 
according to the general procedure F. Trituration was carried out with deionised water 
(5 × 10 mL) to give a colourless liquid (9.89 g, 19.0 mmol), 94 % yield. 
Chemical formula: C14H21F6N3O7S2; Molecular weight: 521.45 g mol
−1
;
 
Tdec: 279 °C 
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1
H NMR (400 MHz, CDCl3) δ 8.81 (bs, 1H), 7.36 (dd, J = 1.8, 1.8 Hz, 1H), 7.32 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.03 (s, 2H), 4.39–4.32 (m, 2H), 3.95 (s, 3H), 3.69–3.61 (m, 2H), 
3.46 (t, J = 6.7 Hz, 2H), 1.60–1.49 (m, 2H), 1.42–1.29 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 165.83, 137.75, 123.89, 123.37, 119.81 (q, 
1
JC-F = 
321.0 Hz), 71.31, 67.94, 66.06, 50.04, 36.68, 31.67, 19.30, 13.98. 
19
F NMR (376 MHz, 
CDCl3) δ −79.08. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium 
bis(trifluoromethylsulfonyl)imide (53)
11
 
The title compound (53)          
was synthesised from 3-{2-[2-        
(2-butoxy-ethoxy)ethoxy]-2-oxo 
ethyl} -1-methyl-1H-imidazol-3-
ium bromide (49) (6.56 g, 
18.0 mmol), deionised water (20 mL) and LiNTf2 (5.69 g, 19.8 mmol), according to the 
general procedure F. Trituration was carried out with deionised water (5 × 10 mL) to 
give a colourless liquid (9.05 g, 16.0 mmol), 89 % yield. 
Chemical formula: C16H25F6N3O8S2; Molecular weight: 565.50 g mol
−1
;
 
Tdec: 253 °C 
1
H NMR (400 MHz, CDCl3) δ 8.89 (bs, 1H), 7.37 (dd, J = 1.8, 1.8 Hz, 1H), 7.29 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.06 (s, 2H), 4.41–4.35 (m, 2H), 3.98 (s, 3H), 3.77–3.71 (m, 2H), 
3.66–3.62 (m, 2H), 3.61–3.56 (m, 2H), 3.45 (t, J = 6.8 Hz, 2H), 1.60–1.50 (m, 2H), 
1.41–1.29 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 165.76, 
138.25, 123.86, 123.11, 119.86 (q, 
1
JC-F = 321.4 Hz), 77.37, 70.76, 70.10, 68.55, 66.08, 
50.22, 36.86, 31.80, 19.39, 14.05. 19F NMR (376 MHz, CDCl3) δ −79.00. 
1
H and 
13
C NMR data are in agreement with the literature.
11
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6.3.4 Octyl Sulfate ILs 
General Procedure G: Preparation of Octyl Sulfate ILs (54–57) 
 
3-(2-Butoxy-2-oxoethyl)-1-methyl-1H-imidazol-3-ium octyl sulfate (54)
11
 
A flask was charged            
with 3-(2-butoxy-2-oxoethyl) 
1-methyl-1H-imidazol - 3-ium 
bromide (46) (7.68 g, 
27.7 mmol) and deionised water (20 mL). Whilst stirring NaOctSO4 (6.68 g, 29.1 mmol) 
was added in one portion and the reaction was stirred overnight at rt. The water was 
removed via rotary evaporation and the IL was dissolved in DCM (20 mL) and washed 
with deionised water (3 × 5 mL). The volatiles were removed via rotary evaporation and 
the product was dried under reduced pressure at 50 °C for 2 days to give the title 
compound (54) as a colourless grease (10.31 g, 25.36 mmol), 92 % yield. 
Chemical formula: C18H34N2O6S; Molecular weight: 406.54 g mol
− 
;
 
Tdec: 159 °C 
1
H NMR (400 MHz, CDCl3) δ 9.37 (bs, 1H), 7.54 (dd, J = 1.7, 1.7 Hz, 1H), 7.48 (dd, J 
= 1.7, 1.7 Hz, 1H), 5.17 (s, 2H), 4.13 (t, J = 6.8 Hz, 2H), 4.00 – 3.86 (m, 5H), 1.66–1.51 
(m, 4H), 1.39–1.10 (m, 12H), 0.87 (t, J = 7.4 Hz, 3H), 0.81 (t, J = 6.8 Hz, 3H). 13C 
NMR (101 MHz, CDCl3) δ 166.39, 139.62, 123.51, 122.80, 68.01, 66.94, 50.12, 36.79, 
31.96, 30.47, 29.65, 29.50, 29.40, 26.01, 22.80, 19.10, 14.26, 13.78. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-[2-(2-Ethoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium octyl sulfate (55)
11
 
The title compound (55)      
was synthesised from 3-[2-  
(2-ethoxyethoxy)-2-oxoethyl] 
-1-methyl-1H-imidazol-3-ium                    
bromide (47) (7.07 g, 24.1 mmol), deionised water (20 mL) and NaOctSO4 (5.88 g, 
25.3 mmol), according to the general procedure G to give a light yellow grease (8.58 g, 
20.3 mmol), 84 % yield. 
Chemical formula: C18H34N2O7S; Molecular weight: 422.54 g mol
−1
;
 
Tdec: 157 °C 
1
H NMR (400 MHz, CDCl3) δ 9.49 (bs, 1H), 7.49 (dd, J = 1.8, 1.8 Hz, 1H), 7.40 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.25 (s, 2H), 4.37–4.30 (m, 2H), 3.99 (s, 3H), 3.99 (t, J = 6.9 Hz, 
2H), 3.68–3.63 (m, 2H), 3.52 (q, J = 7.0 Hz, 2H), 1.70–1.57 (m, 2H), 1.40–1.21 (m, 
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10H), 1.19 (t, J = 7.0 Hz, 3H), 0.85 (t, J = 6.7 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 
166.56, 138.97, 123.84, 123.14, 67.97, 67.85, 66.79, 65.82, 50.04, 36.71, 31.93, 29.61, 
29.47, 29.37, 25.98, 22.77, 15.20, 14.23. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-[2-(2-Butoxyethoxy)-2-oxoethyl]-1-methyl-1H-imidazol-3-ium octyl sulfate (56)
11
 
The title compound (56)     
was synthesised from 3-[2-   
(2-butoxyethoxy)-2-oxoethyl] 
-1-methyl-1H-imidazol-3-ium 
octyl bromide (48) (7.48 g, 23.3 mmol), deionised water (20 mL) and NaOctSO4 
(5.68 g, 24.5 mmol), according to the general procedure G to give a colourless liquid 
(7.82 g, 17.4 mmol), 75 % yield. 
Chemical formula: C20H38N2O7S; Molecular weight: 450.59 g mol
−1
; Tdec: 182 °C 
1
H NMR (400 MHz, CDCl3) δ 9.65 (bs, 1H), 7.38 (dd, J = 1.8, 1.8 Hz, 1H), 7.29 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.24 (s, 2H), 4.39–4.31 (m, 2H), 4.02 (t, J = 6.9 Hz, 2H), 4.01 (s, 
3H), 3.69–3.62 (m, 2H), 3.46 (t, J = 6.7 Hz, 2H), 1.71–1.61 (m, 2H), 1.60–1.51 (m, 2H), 
1.43–1.17 (m, 12H), 0.92 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 6.7 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ 166.39, 139.57, 123.57, 122.87, 71.38, 68.05, 68.00, 65.93, 50.10, 
36.79, 31.96, 31.73, 29.65, 29.50, 29.40, 26.01, 22.80, 19.37, 14.26, 14.06. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 
3-{2-[2-(2-Butoxyethoxy)ethoxy]-2-oxoethyl}-1-methyl-1H-imidazol-3-ium octyl 
sulfate (57)
11
 
The title compound (57)    
was synthesised from 3{2-    
[2-(2-butoxyethoxy)ethoxy]-
2-oxoethyl}-1-methyl -1H -
imidazol-3-ium bromide (49) (7.54 g, 20.6 mmol), deionised water (20 mL) and LiNTf2 
(5.04 g, 21.7 mmol), according to the general procedure G. The reaction was stirred for 
2 days to give a light yellow gel (10.08 g, 20.38 mmol), 99 % yield. 
Chemical formula: C22H42N2O8S; Molecular weight: 494.64 g mol
−1
; Tdec: 159 °C 
1
H NMR (400 MHz, CDCl3) δ 9.64 (bs, 1H), 7.48 (dd, J = 1.8, 1.8 Hz, 1H), 7.33 (dd, 
J = 1.8, 1.8 Hz, 1H), 5.27 (s, 2H), 4.39–4.33 (m, 2H), 4.04–3.98 (m, 5H), 3.76–3.70 (m, 
2H), 3.67–3.61 (m, 2H), 3.61–3.55 (m, 2H), 3.45 (t, J = 6.8 Hz, 2H), 1.70–1.60 (m, 2H), 
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1.60–1.50 (m, 2H), 1.42–1.15 (m, 12H), 0.90 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 6.7 Hz, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 166.53, 138.75, 123.97, 123.17, 71.30, 70.65, 
70.02, 68.65, 67.99, 65.64, 49.99, 36.69, 31.90, 31.70, 29.57, 29.43, 29.35, 25.95, 
22.74, 19.33, 14.21, 14.03. 
1
H and 
13
C NMR data are in agreement with the literature.
11
 
 Experimental Preparations for PLLA and PLLA/IL Films 6.4
PLLA was mixed with IL (0, 10, 20 and 30 wt%) (Table 5.1) in a laboratory scale co-
rotating twin-screw extruder under N2 at 200 °C and 100 rpm for approximately 7 min. 
Films with a thickness of 0.5 ± 0.05 mm were prepared by melt compressing the 
extruded PLLA/IL blends of various weight ratios at 200 °C, under ca 5 kN force in a 
hot press followed by quenching to room temperature in a cold press. To ensure 
consistency in the film thickness a rectangular steel spacer (0.5 mm) was used. 
  
Table 6.1 Mass of IL and PLLA used to synthesis PLLA/IL films with 0, 10, 20 and 
30 wt% IL. 
IL 
(wt%) 
Mass (g) 
PLLA IL 
0 8.0  0.0 
10 7.2  0.8 
20 6.4 1.6 
30 5.6 2.4 
 Antimicrobial Screening Test Procedures 6.5
6.5.1 Antibacterial Activity – DCU 
Mueller-Hinton broth was purchased from Oxoid. Five bacterial strains were used in 
this study: the Gram-positive bacterium Bacillus subtilis DSMZ 10 (B. subtilis) and the 
Gram-negative bacteria Escherichia coli DSMZ 498 (E. coli), Pseudomonas fluorescens 
DSMZ 270 50090 (P. fluorescence), Pseudomonas putida CP1 (P. putida CP1) and 
Pseudomonas putida KT2440 (P. putida KT2440). All strains were purchased at DSMZ 
(German Collection of Microorganisms and Cell Cultures).  
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IC50 values for the compounds were determined using a modification of the broth 
microdilution method described by Amsterdam.
12
 Strains were grown in nutrient broth 
overnight, washed with 0.01 M sodium phosphate buffer (pH 7) and the cell number 
adjusted to give an optical density reading of 0.07 at 660 nm. The antimicrobial activity 
of the ILs was tested in 96 well round bottom microplates. 180 μL of Mueller-Hinton 
broth was pipetted into column 1 of the wells and 100 μL into the other wells. 20 μL of 
the chemical solution was transferred into column 1 giving a maximum concentration of 
200 mM. 100 μL of the solution from column 1 was then transferred to the next column 
and mixed. The procedure was repeated to give a series of two-fold dilutions. Each well 
was inoculated with 5 μL of bacterial culture. Wells containing medium only were used 
as blanks and wells containing medium and culture only were used as positive controls. 
All the toxicity tests were carried out in triplicate. The microplates were incubated 
overnight at 30 °C. The presence or absence of growth was determined by measuring 
the optical density of the wells at a wavelength of 405 nm using a plate reader. The IC50 
values were determined as the concentration or range of concentrations that caused a 
50 % reduction in growth. 
6.5.2 Antibacterial Activity – Charles University 
In vitro antibacterial activities of the compounds were evaluated on a panel of three 
ATCC strains (Staphylococcus aureus ATTC 6538, Escherichia coli ATTC 8739, 
Pseudomonas aeruginosa ATTC 9027) and five clinical isolates (Staphylococcus 
aureus MRSA HK5996/08, Staphylococcus epidermidis HK6966/08, Enterococcus sp. 
HK14365/08, Klebsiella pneumoniae HK11750/08, Klebsiella pneumoniae ESBL 
HK14368/08) from the collection of bacterial strains deposited at the Department of 
Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec 
Králové, Czech Republic. The abovementioned ATCC strains also served as the quality 
control strains. All the isolates were maintained on Mueller-Hinton dextrose agar prior 
to being tested.  
 
Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final 
concentration did not exceed 2 %. Mueller-Hinton agar (MH, HiMedia, Čadersky-
Envitek, Czech Republic) buffered to pH 7.4 (±0.2) was used as the test medium. The 
wells of the microdilution tray contained 200 μL of the Mueller-Hinton medium with 2-
fold serial dilutions of the compounds (2000 or 1000 to 0.24 μmol L−1) and 10 μL of 
inoculum suspension. Inoculum in MH medium was prepared to give a final 
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concentration of 0.5 McFarland scale (1.5 × 10
8
 cfu mL
−1
). The trays were incubated at 
35 °C and MICs were read visually after 24 h and 48 h. The MICs were defined as 95 % 
inhibition (IC95) of the control growth. MICs were determined twice and in duplicate. 
The deviations from the usually obtained values were no higher than the nearest 
concentration value up and down the dilution scale. 
6.5.3 Antifungal Activity – Charles University 
In vitro antifungal activities of the compounds were evaluated on a panel of four ATCC 
strains (Candida albicans ATCC 44859, Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) and eight clinical isolates of 
fungi; five yeasts (Candida krusei E28, Candida tropicalis 156, Candida glabrata 20/I, 
Candida lusitaniae 2446/I, Trichosporon asahii 1188) and three filamentous fungi 
(Aspergillus fumigatus 231, Absidia corymbifera 272, Trichophyton mentagrophytes 
445) from the collection of fungal strains deposited at the Department of Biological and 
Medical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, Czech 
Republic. Three of the above ATCC strains (Candida albicans ATCC 90028, Candida 
parapsilosis ATCC 22019, Candida krusei ATCC 6258) also served as the quality 
control strains. All the isolates were maintained on Sabouraud dextrose agar prior to 
being tested. Minimum inhibitory concentrations (MICs) were determined by modified 
CLSI standard of the microdilution format of the M27-A3 and M38-A2 documents for 
yeasts and filamentous fungi respectively.
13,14
   
 
Dimethyl sulfoxide (100 %) served as a diluent for all compounds; the final 
concentration did not exceed 2 %. RPMI 1640 (Sevapharma, Prague) medium 
supplemented with L-glutamine and buffered with 0.165 M morpholinepropanesulfonic 
acid (Serva) to pH 7.0 by 10 N NaOH was used as the test medium. The wells of the 
microdilution tray contained 200 μL of the RPMI 1640 medium with 2-fold serial 
dilutions of the compounds (2000 or 1000 to 0.24 μmol L−1) and 10 μL of inoculum 
suspension. Fungal inoculum in RPMI 1640 was prepared to give a final concentration 
of 5 × 10
3
 ± 0.2 cfu mL
−1
. The trays were incubated at 35 °C and MICs were read 
visually for filamentous fungi and photometrically for yeasts at an absorbance at 540 
nm after 24 h and 48 h. The MIC values for the dermatophytic strain (T. 
mentagrophytes) were determined after 72 h and 120 h. For all other strains MIC values 
were evaluated after 24 and 48 h. The MICs were defined as 50 % inhibition (IC50) of 
the control growth for yeasts or 80 % inhibition (IC80) of the growth of control for 
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filamentous fungi. MICs were determined twice and in duplicate. The deviations from 
the usually obtained values were no higher than the nearest concentration value up and 
down the dilution scale. 
 Closed Bottle Biodegradation Test Procedure   6.6
The CBT measures aerobic biodegradability and is one of six test methods described in 
the OECD Guidelines for Testing of Chemicals
15
 used to evaluate readily 
biodegradability of organic compounds. The test was undertaken at 20 ± 1 °C in the 
dark in the laboratories of the Institute of Sustainable and Environmental Chemistry at 
Leuphana University Lüneburg as described in details elsewhere.
16
 It consisted of four 
different test series all run in duplicate. The blank series contained only mineral medium 
and inoculum. The test series contained additionally the IL as the only organic carbon 
available for the microorganisms during the test. The quality control contained, in 
addition to the blank, the readily biodegradable compound sodium acetate, which was 
used to monitor the activity of the microorganisms. The toxicity control contained both 
the IL and the sodium acetate in addition to the mineral medium ad inoculum. The 
amount of IL and sodium acetate corresponded to a theoretical oxygen demand (ThOD) 
of 5 mgL
−1
. The same mineral salt solution was used for all the test vessels with two 
drops of inoculum obtained from the effluent of the municipal sewage treatment plant in 
Lüneburg, Abwasser, Grünund Lüneburger Service GmbH, Germany. 
 
According to the guidelines, for the test to be valid the reference compound sodium 
acetate needs to degrade by at least 60 % within 14 days. Toxicity towards the test 
microorganisms was evaluated by comparing the oxygen consumption of the toxicity 
control to the predicted level of oxygen consumption, calculated from the oxygen 
consumption of the quality control and the test control. A compound is labelled toxic if 
the difference between the predicted oxygen consumption and the measured oxygen 
consumption exceeds 25 %.
15
  
 
The biochemical oxygen demand (BOD) was measured in accordance with international 
standard methods
17
 using sensor spots in the bottles and an oxygen electrode (Oxi 196 
with EO 196-1.5 WTW Weilheim, Germany)
18
 at a day 0, 0 (after 3 h), 1, 7, 14, 21 and 
28. 
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Appendices 
Appendix A – HMBC Spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A1 HMBC spectrum of IL 22 in CDCl3 showing the presence of the multiple bond 
correlation between H10 to C4, and the absence of the correlation between H12 and C4.  
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A2 Full HMBC spectrum of IL 22 in CDCl3.  
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A3 HMBC spectrum of IL 23 in CDCl3 showing the presence of the multiple bond 
correlation between H10 to C4, and the absence of the correlation between H12 and C4.  
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A4 Full HMBC spectrum of IL 23 in CDCl3. 
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Appendix B – Antimicrobial Screening Data 
B1 Antibacterial screening results for ILs 8–11 (MIC, IC95).
1,2
 
Strain Time (h) 
IL MIC (µM) 
8–11 
SA 
24h >2000 
48h >2000 
MRSA 
24h >2000 
48h >2000 
SE 
24h >2000 
48h >2000 
EF 
24h >2000 
48h >2000 
EC 
24h >2000 
48h >2000 
KP 
24h >2000 
48h >2000 
KP-E 
24h >2000 
48h >2000 
PA 
24h >2000 
48h >2000 
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B2 Antifungal screening results for ILs 8–11 (MIC, IC80 or IC50).
1,2
 
Strain Time (h) 
IL MIC (µM)
a
 
8–10 11 
CA1 
24h >2000 2000 
48h >2000 2000 
CA2 
24h >2000 >2000 
48h >2000 >2000 
CP 
24h >2000 >2000 
48h >2000 >2000 
CK1 
24h >2000 >2000 
48h >2000 >2000 
CK2 
24h >2000 >2000 
48h >2000 >2000 
CT 
24h >2000 2000 
48h >2000 >2000 
CG 
24h >2000 >2000 
48h >2000 >2000 
CL 
24h >2000 2000 
48h >2000 >2000 
TA 
24h >2000 >2000 
48h >2000 >2000 
AF 
24h >2000 >2000 
48h >2000 >2000 
AC 
24h >2000 >2000 
48h >2000 >2000 
TM 
72h >2000 >2000 
120h >2000 >2000 
a
IC50 values were assessed for AF, AC and TM and IC80 for all other strains. 
References 
1. M. Ghavre, PhD Thesis, Dublin City University, 2012. 
2. M. Gurbisz, PhD Thesis, Dublin City University, 2012. 
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Appendix C – TGA Curves  
 
C1 TGA curve for IL 46. 
 
 
C2 TGA curve for IL 47. 
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C3 TGA curve for IL 48. 
 
 
C4 TGA curve for IL 49. 
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C5 TGA curve for IL 50. 
 
 
C6 TGA curve for IL 51. 
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C7 TGA curve for IL 52. 
 
 
C8 TGA curve for IL 53. 
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C9 TGA curve for IL 54.  
 
 
C10 TGA curve for IL 55. 
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C11 TGA curve for IL 56. 
 
 
C12 TGA curve for IL 57. 
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C13 TGA curve for PLLA. 
 
 
C14 TGA curve for PLLA/IL52 with 20 wt% IL. 
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Appendix D – Tensile Testing Graphs  
 
Appendix D1 Elongation at break for PLLA/IL50 with 20 and 30 wt% IL. 
 
  
Appendix D2 Elongation at break for PLLA/IL51 with 20 and 30 wt% IL. 
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Appendix D3 Elongation at break for PLLA/IL52 with 20 and 30 wt% IL. 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D4 Elongation at break for PLLA/IL53 with 20 and 30 wt% IL. 
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Appendix D5 Young’s modulus for PLLA/IL50 with 20 and 30 wt% IL. 
 
 
Appendix D6 Young’s modulus for PLLA/IL51 with 20 and 30 wt% IL. 
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Appendix D7 Young’s modulus for PLLA/IL52 with 20 and 30 wt% IL. 
 
 
Appendix D8 Young’s modulus for PLLA/IL53 with 20 and 30 wt% IL. 
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Appendix D9 Tensile strength for PLLA/IL50 with 20 and 30 wt% IL. 
 
 
Appendix D10 Tensile strength for PLLA/IL51 with 20 and 30 wt% IL. 
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Appendix D11 Tensile strength for PLLA/IL52 with 20 and 30 wt% IL. 
 
 
Appendix D12 Tensile strength for PLLA/IL53 with 20 and 30 wt% IL. 
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Appendix E – DSC Traces  
  
Appendix E1 DSC trace for PLLA. 
 
 
Appendix E2 DSC trace for PLLA/IL50. 
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Appendix E3 DSC trace for PLLA/IL51. 
 
 
Appendix E4 DSC trace for PLLA/IL52. 
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Appendix E5 DSC trace for PLLA/IL53. 
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Appendix F – High Temperature Dielectric Data  
Appendix F1 Dielectric properties of mandelic acid IL 20 measured at 20–120 °C and 
910 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 2.16 0.00 0.00 
30 2.41 0.01 0.00 
35 2.53 0.00 0.00 
40 2.64 0.00 0.00 
45 2.74 0.00 0.00 
50 2.83 0.01 0.00 
55 2.90 0.00 0.00 
60 2.95 0.01 0.00 
65 3.00 0.00 0.00 
70 3.03 0.00 0.00 
75 3.07 0.01 0.00 
80 3.12 0.02 0.01 
85 3.67 0.18 0.05 
90 3.87 0.27 0.07 
95 3.94 0.33 0.08 
100 4.01 0.40 0.10 
105 4.07 0.48 0.12 
110 4.08 0.55 0.13 
115 4.15 0.67 0.16 
120 4.05 0.75 0.18 
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Appendix F2 Dielectric properties of mandelic acid IL 20 measured at 20–120 °C and 
2470 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 2.20 0.00 0.00 
30 2.30 0.01 0.00 
35 2.34 0.00 0.00 
40 2.39 0.00 0.00 
45 2.43 0.00 0.00 
50 2.46 0.01 0.00 
55 2.50 0.00 0.00 
60 2.51 0.01 0.00 
65 2.54 0.00 0.00 
70 2.56 0.00 0.00 
75 2.58 0.01 0.00 
80 2.62 0.02 0.01 
85 3.10 0.18 0.04 
90 3.27 0.27 0.05 
95 3.31 0.33 0.06 
100 3.36 0.40 0.07 
105 3.40 0.48 0.08 
110 3.40 0.55 0.09 
115 3.42 0.67 0.10 
120 3.31 0.75 0.12 
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Appendix F3 Dielectric properties of mandelic acid IL 23 measured at 20–105 °C and 
910 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 2.25 0.00 0.00 
25 2.26 0.00 0.00 
30 2.23 0.00 0.00 
35 2.22 0.00 0.00 
40 2.20 0.00 0.00 
45 2.14 0.00 0.00 
50 2.00 0.00 0.00 
55 1.87 0.00 0.00 
60 1.77 0.00 0.00 
65 1.67 0.00 0.00 
70 1.61 0.00 0.00 
75 1.55 0.00 0.00 
80 1.50 0.01 0.01 
85 1.49 0.03 0.02 
90 1.83 0.22 0.12 
95 1.07 0.27 0.25 
100 1.44 0.37 0.26 
105 1.37 0.34 0.25 
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Appendix F4 Dielectric properties of mandelic acid IL 23 measured at 20–105 °C and 
2470 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 2.31 0.00 0.00 
25 2.31 0.00 0.00 
30 2.31 0.00 0.00 
35 2.30 0.00 0.00 
40 2.30 0.00 0.00 
45 2.28 0.00 0.00 
50 2.24 0.00 0.00 
55 2.19 0.00 0.00 
60 2.16 0.00 0.00 
65 2.13 0.00 0.00 
70 2.10 0.00 0.00 
75 2.09 0.01 0.00 
80 2.08 0.01 0.00 
85 2.09 0.02 0.01 
90 2.36 0.14 0.06 
95 1.59 0.16 0.10 
100 1.93 0.24 0.12 
105 1.91 0.23 0.12 
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Appendix F5 Dielectric properties of mandelic acid IL 50 measured at 20–120 °C and 
910 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 4.40 1.32 0.30 
25 4.92 2.19 0.45 
30 5.12 2.73 0.53 
35 5.53 3.18 0.57 
40 6.08 3.66 0.60 
45 6.73 4.10 0.61 
50 7.44 4.48 0.60 
55 8.20 4.83 0.59 
60 8.93 5.20 0.58 
65 9.63 5.40 0.56 
70 10.25 5.48 0.53 
75 10.94 5.57 0.51 
80 11.55 5.71 0.49 
85 12.18 5.71 0.47 
90 12.79 5.60 0.44 
95 13.32 5.61 0.42 
100 13.80 5.43 0.39 
105 14.34 5.37 0.37 
110 14.84 5.21 0.35 
115 15.24 5.10 0.33 
120 15.64 4.93 0.32 
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Appendix F6 Dielectric properties of mandelic acid IL 50 measured at 20–120 °C and 
2470 MHz, where 𝜺′ is the dielectric constant, 𝜺′′ is the dielectric loss and tan 𝜹 is the 
loss tangent. 
Temperature (°C) 𝜺′ 𝜺′′ tan 𝜹 
20 4.50 0.96 0.21 
25 4.90 1.46 0.30 
30 5.06 1.78 0.35 
35 5.28 2.06 0.39 
40 5.55 2.34 0.42 
45 5.84 2.66 0.45 
50 6.15 2.92 0.47 
55 6.48 3.26 0.50 
60 6.79 3.50 0.52 
65 7.11 3.80 0.53 
70 7.44 4.13 0.56 
75 7.79 4.37 0.56 
80 8.10 4.65 0.57 
85 8.51 4.92 0.58 
90 8.87 5.13 0.58 
95 9.27 5.45 0.59 
100 9.68 5.60 0.58 
105 10.12 5.79 0.57 
110 10.62 6.05 0.57 
115 11.04 6.35 0.58 
120 11.55 6.51 0.56 
 
